ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000289.1|A40926_2 # 1373 # 2578 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.747	BGC0000289.1|A40926_2 	1373	2578	-	Loose	500	26.1794	TRU-1	37.78	3004450	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	TRU beta-lactamase	GTGCGGGAGCGTCCCGGCAGCGGGCCCGAGCGTCCCGGCAGCGGGCCCGAGCGTCCCGGCAGCGGGCCCGAGCGTCCCGGCAGCGGGCCCGAGCGTCCTGACAGCGTGCACGAAAGTCCCGTCTGCCTCGCCGAGTACGAGGAGATCGCCGCCAAGGTCCTCCCCGCCGACGTCCGGGACTTCATCGACGGCGGGAGCGGCCGCGAGCAGACCCTCCGTGCGAATCGGGCCGCCTTCGACCGGGTGTTCCTGGTGCCGCGGGTGCTCCAGGACGTGTCGGCGTGCTCCACCCGTGCGACGCTGCTGGGCCACCCCGCGACGATGCCGGTGGCGGTGGCCCCCGTCGCCTACCACCGGCTCGTGCATCCCGACGGTGAGCTGGCGACGGCCCGGGCGGCGCGGGACGCCGGGGTCCCGTTCACCGTCAGCACCTTGAGCAGCGTCCCGGTGGAGGACGTCACCGCCCTGGGGGGACACGTCTGGTTCCAGCTCTACTGCCTTCGCGAGCACGCCGCCACCCTCGGCCTGATCCGCCGGGCCGAGGACGCGGGGTGCCGGGCGTTGATGCTCACGCTCGATGTGCCGTGGATGGGCCGCAGGCCACGTGACATCCGCAACCGGTTCCGCCTGCCCCCGCACGTGCGGCCCGTGCACCTGACGGCGAACTCCGGGACCGAGGCTCATCGGGGTGCCTCCGGCGGCTCCGCGCTGGCGGCGCACACGGCCATGGAGCTCTCCGCCGCGGTGGACTGGTCGTACCTCGAGACCCTCCGGGCCGCCAGCGGGCTCCCGCTGGTGGTCAAGGGCATTCTGCACCCCGAGGACGCCCGCCGCGCCGCGGACCTCGGCATCGACGGCATCGTGGTCTCCAACCACGGCGGACGTCAGCTCGACGGCGCCGTGGCCAGTCTCGACGCGCTGCCGGGGGTGGCGGAGAGCGTCGGGGGCCGCTGCGAGATCATGCTCGATGGTGGCGTCCGGTCGGGAGCCGACGTCCTCAAGGCGCTGGCGCTCGGGGCGTCGGGTGTGCTCGTCGGACGCCCCGTGATCTGGGGTCTGGCCGCGGACGGCGAACGGGGGGTCCGTACGGTGCTCGGCCTCCTGGGTGCCGAGATCGAGGACGGGCTCGGCCTGGCAGGCTGCGGCGACGTCGCCGCAGCCCAGGCACTCAGGACGACCCGCCCCGGCGCGGGGTTCGTCTCCTGA	MRERPGSGPERPGSGPERPGSGPERPGSGPERPDSVHESPVCLAEYEEIAAKVLPADVRDFIDGGSGREQTLRANRAAFDRVFLVPRVLQDVSACSTRATLLGHPATMPVAVAPVAYHRLVHPDGELATARAARDAGVPFTVSTLSSVPVEDVTALGGHVWFQLYCLREHAATLGLIRRAEDAGCRALMLTLDVPWMGRRPRDIRNRFRLPPHVRPVHLTANSGTEAHRGASGGSALAAHTAMELSAAVDWSYLETLRAASGLPLVVKGILHPEDARRAADLGIDGIVVSNHGGRQLDGAVASLDALPGVAESVGGRCEIMLDGGVRSGADVLKALALGASGVLVGRPVIWGLAADGERGVRTVLGLLGAEIEDGLGLAGCGDVAAAQALRTTRPGAGFVS	MKQRIALSLLALGPLLLVPRVYAAADEPMANIVEKAVQPLLEEYRIPGMAVAVLKEGKPHYFNYGVANRESGRRISERTLFEIGSVSKTFTATLGTYAVVKGGFRLDDKVSQHAPWLQNSAFDRVTMAQLATYSAGGLPLQFPDAVDSNERMRQYYRQWSPLYAAGTHREYSNPSIGLFGHLAASTLGQPFRQLMSQTLLPKLDLQHTYLEVPDAAMVDYAYGYSKEDKPVRVNPGVLADEAYGIKTSAADLIKFVGANMTGSGDKAVQQALAMTRTGFYSVGEMTQGLGWESYAYPVTEQALLAGNSPAVSFKANPVKPFVAPRVMGNERLYNKTGSTNGFGAYVVFVPARGVGIVMLANRNYPIEARVKAAYAIMRHLAP	104.97	gnl|BL_ORD_ID|2498|hsp_num:0	2889			705	834	cefalotin
BGC0000289.1|A40926_3 # 2592 # 3623 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.698	BGC0000289.1|A40926_3 	2592	3623	-	Loose	200	29.6462	BRP(MBL)	43.75	3001205	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic inactivation	Bleomycin resistant protein	ATGTACGTAGCGGATCTGAAGGTCGCCACTCTCCCTTGGACCGACGAATACCGCTTCGCCGTCGTGGGCACGGCGAACGCCAGCGACCATCGCAGCGTCGCGCTCCGGCAGGGCCGCATCACCCTCGTCCTCACCCAGGCCACGTCCGACGGCCATCCGGCTTCGGCCTATGTGCGGACGCACGGCGACGGGGTCGCCGACATCGCCCTGCGGACCCCCGACGTCGACGTCGTCTTCACCCATGCCGTGGCCGCCGGCGCCCGGCCCGTACGGTCCCCGTCCCGGCACCCCGGCCCCGGGCCGGCCTGCTCCGCCGCGATCGGCGGCTTCGGCGACGTGGTCCACACCCTCGTCCAGCGGGACCCCGGCGACGACCCCGGCCTGCCGGTCGGCTTCTCCGAGGCTCCGTCCGCCGCCGAGTCCGGTGCGGACGCGGCGGAGCTGCTCGACATCGACCACTTCGCCGTGTGCCTGCCCACGGGTGACCTCGACATCATCACCGACTTCTACGTCGCCACCCTCGGCTTCAGCGAGACCTTCAAGGAACGCATCGAGGTCGGCACCCAGGCCATGGAGTCCAAGGTGGTGCAGAGCGCCTCCGGCGCCGTCACGCTGACACTCATCGAACCCGACCCGATGGCCGAGGCCGGCCAGATCGACATGTTCCTCGAACGGCACGCCGGTGCCGGGGTGCAGCACGTCGCCTTCTCCTCCTCGGACGCCGTGCACGCCGTGAACACCCTGTCCGAGCGGGGCGTCCGCTTCCTCAGCACGCCGGGCAGCTACTACGACCTGCTCGAATCACGGATCCAGATCCGGGGTCACACGGTGGACCAGTTGCGCGCGACGGGACTGCTCGCTGACGAGGATCACGGCGGACAGCTCTTCCAGATCTTCACGGCGTCCACCCATCCGCGCGAGACCCTCTTCTTCGAGGTCATCGAGCGGCAGGGAGCCCGCACCTTCGGAGGCGCCAACATCAAGGCCCTCTACGAGGCCGTCGAGGTGGCGAGGTCCCAGCAGCGTGCATGA	MYVADLKVATLPWTDEYRFAVVGTANASDHRSVALRQGRITLVLTQATSDGHPASAYVRTHGDGVADIALRTPDVDVVFTHAVAAGARPVRSPSRHPGPGPACSAAIGGFGDVVHTLVQRDPGDDPGLPVGFSEAPSAAESGADAAELLDIDHFAVCLPTGDLDIITDFYVATLGFSETFKERIEVGTQAMESKVVQSASGAVTLTLIEPDPMAEAGQIDMFLERHAGAGVQHVAFSSSDAVHAVNTLSERGVRFLSTPGSYYDLLESRIQIRGHTVDQLRATGLLADEDHGGQLFQIFTASTHPRETLFFEVIERQGARTFGGANIKALYEAVEVARSQQRA	MADHVTPNLPSRDFDVTEAFYAKLGFATSWKDRGWMILQRGGLQLEFFPYPDLDPATSSFGCCLRLDDLDAMVALVNAAGAEEKSTGWPRFKAPQLEASGLRIGYLIDPDCTLVRLIQNPD	283.47	gnl|BL_ORD_ID|2356|hsp_num:0	255			6	99	bleomycin; bleomycinic acid; bleomycin A2; bleomycin B2
BGC0000289.1|A40926_4 # 3891 # 6494 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.714	BGC0000289.1|A40926_4 	3891	6494	-	Loose	500	27.7202	RCP-1	31.03	3003563	protein homolog model	n/a	n/a	penam	antibiotic inactivation	RCP beta-lactamase	GTGCTGTTCGGGCGAGATCGTGAACTGAAGAGTCTGACGAGGTTGCTCGATTCCACCGCGGCCGGCCGCGGTGGAGTGGCCGTCATCACGGGGCCTGTGGTCGGCGGCAAGACCGCCATCCTCCACGAGCTCGGCATGCGATCCATCGCGGCCGGCATCCGGCTGGTCACGGCCCGCTGCACGCCGGCGGAGCAGTCGCTGGACTGGGGGGTCGCCGACCAGATCCTGGGCCGCGGGGCAGCGGAGCGGCTGACCGCGCGCAGGGGCGGTGACGCGGTCGAGGACGTCTGCGTCTCCCTGTTCCAGATGGCCGAGGCGAACCCGATCCTCCTGACGATCGACGACGTGGATCTCGCCGACGATCCGTCCCTGCTGGCCATCCTGTCCATGACGCCCCTGCTGACGGACACCAGGATGATGATCGCCGTCACGATCTGCCAGGACCGGCCGCCGGCCCCTCTCCCCCATGTCGCCGAGTCCTTGCTGCGCCTGCCCGGCATCGAGCTGGTCGAGCTGCCGCTCCTGCCCCGTCCGGCGGTCAGGCAGTTCGCCACCGAGCACCTCGGGGCCGAGACGGCCGACCAGCTCGCCGACGACCTCTACCGCTTCAGCGGCGGCAGCCCGCTGCTGGTCCGGGCGCTGATCGAGGATCAGGAGGCCGGCGCGCCCGGGCTCGTGGTCGGCGACTCCTTCATGAGCGCGGTGGCAGCGTGCGTTCATGGCTGCGAGCCGGAGGCCGTCCGCGTCGCGGAGGCGGTGGCCGTCCTCGGCGAGCACGCCACGCCGGACGCGGTGGGCGAGCTCGTGGGCATCGCCCCTCCTGCCGCGACACGCTCGATGGGGATGCTGGAGCGCGCCGGGCTCCTGGCCGGGGGGCGCTTTCGTCATGAGGCGGGCCGCCTGGCCGTACTCGGGCGCATGACCTCCTACGGCAGGATGGAGATCCTCCGGCGGGCCGCGGAGATCCTCCATCGGCGGGGAGGCCCACCGTCGGCTGTGGCCACGCGCTTGCTGGAGGCGGGCTGGTCGGGTGAGGAGTGGGCTTTCGACGTCCTCGTCGAAGCGGGAAGGCAGGCGTTCGACGAGGGTGATTTCGTCGCTGTCATGAAGTGCTTACGGCTCGCCCTGGCGTCCGGCTGGGGCACGCCTCGCCGGCTGGACGTGAAGGTGATGCTCGCCGCGGCGGAGTGGCGCGTCGACCCGGCAGTGGCGGCACGTCACGTGCCCGATCTGCTCGACGCCACGCGCTCGGGTGCGTTGCGTGGATCTCACGGGATGGAGCTGTTCCGCCAGCTGCTGTGGTACGGCCGGTTCGCCGACGCGGCGGAGCTGATCGATCGGCTGAGGCCGAGCGTCGCCGACAGGGACGCCGACGCGTCCTTGATCGCGATGTGCCACGTCCACCCGGTGCTTCTCGACAGATTGCCCCGGTCCGCCCGCGGCTCGATGGGCCAGACAGTCGAGGACGCGCGCCGGATCCTGCGTCAGGCGGAGCCGACGGATGAGGCGATGGACAGCATCATCTCGGCTCTGATGGCACTGCTGCTGGGCGGAGTGTCGGAGGTGGCGGCCTCCTGCGAGACGCTCCTCAAGGAGCCCGGGGTGACGAAGGCGCCCACCTGGAAGGCGATCATCTCCGCCATCCGGGCGGAGACGGCGTGGCGCAAGGGCGACCTGGCGGGGGCCGAGGCCCATGCGCAGGAGGCGCTGACCATACTGCAGCCCAGCGGCTGGGGCGTCGCGATCGGCGCGCCACTCAGCACCCTGCTCCATGCCCAGACCGCGATGGGCCACCTCGACGAGGCGAAGGCGACCGTGGCGGTGCCGATGCCCCGCGAGACGGCGGAGACCGCCTTCGGGATCGGCTACGAGCTCGCGAGGGCGCACTACCACCTGGTCACGGAGCAGCCTCGCGCCGCCTTCGCCGGCTTCCTGGCATGCGGGCAGGCGGTCCAGCGCTGGGGCAGCAGCCTGTCCGACGTGGTCCCCTGGCGCCTCGGCGCGGCGCGAGCGTGCCTGCAACTGGGCTGGCGTCGCAGGGCGGCCGATCTGGTCACGGCCCAGATCGCCCACACCTCCTCCGGTGACCTGCGGACGTACGGGGTCGCCCTCCGCCTGCACGCGCAGCTGAGCAAGCCCGCACAGCGCCAGCGGTTGCTGATGCAGTCCGTGGACGCGCTGGAGGCCGCCCAGGATCGCTACCAGCTGGCCCTTTCCCTCTGCGACCTCGCCGGGACCCCACAGCTCAAGGGCGGCAAGGACGAGGCCCGGGCCTACTGGGTGCGGGCGCAGGAGCTGGCCCGCGAGTGCAACGCGAAGCCCTTGATGAGGAGGCTCGCCGCACAGCACGATCATGGTGAGACCGCACCGTTGAGCGGCGCCGAACGGCGGGTCGCCGTGCTCGCCGCCCGTGGGCACACCAATCGTGAGATCGCCGAGGCGCTCTACATCACGCGCAGCACGGTCGAGCAGCATCTCACCAGGATCTATCGGAAACTCCACGTACAGACTCGGGGTGACCTGGGCAACCTCTTCGCCGCGGACATCGCCGATAAGGCGACGGCCACAGCCGGCCGCGAGCCGCGTGAGGCAGTGCGGCTGTAG	MLFGRDRELKSLTRLLDSTAAGRGGVAVITGPVVGGKTAILHELGMRSIAAGIRLVTARCTPAEQSLDWGVADQILGRGAAERLTARRGGDAVEDVCVSLFQMAEANPILLTIDDVDLADDPSLLAILSMTPLLTDTRMMIAVTICQDRPPAPLPHVAESLLRLPGIELVELPLLPRPAVRQFATEHLGAETADQLADDLYRFSGGSPLLVRALIEDQEAGAPGLVVGDSFMSAVAACVHGCEPEAVRVAEAVAVLGEHATPDAVGELVGIAPPAATRSMGMLERAGLLAGGRFRHEAGRLAVLGRMTSYGRMEILRRAAEILHRRGGPPSAVATRLLEAGWSGEEWAFDVLVEAGRQAFDEGDFVAVMKCLRLALASGWGTPRRLDVKVMLAAAEWRVDPAVAARHVPDLLDATRSGALRGSHGMELFRQLLWYGRFADAAELIDRLRPSVADRDADASLIAMCHVHPVLLDRLPRSARGSMGQTVEDARRILRQAEPTDEAMDSIISALMALLLGGVSEVAASCETLLKEPGVTKAPTWKAIISAIRAETAWRKGDLAGAEAHAQEALTILQPSGWGVAIGAPLSTLLHAQTAMGHLDEAKATVAVPMPRETAETAFGIGYELARAHYHLVTEQPRAAFAGFLACGQAVQRWGSSLSDVVPWRLGAARACLQLGWRRRAADLVTAQIAHTSSGDLRTYGVALRLHAQLSKPAQRQRLLMQSVDALEAAQDRYQLALSLCDLAGTPQLKGGKDEARAYWVRAQELARECNAKPLMRRLAAQHDHGETAPLSGAERRVAVLAARGHTNREIAEALYITRSTVEQHLTRIYRKLHVQTRGDLGNLFAADIADKATATAGREPREAVRL	MRFTATVLSRVATGLALGLSMATASLAETPVEALSETVARIEEQLGARVGLSLMETGTGWSWSHREDELFLMNSTVKVPVCGAILARWDAGRLSLSDALPVRKADLVPYAPVTETRVGGNMTLDELCLAAIDMSDNVAANILIGHLGGPEAVTQFFRSVGDPTSRLDRIEPKLNDFASGDERDTTSPAAMSETLRALLLGDVLSPEARGKLAEWMRHGGVTGALLRAEAEDAWLILDKSGSGSHTRNLVAVIQPEGGAPWIATMFISDTDAEFEVRNEALKDLGRAVVAVVRE	295.90	gnl|BL_ORD_ID|895|hsp_num:0	882			579	807	
BGC0000289.1|A40926_5 # 6599 # 7564 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.655	BGC0000289.1|A40926_5 	6599	7564	-	Loose	2200	26.1794	rpoB2	23.66	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGGACCCGACGGGAGTTGACATAGCCACTCTCCCTGTCGTCGAAATCGAGCTGTCCCGGCTGTCCTCTGTGTACTCACCCCGGACTTCGGGCGAGGATCCAGAGCACGTCGAGACCCTGTTGTCGGCACAAGGGGAGCTTCCGCCCATTCTCGTCCACCGTCCAACGATGCGGGTGATCGACGGCCTGCACCGGTTGAAGGTGGCGCGGGTCAGGGGTGAAACAACAATCTCGGTGAGGCTGATCGACGGCACCGAATCGGACGCCTTCGTCCTGGCCGTCGAGGCGAACGTGCGGCACGGGCTGCCGCTCTCACTGGCCGACCGCAAGCGTGCGGCCGTCCGGATCATCGGGACACATCCGCAGTGGTCTGATCGACGGGTGGCCTCGGCGACCGGCATCTCCGCCGGCACGGTGGCCGACCTGCGCAGGCGCAGAGGACAAGGCGGTGACGAGGCCAGAATCGGGCGGGACGGGCGCATCCGTCCGGTGGACAGCTCAGAGGGGAGGAGACTCGCCGCCGAGCTCATCCGCAGCCATCCGGACCTTTCGCTCCGCCAGGTCGCCAAACAGGTCGGCATCTCCCCGGAGACGGTCCGGGATGTGAGAGGCCGGTTGGAGCACGGTGAGAGCCCGATTCCGGACGGGAGCCGGAGATTAAGGACCAAGCCGGAATTACTGCGTCGGGCAGAACAGGATTTCGGCCACGTCGACGGCCGAGACCGCCAAGCCGTGCTGGAAAGGCTCAAGGCCGATCCCGCATTACGTCTGACCGAAACCGGCCGAATTTTGTTGCGAATGCTATCATTGCACTCCATCGACGGGCAGGAATGGGAAAGGATCTTGCGCGGAGTGCCGCCGCATTGGGGCACCGTTGTCGCGAGATGCGCCAGGGATCATGCCCAGATCTGGGCAGCGTTCGCGGATCGCCTGGAGGGGCGGGCGACCGATCTGGCCGCTGGATGA	MDPTGVDIATLPVVEIELSRLSSVYSPRTSGEDPEHVETLLSAQGELPPILVHRPTMRVIDGLHRLKVARVRGETTISVRLIDGTESDAFVLAVEANVRHGLPLSLADRKRAAVRIIGTHPQWSDRRVASATGISAGTVADLRRRRGQGGDEARIGRDGRIRPVDSSEGRRLAAELIRSHPDLSLRQVAKQVGISPETVRDVRGRLEHGESPIPDGSRRLRTKPELLRRAEQDFGHVDGRDRQAVLERLKADPALRLTETGRILLRMLSLHSIDGQEWERILRGVPPHWGTVVARCARDHAQIWAAFADRLEGRATDLAAG	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	27.62	gnl|BL_ORD_ID|2431|hsp_num:0	2831			429	816	rifampin; rifaximin; rifabutin; rifapentine
BGC0000289.1|A40926_6 # 8516 # 9625 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.741	BGC0000289.1|A40926_6 	8516	9625	+	Loose	1250	25.409	mecA	33.33	3000617	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	GTGACCCTGGAGAGGACGCTCATCGTCGGCACCGGTCTGATCGGCACCTCCGCCGCGCTCGCCCTTCGCGAGAAGGGGGTGGCGGTCTACCTGTCCGACGTCGACGCACATGCCGTACGGCTGGCGCGAGCGCTCGGCGCGGGCCAGGAGTGGACCGGTCAGCGCGTGGACCTGGCATTGATCGCCGTGCCCCCGCCCAGCGTGGGGCAGCGGCTGGCCGATCTGCAGCAGCGGCGGGCCGCGCGGGCGTACACCGATGTGACCAGCGTCAAGGTCGATCCGATCGCCGACGCGGAGCGGCTCGGCTGCGACCTGACCTCCTATGTCCCCGGACACCCGCTCGCCGGCCGGGAGCGGTCCGGCCCGGCCGCCGCCCGTGCCGATCTGTTCCTGGGACGTCCCTGGGCGCTCTGCCCCCGCCCTGAGACGGGTGCGGATGCCGTGCGGCTGGCCAGGGAGCTGGTCTCGATGTGCGGGGCGGAGCCCTACACCGTGAGTGCGGGCGAGCACGACACGGCGGTGGCGCTGGTGTCGCACGCCCCGCACGTGGCCGCGTCCGCGGTGGCGGCGCGGCTGAGGGACGGCGACGACGTCGCGCTGGCCCTGGCGGGGCAGGGGCTGCGCGACGTGACGCGGATCGCCGCAGGGGACCCCCTGCTGTGGCGGATGATTCTCGCCGCGAACGCCCTGCCGGTGGCCGGGGTGCTGGAGCGGATCGCGGCCGATCTCGCCGCGGCGGCCTCGGCGCTGCGGTCCGGCGATCTCGACGATGTGACGGATCTGCTGCGGCGCGGCGTGGACGGCCACGGCCGGATCCCCGACAAGCACGGCGGCCCGGCGCGTGACTACACGGTGATCCAGGTGGTGCTGCAGGATCGGCCGGGAGAGCTGGCGAGGCTCTTCAACGCGGCGGGGCTCGCGGACGTCAACATCGAGGACATCCGCCTGGAGCACTCGGCCGGCCTGCCGGTCGGGGTGGTCGAGGTCTCCGTGCGCCCGGAGGACACCGGCCGGCTCACCGAGGCACTGCGCTTCCACGGCTGGCACGTCCCGCCCGTCCCCGACGGCAACTCGAGGATCGACCGGACGCGAGCTATGGTGTCAGACTGA	MTLERTLIVGTGLIGTSAALALREKGVAVYLSDVDAHAVRLARALGAGQEWTGQRVDLALIAVPPPSVGQRLADLQQRRAARAYTDVTSVKVDPIADAERLGCDLTSYVPGHPLAGRERSGPAAARADLFLGRPWALCPRPETGADAVRLARELVSMCGAEPYTVSAGEHDTAVALVSHAPHVAASAVAARLRDGDDVALALAGQGLRDVTRIAAGDPLLWRMILAANALPVAGVLERIAADLAAAASALRSGDLDDVTDLLRRGVDGHGRIPDKHGGPARDYTVIQVVLQDRPGELARLFNAAGLADVNIEDIRLEHSAGLPVGVVEVSVRPEDTGRLTEALRFHGWHVPPVPDGNSRIDRTRAMVSD	MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETKSRNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVTIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDIDE	55.24	gnl|BL_ORD_ID|1216|hsp_num:0	1321			174	246	methicillin
BGC0000289.1|A40926_7 # 9653 # 10306 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.697	BGC0000289.1|A40926_7 	9653	10306	+	Loose	400	184.496	vanR gene in vanO cluster	51.15	3002930	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGCGCGTTCTGGTGGTGGAGGACCAAGTCGACCTGGCCGACTCGGTGGCGCGGGTGCTGCGTCGCGAGGGCATGGCCGTCGATGTCAGTCATGACGGCGATGACGCACAGGAGCGCCTCTCCGTGATCGACTACGACGTCGTGGTGCTTGATCGGGATATTCCCGGCGTCCATGGCGACGAGCTGTGCGCTGAGATCGCCGTGGACGATCGCAGGACCCGGGTGCTGATGCTCACCGCGTCCGGGACGACCGCTGACCGGGTGGCGGGCCTGAGCCTGGGCGCCGACGACTATCTGCCGAAGCCGTTCGCCTTCGCCGAGCTGGTGGCGCGCATCCGCGCCCTGGGCAGGCGCGCGCATCCTCCCGCGCCGCCGATCCTGGTCCACGGCGACCTGCGGCTCGATCCGGCGCAACGGGTGGCGATCAGGGGCGGCATGCGGCTGCCGCTGACCACCAAGGAGCTGGCGGTCCTGGAGCATCTGCTGACCGCGCGCGGCCGGGTGGTGTCGGCCGAGGAGCTGCTCGAACGGGTCTGGGACGAGCAAGCCGACCCGTTCACCACCACCGTGAAGGCGACGATCAACCGGCTGCGCTCGAAGCTCGGCCAGCCGCCGGTGATCGAAACCGTCCCGCGCGAGGGATATCGCATCTGA	MRVLVVEDQVDLADSVARVLRREGMAVDVSHDGDDAQERLSVIDYDVVVLDRDIPGVHGDELCAEIAVDDRRTRVLMLTASGTTADRVAGLSLGADDYLPKPFAFAELVARIRALGRRAHPPAPPILVHGDLRLDPAQRVAIRGGMRLPLTTKELAVLEHLLTARGRVVSAEELLERVWDEQADPFTTTVKATINRLRSKLGQPPVIETVPREGYRI	MASMRVLVVEDERFMAEAIRDGLRLEAIAADIAGDGDTALDLLGVNAYDIAVLDRDIPGPSGDEIAQRIVASGGGIPILMLTAADRMDDKASGFELGADDYLTKPFELQELVLRLRALDRRRAHSRPPVREIAGLQLDPFRREVYRDGRYVALTRKQFAVLEVLVAAEGGVISAEELLERAWDENADPFTNAVRITVSTLRKRLGEPWLIATVPGVGYRIDTEPDARGGGDGG	93.13	gnl|BL_ORD_ID|4742|hsp_num:0	1689			9	660	vancomycin
BGC0000289.1|A40926_8 # 10402 # 10992 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.733	BGC0000289.1|A40926_8 	10402	10992	+	Loose	50	41.2022	vanY gene in vanB cluster	27.74	3002956	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanY; glycopeptide resistance gene cluster	ATGAGGAGAAGCGAGGGTGACGACGAACCACGCACTCTCCCGCCTCGGGCCCGGGACCGGGTGTACACCGCGGTCACGCGGGTGCTCGCCGTGCTCCTGCTGCCCGTGGCGTTCGTCCGTCAGCCCGGCCGCGCCCGCGAGCTGGCCTGCGGCTGGGCGTTGAGGATGCGATTCCCGGCAGAGGACCTCACCGGGCTCACCGACGGCGCCAGGGCGGCGTTCACCGCGGCGCGGGCCGAGGCGCTGTGGCGTCACGGCCAGCTCGTCGGTCTCACTTCCGGATACCGCGATCCCCGGGTCCAGCAGCGGATGTTCGAGGAGGAGGTGCGCCGCTCAGGGTCCGTGGCCGCCGCACGGATGTTCGTGGCGCCGCCGGCCGAGTCCAACCACGTCAAGGGCATGGCGCTGGACGTACGCCCGCACGAGGGCGCGCGCTGGCTGGAGGCGCACGGCGCCCGCTACGACCTCTACCGCATCTACGACAACGAGTGGTGGCACTTCGAACACCGCCCGGAGTGCGGTGGCACGCCACCACGGCGGCTACCCCACCCAGGCGCGGCCTGGGCGAGCCGGAACGGGGGCCGGGTCTAG	MRRSEGDDEPRTLPPRARDRVYTAVTRVLAVLLLPVAFVRQPGRARELACGWALRMRFPAEDLTGLTDGARAAFTAARAEALWRHGQLVGLTSGYRDPRVQQRMFEEEVRRSGSVAAARMFVAPPAESNHVKGMALDVRPHEGARWLEAHGARYDLYRIYDNEWWHFEHRPECGGTPPRRLPHPGAAWASRNGGRV	MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK	73.13	gnl|BL_ORD_ID|602|hsp_num:0	556			384	771	vancomycin
BGC0000289.1|A40926_9 # 11041 # 12000 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.697	BGC0000289.1|A40926_9 	11041	12000	-	Loose	700	26.9498	EreB	41.03	3000363	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	ATGGATGCTGAGAGCGTGCGCAGGCAGCTGCGGCTGGGAGAGAACGCCACGGCGTGGCTCTCCCGGCTCGAGGAGCTCGGACCGCCCCCCGAGCCGGTGCGCCTGCCTCAGGGCGATGAGGCTCGTGATCTCTTACACCGGCTGGAGGTGCCGGCTCCCGACGTCGAGGAGATCGTGGCGGCCACCCCCGGCCCGGATCGCGACCCGGCCCTGTGGTGGCTGCTCGAACGCGCCCACCACGAGCTCGTCCGGCACATGGGCGACTACAAGGTGAAGGTACGGGGTGGGCCGACCCTGCCGTACGAGACCGGGGCCGCCGCCCGCTACTTCCACGTGTACGTCTTCCTCGCGACGCTTCCGGCGTTGCGGCGCTTCCACGCGACACGGGACATCCCCGAGGCGACCACCTGGGAGACCCTGACGCAGCTGGGGGAATCGGTGGCCATCCATCGCCGCAAGTACGGCGAGGGCGGCACGAACATGCCGTGGTGGCTCACCCTGCTCGTGCGCGGCCTGGTCTACCGGCTCGGCCGGCTCCAGTACAACCTGGCCGTCGCCAAGGACGGCACGCCCGTCCTCGGCCTGCACATCCCCGAAGTGGGCGGGCCGCTGATCCCCGACATCTATTACGACTCGCTCCGTCGTGCCCGCCCGTTCTTCGAACGGCATTTTCCCGAGCACGGCGCCCGGGCGGCGACAGGCACCTCGTGGCTGCTCGATCCGCAGCTGGCCGAGTATCTCGCCGAGGACTCCCACATCCTGCAGCTCAGACGCGGCTGGACGCTCCTCGACTCCGAACCGCAGGACGGGGACGACGCGATCCTGGAGTTCGTCTTCCGCTACAACGGCCAGCCGCTGGAGGAGCTTCCGCAGCGCTCGACGCTGGAGAAGGCGGTCGTCACCCATTTGCTGGCGGGCCGTCACTGGTATCAGCGGAGCGGCCGCATCGAGCTGCCCTAG	MDAESVRRQLRLGENATAWLSRLEELGPPPEPVRLPQGDEARDLLHRLEVPAPDVEEIVAATPGPDRDPALWWLLERAHHELVRHMGDYKVKVRGGPTLPYETGAAARYFHVYVFLATLPALRRFHATRDIPEATTWETLTQLGESVAIHRRKYGEGGTNMPWWLTLLVRGLVYRLGRLQYNLAVAKDGTPVLGLHIPEVGGPLIPDIYYDSLRRARPFFERHFPEHGARAATGTSWLLDPQLAEYLAEDSHILQLRRGWTLLDSEPQDGDDAILEFVFRYNGQPLEELPQRSTLEKAVVTHLLAGRHWYQRSGRIELP	MRFEEWVKDKHIPFKLNHPDDNYDDFKPLRKIIGDTRVVALGENSHFIKEFFLLRHTLLRFFIEDLGFTTFAFEFGFAEGQIINNWIHGQGTDDEIGRFLKHFYYPEELKTTFLWLREYNKAAKEKITFLGIDIPRNGGSYLPNMEIVHDFFRTADKEALHIIDDAFNIAKKIDYFSTSQAALNLHELTDSEKCRLTSQLARVKVRLEAMAPIHIEKYGIDKYETILHYANGMIYLDYNIQAMSGFISGGGMQGDMGAKDKYMADSVLWHLKNPQSEQKVIVVAHNAHIQKTPILYDGFLSCLPMGQRLKNAIGDDYMSLGITSYSGHTAALYPEVDTKYGFRVDNFQLQEPNEGSVEKAISGCGVTNSFVFFRNIPEDLQSIPNMIRFDSIYMKAELEKAFDGIFQIEKSSVSEVVYE	76.13	gnl|BL_ORD_ID|1771|hsp_num:0	1921			351	465	erythromycin; roxithromycin; clarithromycin; azithromycin
BGC0000289.1|A40926_10 # 12003 # 13133 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.744	BGC0000289.1|A40926_10 	12003	13133	-	Loose	600	350.132	rgt1438	55.7	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGTGCGCCCCGCCGGACTGCGCGGAGAGACTGGCCGAGGCCGGGGTGCCGCTGGTGCCGGTCGGCACCTCGATGCGCGCGAAGCTGCACGGGAAGAGGCCGCCCTCGCTCGAGGACGTGCCCCGGCTCGACGCCGAGGCCATCGCCACGCAGCTCGACCAGGTCCTGCCGGCCGCCGAGGGGTGCGAGGTGATGGTGGTGAGCGGCGTGCTGTCGGCGGCGGTCGCCGTCCGGTCGGTGGCCGAGAAGCTCGGCATCCCCTACGTCTACGTCTTCTACTGCCCCATCTATGTGCCGTCGCCGTACTACCCGCCGCCGCCACCCCTCGGTGAGCAGCCCGCGCGGGACGTGACCGACAACCGGGTGCTGTGGGACCGCAACAACCAGGGCGCCTACCAGCGGTTCGGTGCCGCGCTCAACAGCCGGCGGGCCTCGATCGGCCTGCCGCCGGTGGACGACATCTTCAGCTACGGCTACACCGATCGCCCCTTCCTGGCCGCGGACCCGGTCCTGGCCCCGCTGCAGCGGACGGACCTCGACGTCGTGCAGACCGGTGCGTGGATCATGCCCGACGAACGGCCCCTGCCCGCCGAGGTGGAGGCGTTCCTGGAGGCCGGCCCGCCACCGGTGCACGTGGAGTTCGGCAGCGGGCCCGCCCCCACCGACGCCGCGAGGGTGGCCATCGAGGCGATCCGGGCCCATGGCCACCGGGTGATCGTCTCCCGTGGCTGGGCCGGCCTAGCCCCGCCCGACGACCGGAGCGACTGCCTGACCGTCGGCGAGGTGAACCACCAGGTGTTGTTCGGCCGGGTGGCCGCCGTCGTCCACGCCGGCAGCGCGGGCATCACGACCGCGGTCACCCGGGCGGGCGCTCCCCAGGTCGTGGTGCCCCAGATGACCGACCAGCCGTACCACGCCGGCCGGGTGGCCGAGCTGGGCATCGGCGTGGCACACGACGGGCGGGTGCCGACCGTGGAGAGCCTGTCGGCCGCGCTCACCACGGCGCTGGCTCCCGAGACCCGCGCGCGGGCGATCGACGTGGCCGGGAAGATCCGCGCCGACGGGGCGGCCGTGGCCGCGAAACTCCTGCTCGACACGGCCGCCGGGGCCGGGCGGAACAGAACGGAGTGA	MCAPPDCAERLAEAGVPLVPVGTSMRAKLHGKRPPSLEDVPRLDAEAIATQLDQVLPAAEGCEVMVVSGVLSAAVAVRSVAEKLGIPYVYVFYCPIYVPSPYYPPPPPLGEQPARDVTDNRVLWDRNNQGAYQRFGAALNSRRASIGLPPVDDIFSYGYTDRPFLAADPVLAPLQRTDLDVVQTGAWIMPDERPLPAEVEAFLEAGPPPVHVEFGSGPAPTDAARVAIEAIRAHGHRVIVSRGWAGLAPPDDRSDCLTVGEVNHQVLFGRVAAVVHAGSAGITTAVTRAGAPQVVVPQMTDQPYHAGRVAELGIGVAHDGRVPTVESLSAALTTALAPETRARAIDVAGKIRADGAAVAAKLLLDTAAGAGRNRTE	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	91.48	gnl|BL_ORD_ID|116|hsp_num:0	134			96	1221	rifampin; rifaximin; rifabutin; rifapentine
BGC0000289.1|A40926_11 # 13283 # 14752 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.669	BGC0000289.1|A40926_11 	13283	14752	-	Loose	600	51.9878	Streptomyces venezuelae rox	28.16	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGGAAGAGTTCGATGTGGTGGTCGCCGGCGGCGGCCCTGGCGGTTCGACCGTGGCGACACTGGTGGCCATGCAGGGTCATCGGGTGCTGCTGGTGGAGAAGGAAGTCTTTCCGCGGTATCAGATCGGCGAGTCGTTGCTGCCCTCGACCGTGCACGGGGTGTGCCGGATGCTCGGGGTGACGGACGAGCTCGCGGCGGCGGGGTTTCCCGTGAAGCGCGGGGGCACCTTCCGGTGGGGGGCGCGGCCGGAGCCGTGGACGTTCTCCTTCTCCGTCTCTCCGCGGATCACGGGTCCGACGACTTTCGCCTACCAGGTGGAGCGGGCACGCTTCGACGAGATCCTGCTCGGCAACGCCAGACGCAAGGGCGTGGTGGTGCGTGAGGGATGCTCGGTCACCGAGGTGATCGAGGACGGCGATCGGGTCACCGGCCTGCGTTACGTCGATCCTGACGGCGGCGAGCACGCGGTGTCCGCGCGTTTCGTGATCGACGCGTCGGGCAACAAGAGCCGGTTGTATTCCAGCGTCGGTGGCACGCGGAACTATTCGGAGTTCTTCCGCAGCCTGGCGCTGTTCGGTTACTTCGAGGGCGGCAAGCGGCTGGCGGAGCCGTACTCGGGCAACATCCTGAGCGTGGCCTTCGACAGCGGCTGGTTCTGGTACATCCCGCTGAGCGACACGCTGACCAGCGTGGGCGCGGTGGTGCGCCGGGAGATGGCGGAGAAGATCCAGGGCGATCGGGAGAAGGCGCTGGCCGCGCTGATCGCCGAGTGCCCGCTGATCTCGGAGTACCTCGCGCCGGCGCGCCGGGTGACGACCGGCAAGTACGGGCAGCTGCGGGTCCGCAAGGACTACTCCTACCACCAGACGAAGTTCTGGCGGCCCGGGATGATCCTGGTGGGCGATGCCGCGTGCTTCGTGGACCCGGTGTTCTCCTCCGGGGTGCACCTGGCCACCTACAGCGGCCTCCTGGCGGCCCGGTCGATCAACAGCGTCCTGGCCGGTGACGTCGAGGAGAAGATCGCGCTGCATGAGTTCGAGGCGCGATATCGCCGCGAGTACAGCGTGTACTACGAGTTCCTGCTGGCGTTCTACGAGATGAACGTGAACGAGGAGTCGTATTTCTGGCACGCCAAGAAGGTCACCAACAACAAGGAGTACACCGAGCTGGAGTCGTTCGTGGACCTGGTGGGCGGTCTGTCCTCCGGCGAGACGGCGCTGGCGACCTCAGGGCGGATCGCCGAGCGCAGCGCCGAGTTCGCCGCGGCCGTCGATCAGATGGCCGACGGCGACGACTCCAGCATGGTGCCGCTGTTCAAGTCACAGGTGGTCAAACAGGTGATGCAGGAGGGCGGGCAGGAGCAGATGAGGGCGGTGCTCGGTGCGGACGCCGAGCCCGAGCAGCCACTGTTCCCCGGCGGGCTGGTGACCTCACCCGACGGGATGAGATGGCTGACACATCACCCCTGA	MEEFDVVVAGGGPGGSTVATLVAMQGHRVLLVEKEVFPRYQIGESLLPSTVHGVCRMLGVTDELAAAGFPVKRGGTFRWGARPEPWTFSFSVSPRITGPTTFAYQVERARFDEILLGNARRKGVVVREGCSVTEVIEDGDRVTGLRYVDPDGGEHAVSARFVIDASGNKSRLYSSVGGTRNYSEFFRSLALFGYFEGGKRLAEPYSGNILSVAFDSGWFWYIPLSDTLTSVGAVVRREMAEKIQGDREKALAALIAECPLISEYLAPARRVTTGKYGQLRVRKDYSYHQTKFWRPGMILVGDAACFVDPVFSSGVHLATYSGLLAARSINSVLAGDVEEKIALHEFEARYRREYSVYYEFLLAFYEMNVNEESYFWHAKKVTNNKEYTELESFVDLVGGLSSGETALATSGRIAERSAEFAAAVDQMADGDDSSMVPLFKSQVVKQVMQEGGQEQMRAVLGADAEPEQPLFPGGLVTSPDGMRWLTHHP	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	102.73	gnl|BL_ORD_ID|4833|hsp_num:0	5820			3	486	rifampin; rifaximin; rifapentine
BGC0000289.1|A40926_12 # 14812 # 16074 # -1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.662	BGC0000289.1|A40926_12 	14812	16074	-	Loose	500	26.9498	OXA-114x	36.59	3005723	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGCGGATCGACAGCGAATGGAGTTTCGACCCGGGTATGGATGACGATATCGATGCGGGCGCGCCGGTCCTGCAGCCGACGGCGAACTACATGATGCGGACGCACTGTGATCCGCATGAGGACATGTTCGCGCTCAGGGCGCATGGCCCACTGGTCCGGATAGGCGGTGACGCGGCCACTCAGCTGCGTGTCGACTATGTCTGGCAGGCTTTGGGATACGACGTCGTGCGCAGAATACTCGGCGATCACGAGAACTTCACGACGCGCCCCCGGTGGAGTTCGGCGCCATCGATCGCCGGAGAGCCCATACCGCCGAATCTGGTCGGTCAGCTGTCGGTCTATGATCCGCCCGAGCACACGCGGCTGCGCGGGATGCTGACCCCGGAGTTCACGGCCCGCCGGATCCGCCGGCTGGAGCCCGCCATGCAGGACCTCATCGATGACCGCATCGACGAGCTGGAGGCCGCGGGGCCGCCCGCGGACGTCCAGGCGCTGTTCGCCGATCCGGTCGGCGGAGGAGTGCTGTGTGAGCTGCTCGGCATCCCGCGTGATGATCGGATCGAGTTCATCCGGCGTGTCAGGCAGAACGTCGATCTCAGCCGCGGGTTCAAGGCCCGGGCGGCCGACAGCGCGGCGTTCAACCGGTATCTGAACGGCCTCATCATCCGGCAGCGGAAGGACCCTGACGAGGGGTTCATCGGGATGCTGGTGCGGGAGCACGGAGACGATGTCACGGACGAGGAGCTGAAGGGCGTACTCACGGCGCTGATCCTGGGTGGTGTCGAAACCGTCGCGGGGTCGATCGGCTTCGGGGTTCTCGCGCTGCTGGATCATCCCGACCAGCGACAGTCTCTCTTCGCCGGACGCGAGGAGGCCGACCGGGTGGTCGGTGAGCTGCTGCGGTTCCTGTCGCCCGTGCAGCAGCCGAATCCACGGCTCGCCGTCCGGGACGTGGTCGTCGACGGCCAGCTGATCAAGGCCGGGGATTACGTCCTGTGCTCGATTCTGATGGCGAATCGCGACGAGGCGCTGACGCCGAATGCCAACGTCCTCGACGTGCGCCGTGACTGCGGCTCGCACGTCGGGTTCGGGCACGGCATCCATTACTGCATAGGCGCGGCGATAGCCAGGACGCTGCTGCGCATGGCGTATCAGAGTTTGTGGCGCCGGTTTCCCGGGCTGCGCCTGGCGGTGTCCGCCGAGGAAGTGAAGTTCCGTAACGCGTTCATCGATTGCCCGGACGAGTTGCCGGTCACCTGGTAG	MRIDSEWSFDPGMDDDIDAGAPVLQPTANYMMRTHCDPHEDMFALRAHGPLVRIGGDAATQLRVDYVWQALGYDVVRRILGDHENFTTRPRWSSAPSIAGEPIPPNLVGQLSVYDPPEHTRLRGMLTPEFTARRIRRLEPAMQDLIDDRIDELEAAGPPADVQALFADPVGGGVLCELLGIPRDDRIEFIRRVRQNVDLSRGFKARAADSAAFNRYLNGLIIRQRKDPDEGFIGMLVREHGDDVTDEELKGVLTALILGGVETVAGSIGFGVLALLDHPDQRQSLFAGREEADRVVGELLRFLSPVQQPNPRLAVRDVVVDGQLIKAGDYVLCSILMANRDEALTPNANVLDVRRDCGSHVGFGHGIHYCIGAAIARTLLRMAYQSLWRRFPGLRLAVSAEEVKFRNAFIDCPDELPVTW	MTVRRLSCALGAALSLSALGGDPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLPVKAAAYELAENLFEAGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVYARLLQDERATRPNAGLRARDELVRDWPAMAGAWRP	152.73	gnl|BL_ORD_ID|3753|hsp_num:0	4823			24	147	cloxacillin; oxacillin; cefalotin
BGC0000289.1|A40926_13 # 16156 # 17352 # -1 # ID=1_13;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.694	BGC0000289.1|A40926_13 	16156	17352	-	Loose	500	26.1794	APH(3')-Ib	37.93	3002642	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	TTGAGTGGTGACGGCGCGCGGCCCCTCCATACTCGGCGGCAGGACCTGGATCCGGCGGACGAACTGCGCGCCGCCGGAACGCTGACGAGGATCACCATCGGATCAGGAGCGGACGCGGAGACCACCTGGCTGGCCACGGGGTACACCGTCGTGCGGCAGGTGCTCGGCGATCACCGGCGGTTCAGCACCCGGCGCCGCTGGAACGAACGGGACGAGATCGGCGGAAGAGGCAACTTCCGGCCGCGTGAGCTGGTCGGGAACCTGATGGACTACGACCCGCCTGAGCACACGCGGCTCCGCCAGAAGCTGACCCCGGGATTCACCCTGCGCCGGATCCGGCGGCTGAAGCCGTACATCGAACAGATCGTGACCGAACGGCTCGACGCCCTGGAACGGGCGGGCCCCCCTGCGGATCTGGTCGAACTCGTCGCCGACGAGGTGCCAGGGGCCGTGCTGTGCGAGCTGATCGGGGTGCCACGGGACGACCGCGCCATGTTCATGCAGCTGTGTCACGGCCATCTCGACGCCTCGCGCAGCCAGAAGAGGCGGGCGGCCGCCGGCGCGGCGTTCTCCCGCTACCTGCTGGCCATGATCGCCAGGGAGCGGAAGGATCCCGGCGAGGGGCTGCTCGGAGCCGTCCTCGCCGAGTACGGTGACACGGCCACGGACGAGGAGCTGCGGGGCTTCTGCGTTCAGGTGATGCTGGCCGGCGACGACAACATCTCCGGCATGATCGGGCTCGGCGTGCTGGCCCTGCTCAGACACCCCGAGCAGATCGCCGCGTTGCAGGGCGACGACCAGTCGGCGGATCGGGCGGTCGACGAGCTGATCCGCTACCTGACCGTCCCCTATGCGCCGACGCCCCGGGTCGCCATGGAGGACGTCACCATCGGGGGCCAGGTGATCAAGGAGGGAGAGACCGTCTCCTGCTCTCTGCCCATGGCCAACCGTGACCCTGCCCTGCTGCCGGATGCCGGCCGCCTCGATGTCCGGCGCGAGCCCGTCCCCCATGTCGCGTTCGGGCACGGCGTCCATCATTGCCTGGGAGCCGCTCTGGCCCGCCTCGAACTGCGCACGGTCTACACCGCCCTGTGGCGGCGTTTTCCCACGCTGAGGCTCGCGGATCCCGATCGGGAGCCATCGTTCCGGTTGACCACTCCCGCGTATGGATTGACCAGTCTGATGGTCGCCTGGTGA	MSGDGARPLHTRRQDLDPADELRAAGTLTRITIGSGADAETTWLATGYTVVRQVLGDHRRFSTRRRWNERDEIGGRGNFRPRELVGNLMDYDPPEHTRLRQKLTPGFTLRRIRRLKPYIEQIVTERLDALERAGPPADLVELVADEVPGAVLCELIGVPRDDRAMFMQLCHGHLDASRSQKRRAAAGAAFSRYLLAMIARERKDPGEGLLGAVLAEYGDTATDEELRGFCVQVMLAGDDNISGMIGLGVLALLRHPEQIAALQGDDQSADRAVDELIRYLTVPYAPTPRVAMEDVTIGGQVIKEGETVSCSLPMANRDPALLPDAGRLDVRREPVPHVAFGHGVHHCLGAALARLELRTVYTALWRRFPTLRLADPDREPSFRLTTPAYGLTSLMVAW	MNDIDREEPCAAAAVPESMAAHVMGYKWARDKVGQSGCAVYRLHSKSGGSDLFLKHGKDAFADDVTDEMVRLRWLAGHISVPSVVSFVRTPNQAWLLTTAIHGKTAYQVLKSDFGARLVVVDALAAFMRRLHAIPVSECSVQQWTTHAGLPERGSIEAGVVDVDDFDKEREGWTAEQVWEAMHRLLPLAPDPVVTHGDFSLDNLLIVEGKVVGCIDVGRAGIADRYQDLAVLWNCLEEFEPSLQERLVAQYGIADPDRRKLQFHLLLDELF	146.86	gnl|BL_ORD_ID|772|hsp_num:0	835			555	642	neomycin; ribostamycin; kanamycin A; gentamicin B; paromomycin; lividomycin; gentamicin
BGC0000289.1|A40926_14 # 17342 # 18496 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.700	BGC0000289.1|A40926_14 	17342	18496	-	Loose	1000	29.6462	MCR-3.13	25.24	3007269	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGGTGGTTCCGCTGCCGCATCAGCGGCTGAGGCTCGATCCCGTGCCGGCGCTCTTCGACCTGCAAGAGGACGGGCCGCTGCACGAGTACGACACCGAGCCGGGGCTGGACGGCCACAAGCAGTGGCTCGTCACCGGATATGGCGAGATCAGAGAGATTCTCGCCGACGCCAACCGGTTCAGCTCGATGCGCCCGGTCGAGGACGAGGCGGAGCGCGCCTGGCTGCCGGGAATCCTGCAGTCGTACGACGCGCCCGATCACACCCGGTTGCGCAGGACCGTGACCAGGGCGAACACCGCCCGGCGGATCGAGAGCCTGCGGCCTGTCGTCGAAGAGACCGTCGAGGACTGCTTGGCCGATCTGGAGAGCATGGGGTCGCCGGTCGACTTCGTCAGGAACGCCGCCTGGCCCATCCCGGCGCTGATCGCCTGCGACTTCCTCGGCGTCCCCCGTGACGACCAGGCCGAGCTGTCGAGGATGTTCCGGGACAGCCGGGAGAGCCGAGTCCCCAGGCAGCGGAACGTGTCGGGCCTGGGCATCGTCGACTACGCCAGGAAACTGGCGGCTCGCGAACGCCTCGATCCCGGCACCGGGATGATCGGCGGCATCGTGCGCGAGCACGGAGGCGAGGTCACCGACGAGGAGCTGGCGGGGCTCGTCGAGGGGATCATGATCGGGGCGGTCGAGCAGATGGCCTCGCAGCTGGCGATCGCGGTGCTCCTCCTCGTGACCCACCCCGACCAGATGGCGCTGCTGCGCGAGCGTCCGGAGCTCGCGGACAGCGCGGCCGAGGAGGTGTTCCGCTACGCGTCGATCGTCGAGACCCCCTCTCCCCGGACCGCACTGGTCGACACGCGCCTGGCCGGACGGGACATCCACGCCGGTGATGTCCTGACCTGCTCGATCCTGGCGGGCAATCGTGCGCGCGAGGACCGCTTCGACCTCACCCGGGGCAACCCCGAACACCTCGCGTTCGGGCACGGCGTCCACTTCTGCCTCGGGGCACCGCTGGCCAGGCTCCAGGCGCAAGTGGCGTTGCCGGCGTTGGTCCGCCGGTTCCCGTCGCTGCGGCTGGCGGTCCCGGCAGAGGACCTGCGGTTCAAACCGGGGAAGCCGGCCCCCTTCGCCGTGGAGGAGCTTCCCGTTGAGTGGTGA	MVVPLPHQRLRLDPVPALFDLQEDGPLHEYDTEPGLDGHKQWLVTGYGEIREILADANRFSSMRPVEDEAERAWLPGILQSYDAPDHTRLRRTVTRANTARRIESLRPVVEETVEDCLADLESMGSPVDFVRNAAWPIPALIACDFLGVPRDDQAELSRMFRDSRESRVPRQRNVSGLGIVDYARKLAARERLDPGTGMIGGIVREHGGEVTDEELAGLVEGIMIGAVEQMASQLAIAVLLLVTHPDQMALLRERPELADSAAEEVFRYASIVETPSPRTALVDTRLAGRDIHAGDVLTCSILAGNRAREDRFDLTRGNPEHLAFGHGVHFCLGAPLARLQAQVALPALVRRFPSLRLAVPAEDLRFKPGKPAPFAVEELPVEW	MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAVSLPILLVAALNFVFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPIIGWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGRNNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETARGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNLARNSEGLLDVLQKTGVSIFWKENDGGCKGVCDRVPNIEIKPKDYPKFCDKNTCYDEVVLQELNSEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTIRYTDFVIAEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYKFAPDDQTRVPMQVWMSPGFIKEKGMNMECLQKNAAANRYSHDNIFSSVLGIWDVKTAIYEQELDIFKQCRNN	71.11	gnl|BL_ORD_ID|4889|hsp_num:0	5874			441	744	colistin A; colistin B
BGC0000289.1|A40926_15 # 18518 # 19699 # -1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.683	BGC0000289.1|A40926_15 	18518	19699	-	Loose	590	28.8758	HERA-3	24.48	3004818	protein homolog model	n/a	n/a	penam	antibiotic inactivation	HERA beta-lactamase	GTGGAAGTGTTCGAGGAGCTCAACGTCGTCCTGCCCGGGGAGCTGCACTGGAGGGACCGGTTCGATCCGGTGCCACAGCTGCGGTCCTTCATGGCCGAGGGCCCGATGACCGAGCTGGGCGCCGAGGAAGGCCCTGGAGGGCGGACCGCGTGGCTCGCCACCGGGTTCGACGAGGTCCGGCAGGTGCTGGGCTCGGACAAGTTCAGCTCCAGGTTGCTCTACGGCGGGACCGCGGCCGGAATCGTCTTTCCCGGCTTCATCACCCAGTACGACCCGCCGGAGCACACGCGACTGCGCCGGGTGGTCTCGCCCGCGTTCACCGTCCGGCGGATGGAGCGGTTCCGCCCGCAGGTCGATCAGGTCGTCGAGGACTGCCTGGACGCCATCGAGTCCATCGGTGGCCCGCTGGACTTCGTCCCGCATTTCGGGTGGTCCATCGCGACGACGGCGACCTGCGACTTCCTCGGCATTCCACGTGATGATCAGGCGGAGCTGTCACGCAGCCTGCACGCCAGCCGGTCCCAGCGGGCGGCCAGCAGACGCGGAGCCGCCGGGAACAAGTTCATGACCTACATGGGCCAGGTCGTGGCTCGCACGCGCCGTGATCCCGGCGACGACATGCTCAGCGTCGTGGTGCGCGAACACGGTGACGAGATCACCGACGCGGAGCTGACGGGGCTGGCCGCGTTCGTCATGGGCGCGGGCGGTGACCAGGTGGCTCGTTTCCTCGCGGCGGGCGCGTGGCTGATGGCCGAGGTCCCCGAGCAGTTCGCGCTGCTTCGGGACAAGCCGGACGTCGTGCCTGACTGGCTGGAGGAGATGGTGCGCTATCTCACCATCGACGAGAAGCTCACTCCGCGGATCGCGCTGGAGGACGTGCGCATCGGTGACCGCATCGTCAAGGCCGGCGACACCGTCACGTGCTCGTTGCTGGGAGCGAACCGGCGGCACTTCCCCGGCCCGGACGATCAGTTCGACCTCACCCGCGACAGAGCGCCGAATGTCGCGTTCGGGCACGGCATCCATCACTGTCTTGGCAGACCCCTGGCCGAGCTCATCTTCCGGTCGGCGATCCCGGCTCTGGCACGCCGCTTCCCCGCACTCCGGCTGGCCGAGCCCGAACAAGAGATCAGATTGGGGCCGCCGCCGTTCGACGTGAAAGCACTGCTGCTCGACTGGTAA	MEVFEELNVVLPGELHWRDRFDPVPQLRSFMAEGPMTELGAEEGPGGRTAWLATGFDEVRQVLGSDKFSSRLLYGGTAAGIVFPGFITQYDPPEHTRLRRVVSPAFTVRRMERFRPQVDQVVEDCLDAIESIGGPLDFVPHFGWSIATTATCDFLGIPRDDQAELSRSLHASRSQRAASRRGAAGNKFMTYMGQVVARTRRDPGDDMLSVVVREHGDEITDAELTGLAAFVMGAGGDQVARFLAAGAWLMAEVPEQFALLRDKPDVVPDWLEEMVRYLTIDEKLTPRIALEDVRIGDRIVKAGDTVTCSLLGANRRHFPGPDDQFDLTRDRAPNVAFGHGIHHCLGRPLAELIFRSAIPALARRFPALRLAEPEQEIRLGPPPFDVKALLLDW	MKKITPLFAIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGYRQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISLRMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGDHVTRLDRTEPTLNEATPGDARDTSSPQKMAAGLQKILTAPPLTPANRAVLAQWMRDDKVGDALLRAALPKGWAIADKTGAGGYGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANETIAEIGKQLFAGQP	135.52	gnl|BL_ORD_ID|2551|hsp_num:0	3612			96	483	
BGC0000289.1|A40926_16 # 19795 # 20004 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.662	BGC0000289.1|A40926_16 	19795	20004	-	Loose	730	22.3274	farA	41.38	3003961	protein homolog model	n/a	n/a	antibacterial free fatty acids	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCAACCCGTTCGAGAACGAAGACGGCTCCTTCCTCGTGCTCGTCAACGACGAAGGACAGCACTCGCTCTGGCCCTCGTTCGCGGAGGTGCCGCCTGGCTGGACCCGCGTCCACGGCGTGGCCACCCGCCAGGAATGCCTCGCCTACGTCGAGGAGAACTGGACGGACATCCGGCCGAAGAGTCTCATCGCGGAAGCCGGCGCCTGA	MTNPFENEDGSFLVLVNDEGQHSLWPSFAEVPPGWTRVHGVATRQECLAYVEENWTDIRPKSLIAEAGA	MDTHTDETKLQNTQAKRKRRLTALTLLFALAAAAAGSAFFLWWQHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDTSAAGAPVSKTPGAALPEMESTDWSEVDRTVDEILGQSAP	17.97	gnl|BL_ORD_ID|2189|hsp_num:0	2428			375	453	palmitic acid; oleic acid; linoleic acid
BGC0000289.1|A40926_17 # 20001 # 25592 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.734	BGC0000289.1|A40926_17 	20001	25592	-	Loose	1000	86.6557	almE	25.98	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACCATTGACGACACTCGTGCGAAGCCGCGCTCCAGCGTGGAAGACGTCTGGCCCCTCTCGCCGCTGCAGGAGGGCATGCTCTATCACACCGCCCTCGACGACGACGGGCCCGACACCTACACGGTGCAGACCGTGTACGGCATCGACGGCCCGCTGGACGCCGGGCGGCTGAGGGCGTCGTGGCAGGCGCTCGTGGACCGGCATGCCGCGCTGCGGGCCTATTTCCGCTATGTCAGCGGCGCGCAGATGGTGCAGGTCATCGCGCGGGAGGCGGAGATCCCCTGGCGTGAAACGGATCTCCACGGGCTGCCGGACGACCTCCTCGACAGCGAGGTGGACCGGCTGGCGGCGGACGAGCTGGCCGAGCGGCTCCCCCTCGATGCGGCACCGCTGATGAAGCTGCACCTCATCCGGCTCGGCCCGGCCAGCCACCGGCTCGTGCACACCCTGCACCATGTCCTGCTGGACGGCTGGTCGATGCCGATCCTGCACCGCGAGCTGGCCGCGATCTACGCGGCGGGCGGCGACGCGTCCGGGCTGCCTGCCGCCGTGTCCTACCGGGACTACCTCGCCTGGCTGGGCCGGCAGGACAAGGAGGCGGCCCGGGCGGCCTGGCGGCAGGAGCTCGCCGGACTGGACACGCCCACGCTGGTCGCCCCGGCCGATCCGGCCCGCGTGCCGGACATGGGCACCGCGGTGATCGAGCTCTCCGCGGAGCTGACGGACGGGCTGGCGCGGCTGGCGCGCGGCCACGGCCTCACCTTGAACACCGTCGTCCAGGGTGCGTGGGCCATGGTCCTGGCGCAGCTCGCCGGCCGCACCGACGTGGTGTTCGGCGCGACCGCCTCGGGGCGGCCCGCCGAGCTGGCCGGTGTGGAGTCGATGGTCGGGCAGCTGCTCGGCACCCTGCCGGTACGGGTCCGGCTCGAAGGCGGCCGGCGGGTCGTCGAGCTGCTCGCCGAGCTGCAGCGCAGCCAGTCGGCACTCATGGCGCACCAGCATCTCGGCCTGCAGGAGATGCAGGCCGCCGTCGGGCCCGGGGCGGTCTTCGACACGCTCGTCATCTACGAGAACTTCCCGCGCCAGGGACTCGGCCGGGCCGAAGAGGACGGCGGCCTGGACCTGAGACCGGTGCGGCGCGGACGCAACTCCTCGCACTACCCGTTCACCCTGATCACCGGGCCCGGCGCGCAGATGCCGCTCATCCTCGACTACGACCGCGGCCTCTTCGACGAGGCGGCCGCCGAATCGGTCGTGGGCGCGCTGGCTCGCGTGCTTGAGCGGCTGGTCGCCGAGCCCGACGTCCTCGTCGGCCGGCTGACGCTGCTGAGCGAAGCCGAGCGCGCCCTGGTGGTGGAGGACTGGAACGCGACGGCGGGCCCCACGCCGGGGCAGTCCGTGCTCGATCTCTTCGGACGGCGGGTGGCCACGGCGCCGGACGCGGTGGCGATCACCGATGCCGGCGGCGCGGACCTGACCTACGCCGAGGTCGACCAGGCGGCGAACCGGCTGGCCCGCCACCTCGCCGCTCGTGGCATCGGCCGTGGCGACCGCGTCGGCGTGGTCATGGACAGGTCGCCTGACCTGCTGATCGCGTTCCTGGCGAGCTGGAAGGCGGGCGCCGCGTACGTCCCGGTGGACGTCGAGCACCCGGCCGAGCGGATCGAGTTCGTGCTCGCCGACTCCGGTGTCTCGGCCGTCCTGTGCACCCGGGCCACCAGGGAAGTGGCGCCGGCGGACGCGATCGTCATCGACGCCCCGGAGACCCGCGCGGCCATCGACGCGGGTGCCGCCACGGCGCCGCAGATCCGGCTGAGCGCCGACGACCTGGCGTACGTGATGTACACCTCCGGCTCCACCGGCCTGCCGAAGGGGGTGGGCGTCCCCCATGGGGCCGTGGCCGGCCTGGCGGGCGACGAGGGCTGGCGGATCGGCCCGGGCGACGCCGTGCTGATGCACGCGACGCACGTCTTCGACCCTTCGCTCTACGCGATGTGGGTGCCGCTCGCCATGGGTGGCCGGGTCGTGCTCACCGAGCCGGGAGTGCTGGACGCGCTCGGGATGAGACAGGCCGTCGAACGGGGCGTGACCTTCGTCCATCTCACCGCCGGTACCTTCCGGGCCCTCGCGGAGTCGTCCCCGGAGTGTTTCGCGGGCCTGGTCGAGGTCGGGACCGGTGGTGACGTGGTTCCGGCGCAGTCCGTGGAGCACCTGCGGCGGGCCGTGCCCGGCCTGCGGGTGCGCAACACGTACGGACCGACCGAGACCACCCTGTGCGCGACGTGGAAGCCGATCGAGCCCGGCGAGGAGGTCGGGCGGGAGCTGCCGATCGGCCGTCCCATGACCAACCGCAGGATCTACATCCTGGACGCCTTCCTGCGCCCGGTCGCGCCGGGGGTGGCGGGCGAGCTGTACATCGCGGGCACCGGGCTGGCCCGCGGGTATCTCGGCGGGCCGGGCCTGACGGCAGAGCGGTTCGTGGCCGTTCCGGCCTCCGTGGACCCTTCTCCTGGTGAGCGCATGTACCGCACCGGCGACCTGGCGCGCTGGAACCGCGACGGCGAGGTGGTGTTCCTCGGCCGCACCGACGACCAGGTGAAGATCCGCGGCTACCGGGTGGAGCTCGGCGAGGTGGAGGCCGTGCTGGCGGCCCAGCGCGGCGTGGTCGAGGCGGTCGTCGTGGCGCGGGAGGACCAGCCGGGCGAGAAGCGCCTGGTCGGCTACTTCATCTCCGACGGAACCGATGCGGGGCCGGCGGAGATCCGGCGGGAGATGGCCCTGGTCCTGCCCGCGTACATGGTTCCCCTGGCGGTCGTCGCCCTGCCCGCGCTGCCTGTCACGCCCAACGGCAAGGTGGATCGCCTGGCTCTGCCCGCCCCCGATCTCGTGGGACGTGCGCCGGACAGGGCACAGGAGAGCGAGACCGAGAAGGTGCTGTGCGCGCTCTTCGCCGAGATCCTCGGCGTCGACCGGGTGGGCGTCGACGACGCCTTCCATGATCTCGGCGGCAGTTCGGCACTGGCCATGCGGCTCATCGCGCGGATCCGTGAGGAGCTCGGTGCGGACCTGCCCATCCGGCAGCTGTTCTCCGCGGCCACCCCCGCGGGTGTCGCCCGGGCGCTGGCCGCGAAGTCACGCCCCGCGCTGGAGCCCGCCGAACGGCCGGGCCGGGTACCGCTCACCGCCCAGCAGCTCAGCGCCTGGCTGCTGGCGAGTCCCGGGGAGGCCGCCGGCCTGCACGTCTCGGTCGCGCTGCGCTTGCGCGGCCGGCTGGACGTGCCCGCGCTGGAGGCGGCGCTCGGCGACGTCGCGGCGCGGCACGAGATTCTCCGGACGACCTTCCCCGGCCACGCGCAGAGCGTTCACCAGCACGTACACGACGCCTCGCCGGTTGACCTGACGCCGGTTCCCGCCACCGAGGAGAGCCTGCCCGGGCTGCTCACCGAGCTGCGGGAGTCGGTCTTCGACCTCACCCGGGAGGTGCCGTGGCGCGGTGACCTGTTCCGGCTCTCCGACGGGGAACACGTCCTGCACCTGATGGTGCACCGGATCCTCGCCGATGACGAGTCGCTGGATGTGTTCCTCCGGGACCTGTCGGCGGCGTACGGCGCGCGGCGTGCCGGCCGGGCACCGGAGCGGGCGCCCCTGACACTGCAGTTCGCCGACTACGCGATCTGGGAGCGGCGCCTGCTCGAAGGCGAGCGCGATGCGGACGGCCTGATCAACGAGCAGCTGGTGTTCTGGCGCGACAATCTGGCGGGCATCCACGGGGAGACGGTGCTCCCGTTCGACCGCCCCCGGTCGGCCGTCGCGTCGCGGCGGGCCGGCACGGTGTCGTTGCGACTGGACGCCGGCCCGCACGCCAGGCTGGTGGAGGCGGTGGACCCGATCGGCGCGCACCCGTTCCAGATCGTGCATGCCGCGCTCGCCATGCTGCTGACCAGGCTCGGGGCGGGCCACGACCTGGTGATCGGCACGAAGCTGCCACGGGACGACGACCTCATCGACCTGGAGCCGATGATCGGGCCCTTCGCCCGGCCGCTCGCCCTGCGCACGGACCTCTCGGGCGACCCCACCTTCCTGGAGGTCGTCACCCGGGCGCAGGAGGCGATCCGGTCCGCGCGCCAGCACCTGGACGTGCCCTTCGCCAGGATCGTCGAGCTGCTCGACCTGCCGGTCTCGCTCTCCCGCCATCCCGTGTTCCAGGTGGGGTTGGAGGTGCACGAGGAGGACCTCGGCGCGTGGGACGCGACGGAGCTGCCCGCCCTGCGCACCAGCGTCGAACCTGTCGGGCCGGAGGCCATCGAGCTGGATCTGGCGTTCAGGCTCACCGAGCGCCGCGACGAGGACGGCATCGAGGGCACCCTCCACTATGCCGCCGACCTCTTCGATCAGGCCACGGCCGAGTCGCTGGCACGGCGGCTGGTCAGCTTCCTGGAGCAGGTGGCGGAGGATCCCCAGCGGCGCGTCAGCGACCTGGACGTCCTGCTGGACGACGCCGAACGCGAACGTCCGGCCGAGGCGCCGGCGAAGTGGTCCGAGGCCGTGCCCCCGGTGGCCGCCGACCTGGCCGAGGGCGGTCCGCTCGGCGCGCTCGTGCTCGACGACCGGCTGCGCCCCGCCGTCGCCGTCGGCGAGCTCTACCTCACCGGCGCGGCGGTGGACGCGGAGCCGGGCGACCGGACCCTGGCCTGCCCCTTCGGGGCCACGGGGCGGCGCATGCTGCCCACGGGCCTGCTCGCCCGCTGGACAGCCGGGGGCACCCTGGTCGTCGTCGGCGAGCGGCGGGGATCGAGCGGCTCGGTGAAGACCGGCACGGGCGACTTCGAGGTGCTGCTGCCGCTGCGAGCCGGCGGTAACCGTCCGCCGCTGTACTGCGTCCATGCGAGCGGAGGGCTGAGCTGGAACTACGCGCCCCTGCTGCGGAGCCTGCCCCCCAACCAGCCGGTCTACGGCGTGCAGGCGCGCGGCCTGGCTCGTACGGAGCCGCTGGCGGCCGGCGTCGAGGAGATGGCGGCCGATTACGTCGAGCAGATCCGCGCCGTGCAGCCGACCGGGCCGTACCACCTCCTCGGGTGGTCACTGGGCGGGCGGATCGCGCAGGAGATGGCCAGGGTGCTGGAGGAGCAAGGGGAGCAGGTCGGCCTGCTCGCCCTGCTCGACGCCTATCCCACCGACGTGGGCAGGCTCCGGCGCCCGCGCGGCGACGCGGCCGATCAGGAGGCCGCGGACTTCGACAGGCAGCAGGAGCAGCAGGCGCAGCTCGCCGCCGCGGTGGCCACGGAGGCCGGCGCCAGGAAGCGCCTGGACGAGGTCATGGAGCACCTCGCCCGGGTCGGGCCGCTGCACACCTCCCGCAGCTTCGGCTGCGACATCCTGCTCTTCGTCGCCACAGTGAACCGCCCCTCCCATCTGCCCGTCGCGGACGCCATCGCCAGCTGGCGACCCCTCACCACCGGAACCGTCGAGCCTCACGAGATCGAGATCGACCACATGCAGATGCTGCAGCCCGCGGCGCTGGCCCGGATCGGGGCCGTCGTCGCCGAGAAACTCCGGCCCCGGCCGGACGGTGAAAGGACACAGCGATGA	MTIDDTRAKPRSSVEDVWPLSPLQEGMLYHTALDDDGPDTYTVQTVYGIDGPLDAGRLRASWQALVDRHAALRAYFRYVSGAQMVQVIAREAEIPWRETDLHGLPDDLLDSEVDRLAADELAERLPLDAAPLMKLHLIRLGPASHRLVHTLHHVLLDGWSMPILHRELAAIYAAGGDASGLPAAVSYRDYLAWLGRQDKEAARAAWRQELAGLDTPTLVAPADPARVPDMGTAVIELSAELTDGLARLARGHGLTLNTVVQGAWAMVLAQLAGRTDVVFGATASGRPAELAGVESMVGQLLGTLPVRVRLEGGRRVVELLAELQRSQSALMAHQHLGLQEMQAAVGPGAVFDTLVIYENFPRQGLGRAEEDGGLDLRPVRRGRNSSHYPFTLITGPGAQMPLILDYDRGLFDEAAAESVVGALARVLERLVAEPDVLVGRLTLLSEAERALVVEDWNATAGPTPGQSVLDLFGRRVATAPDAVAITDAGGADLTYAEVDQAANRLARHLAARGIGRGDRVGVVMDRSPDLLIAFLASWKAGAAYVPVDVEHPAERIEFVLADSGVSAVLCTRATREVAPADAIVIDAPETRAAIDAGAATAPQIRLSADDLAYVMYTSGSTGLPKGVGVPHGAVAGLAGDEGWRIGPGDAVLMHATHVFDPSLYAMWVPLAMGGRVVLTEPGVLDALGMRQAVERGVTFVHLTAGTFRALAESSPECFAGLVEVGTGGDVVPAQSVEHLRRAVPGLRVRNTYGPTETTLCATWKPIEPGEEVGRELPIGRPMTNRRIYILDAFLRPVAPGVAGELYIAGTGLARGYLGGPGLTAERFVAVPASVDPSPGERMYRTGDLARWNRDGEVVFLGRTDDQVKIRGYRVELGEVEAVLAAQRGVVEAVVVAREDQPGEKRLVGYFISDGTDAGPAEIRREMALVLPAYMVPLAVVALPALPVTPNGKVDRLALPAPDLVGRAPDRAQESETEKVLCALFAEILGVDRVGVDDAFHDLGGSSALAMRLIARIREELGADLPIRQLFSAATPAGVARALAAKSRPALEPAERPGRVPLTAQQLSAWLLASPGEAAGLHVSVALRLRGRLDVPALEAALGDVAARHEILRTTFPGHAQSVHQHVHDASPVDLTPVPATEESLPGLLTELRESVFDLTREVPWRGDLFRLSDGEHVLHLMVHRILADDESLDVFLRDLSAAYGARRAGRAPERAPLTLQFADYAIWERRLLEGERDADGLINEQLVFWRDNLAGIHGETVLPFDRPRSAVASRRAGTVSLRLDAGPHARLVEAVDPIGAHPFQIVHAALAMLLTRLGAGHDLVIGTKLPRDDDLIDLEPMIGPFARPLALRTDLSGDPTFLEVVTRAQEAIRSARQHLDVPFARIVELLDLPVSLSRHPVFQVGLEVHEEDLGAWDATELPALRTSVEPVGPEAIELDLAFRLTERRDEDGIEGTLHYAADLFDQATAESLARRLVSFLEQVAEDPQRRVSDLDVLLDDAERERPAEAPAKWSEAVPPVAADLAEGGPLGALVLDDRLRPAVAVGELYLTGAAVDAEPGDRTLACPFGATGRRMLPTGLLARWTAGGTLVVVGERRGSSGSVKTGTGDFEVLLPLRAGGNRPPLYCVHASGGLSWNYAPLLRSLPPNQPVYGVQARGLARTEPLAAGVEEMAADYVEQIRAVQPTGPYHLLGWSLGGRIAQEMARVLEEQGEQVGLLALLDAYPTDVGRLRRPRGDAADQEAADFDRQQEQQAQLAAAVATEAGARKRLDEVMEHLARVGPLHTSRSFGCDILLFVATVNRPSHLPVADAIASWRPLTTGTVEPHEIEIDHMQMLQPAALARIGAVVAEKLRPRPDGERTQR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	335.07	gnl|BL_ORD_ID|4935|hsp_num:0	5928			168	1629	colistin A; colistin B
BGC0000289.1|A40926_18 # 25611 # 37862 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.730	BGC0000289.1|A40926_18 	25611	37862	-	Loose	1000	119.013	almE	27.7	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGCTCAGTCGCGGATCGAAGATTTCTGGCCGCTGTCACCACTCCAGCAAGGGTTGCTCTTCCACACGACCTATGACGACGACTGGCCCGGCCTTTATGTGGGCCATTGGATCCTGAACCTGAACGGTCCGGTGGAAGCGGACAGACTGCGTGCCGCATGGGAGGCGCTCCTGGCGCGGCACGCCGCTCTCCGGGCTTGTTTTCGGCAGCGCAAATCAGGTGAGACGGTGCAGCTCATCGCCAGGCAGGTGGAGCTGCCGTGGCGGGTGGTGGACCTCTCCCACCTCAGCGAGCCCGAGGAGGCCGTGCGCGCGGTGGCCGAGGAGGACAGGACGCGGAGGTTCGACCTCGCGAAGGCGCCGTTGCTGCGGCTGACCCTGATCCGTCTCGCCGGCGACGACCACCGCCTGGTGATGACCTGCCACCACGCGATCATGGATGGCTGGTCGATGCCCATCATGCTCGACGAGCTGTCGATGCTGTACGCGGCCGACGGGAGCCCGCTGGACCTGCCCGCGGTGCCGTCGTACCGGGATTACCTGGTGTGGCTGGACCGGCAGGACAAGGAGCGCACGCTGTCGGCATGGGCGGCGGAGCTGCGGGGTGTCGAGGAGCCGACGCTGGTGGCGCCCGCCGATGCGAACCGGGCGCCCGCCATGCCGGAGAACATCACGGTCGAGCTGCCCGAGGACCTCACGCGAGCCCTGAGCGAGCTGGCTCGCACCCATGGGCTGACGCTGAACACAGTGGTGCAGGGCGCGTGGGCGTTGCTGCTCGCCCAGCTCGCGGGCCGGACGGACGTGGTGTTCGGTGCGGCGGTCTCGGCACGCCCGCCGGATCTGCCCGGCGTCGAGGGGATGGTGGGGTTGTTCCTCAACACCGTCCCCGTACGCGTGCGGCTGAGCGGTTCGACGCCGGTCATCGAATTCCTGGCGGATTTGCAGAAGCGGCAGTCGGCGCTCATCCCCCACCAGTACATGGGATTGGCGGATATTCAGAGGACGGCCGGCGCCGGCGCCGTCTTCGACACCTTGCTCGTTTTCCAGAACTTTCCCCGTGAGCTTCGCCCATCGGATGCCGCGGCAGCCTTCGATATTCGAATAGACCAGGGCCGGGAAGCCGCCCATTATCCGCTGACGCTGGTCGCCGTCCCCGGCGAGTCGATGCTGCTCAATCTCGACCATGTGACGGACCTCTTCGACCGGGAAGCCGCGCTCGCCATCCTGGAGCGATTCACCGGGATTCTGCGGCAGCTGGCGGGCGCGGGCGACCTCACGGTGGCCGAGGTCGACGTGACGAGTGCGGCCGAGCGTGCGCTGGTGGTGAACGCATGGAGTGCGGCACCCCGCGTGGCGCCGGGCGAGCTGGCTCCGGATCTCTTCGACCGCCAGGTGGAGCGCGGCCGTGACCGGGTGGCGGTCGTCGAGGGGAAGCGGGCGGTCTCGTTCGGTGAGCTGGCCGAGCACGCGGAGAGGCTCGCCGGCTACCTGAGCGGCCGGGGCGTCCGGCGCGGGGATCGGGTGGCCGTGGTGATGGGCCGGTCACCCGGCCTGATCGCGACGCTGCTGGCGGTGTGGAAGGCGGGAGCGGCGTTCGTGCCGGTGGATCCCGCCTACCCGGCGGAGCGCGTGCAGTTCATGCTCGCGGACGCGGAGCCGGCGGCAGTGGTGACCGAGCGAGCGTGCCAGGCCGCCGTGCCGGCCGGCGGGCTCGATCCGATCGTCCTGGACGACCCGGACACGCTGCGGGCGGTGGCGGAGCACGCCCGTCTCTCCGCGGGTGCGCACGCGGACGACCTCGCGTACGTGATGTACACGTCGGGATCGACGGGCAGGCCGAAGGGCGTCGCGGTCTCGCACGGCAACGTCGCGGCGCTGGCCGGCGAGCCGGGATGGGGGCTGGGGCCCGAGGACGCCGTGCTGATGCACGCCTCGCACGCGTTCGACATCTCGCTGTTCGAGCTGTGGGTGCCGCTGCTGTCGGGCGCCCGGGTCGTGCTCGCCGAGCCGGGCGCGGTGGACGGCGAGGCCCTGGCCGGGTACGTGGCCGGCGGTGTCACCTGCGCTCACCTGACGGCGGGGACCTTCCGGGTGCTGGCCGAGGAGTCACCGGAGTCGGTCGCCGGGCTGCGCGAGGTGCTGACCGGTGGGGACGCGGTGCCGCTCGCGGCGGTGGAACGGGTGCGGCGGGCGTGCCCGGACGTCCGCGTGCGGCATCTCTACGGCCCGACGGAGGCCACGCTGTGTGCGACATGGTGGCTGCTGCAGCCGGGCGAGCCGACGGGGCCGGTGCTGCCGATCGGGCGTCCGCTCGCGGGGCGGCGGGTCTATGTCCTCGACGCGTTCCTGCGGCCCGTGCCCCCGGGGGTGACGGGCGAGCTGTACGTCGCCGGGGCCGGGGTGGCGCAGGGCTATCTGGGCCGCCCGGCGTTGACGGCCGAGCGGTTCGTCGCCGAGCCGTTCGTGCCCGGTGGGCGGATGTACCGGACCGGAGACCTGGCGCGCTGGACGGATCAGGGTGAGCTGGCGTTCGCCGGGCGTGCCGACGACCAGGTGAAGATCCGCGGGTACCGGGTGGAGCCCGGCGAGATCGAGGCGGTCCTCGCCGGCCTTCCAGGTGTCGGTCAGGCCGTGGTGTCCGCGCGGGAAGAGCGCCTGATCGGTTACGTGGTCGCCGAAACAGGGGGGGACCTCGACCCGGTGCGGATACGCGAGCAGCTCGCCGCGACGCTGCCCGAGTTCATGGTTCCGGCCGCGGTGCTGGTGCTGGACGCGTTGCCGCTGACCGGCAACGGAAAGGTGGACCGCCGGGCCCTGCCCGAGCCGGACTTCGCTGCCGGGGCGGTGGACCGGGAGCCGGCCACCGACGCCGAGCGGATCCTGTGCGGAGTGTTCGCCGAGGTCCTGGGGGCGGGGCGGGTCGGGGTCGCAGACAGCTTCTTCGAGCTGGGCGGGGACTCGATCTCGTCGATGCAGGTCGCCGCCCGCGCGCGGCGCCAGGGTATCCCGCTGACCCCCCGACAGGTGTTCGAGCACCGCACGCCCGAGCGGCTGGCGGCGCTGGCTCAACAGGCCCCGGGGAGGCGAGCCTCCTCAGTGGAGCCGGGCGTGGGCGAGATCCCGAGGACGCCGGTGATGCGTGCCCTCGGCGATGACGCGGTGCGCCCCGGTTTCGCGCAGGCGCGGGTCGTCGTCACCCCGGCCGGCTTCGCCCCGGACGCGCTGGTGACCGCCCTGCAGGCCGTCCTGGATGTGCACGATCTGCTACGGACGCGGGTGGAGCCCGACGGACGGCTGATGGTGGCCGAGCCGGGTGCCGTGGACGCGGCCGGCCTGGTGACGCGGGTGGCGGCCGGGAACGGGAACCTCGCTGAGCGCGCCGAGCGCGAGGCCAGGACGGCGGCGGGCACGCTGGACCCGTCCGAAGGGATCATGGTCCGGGCCGTGTGGGTCGACGCGGGCGACGCCGAGCCGGGCCGGTTGGCCTTGGTGGTGCATCACCTGGTCGTCGACGCGGTCTCGTGGGCGATCCTGCTGTCGGATCTGCGGGCGGCCTACGACGAGGCGGTCTCCGGCGGAACCCCCGTCCTCGAACCCGCGGTGACGTCGTACCGGCAATGGGCGCGGCGGCTGGCCGGGCAGGCGCTCAGCGAGAGCACCGTGGCCGAGGCCGGCCATTGGGCCGGCGTGCTCGAAGGCGGCGACCTGCCGCTGGAGCGGCACCCCGGGCAGTCGGCGTCGTGGTCGCGGACACTGTCCGATGCCCAAGCGCGCAACCTGGTGGCGCGCGTGCCGGCAGCCTTCCACTGCGGGGTTCAGGACGTCCTGCTGGCGGGCCTGGCGGGTGCGGTGGCGCGGTGGCGCGGTGCTGACGCCGGGATCCTGGTGGACGTGGAAGGCCACGGCCGCCATGCCGCCGACGGAGAGGATCTGCTGCGTACCGTGGGCTGGTTCACCAGCGTTCATCCGGTCCGCCTCGATGTCTCCGGTGTCGGTCCAGGAGCTGCGGCGGCCGGGGAGTTGCTGAAGGCCGTGAAGGAACAGGCGCGAGCGGTGCCGGGCGACGGGCTCGGCTACGGGCTGTTGCGCTACCTCAACCCCGAAACCGGCGCCCGGCTGGCGGAGCTGCCGTCGGCCCAGATCGGATTCAACTATCTCGGACGGTCCGGCGTCGCCTCCGAGGACACCGCGTGGCAGGTGTGCGAAGGGGCTCTCGGCGGACAGGCGGCCGGGCCGGACCTCGTCCAGTCCCACGCCCTGGAGGTCGGCGCGGACGTTCAGGACACGCCGGCCGGCCCCCGGCTGAGACTCGCCATCGACGGCAGGGACCTCGACCCTGCCGCGGTGGAGCGGCTCGGCGAGGCGTGGCTGGACACGCTGGCCGGCCTCGCCGCTCTCGCCGACACTCCCGGCGCGGGCGGACACACACCGTCCGACTTCGAGCTGGTCGAGGTGCGGCAGCGGGACGTGGACGAACTGGAGGCCGTGGCGCCCGGCCTGACGGACGTCTGGCCACTGTCGCCGCTCCAGGAGGGCATCCTCTTCGAGAGAGCCTTCGACGAGGACGGCGTCGACGTCTACCAGACCCAGCGGATCCTGGACCTCGACGGGCCGCTCGACGCGCAACGGCTGCACGCGGCGTGGCAGTCGGTGATCGACCGGCACGAGACGCTCCGGACGGGCTTCCACCAGCTGGGATCCGGCGAGACGGTGCAGGTCGTCGTGGGCGAGGCCGAGGTCCTGTGGCGTGAGGCGGACCTGTCGCGGCTCGATGAGCCGGACGCGGAGGTGGAACGCCTGCTCGCGGCGGATCAGGCGGAGCGGTTCGACGTCAGCAGGGCGCCGCTGCTGCGGTTGCTGCTGATCCGTCTCGGTGCGGCGCGGCACCGGCTCGTGGTGACGTCGCACCATGTGCTCGTGGACGGCTGGTCCACGCCGATCCTGCTGGGCGAGATGCTGACCGCCTACGCCGACGGACGGGTCTCGCCGGCGCCGCCCTCCTACCGGGACTACGTGGCGTGGCTGAGCCGTCAGGACGAGGACGCGGCACGATCGGCGTGGCGGGCCGAGCTCGCCGGGCTGGACGAACCGACCGTGGTGGGCCTCGACGCGGGCAAGGCGCCGGTGATGCCGGACGGGCATGCCGAATGGCTGTCCGAGGAGGCGACCCGCGCCCTCACCGGCTTCGCCCGTGGTCATGGGCTGACGTTGAGCACGGTCGTGCAGGGCGCCTGGGCCCTGGTGCTGGCGCGGCTGGCGAGACGGACGGATGTGGTGTTCGGCACGGTCGTGTCCGGGCGTCCGGCGGACGCGTTGCCGGATGTCGAGCGGATGGTGGGGATGTTCATCAACACCGTTCCGGTCCGGGTGCGCCTCGACGGGGCTGTTCCGGTGCTGGACCTGCTCCAGGACCTGCAGCGGCGCCAGTCGTCCTTGACGGAGCATCAGCACCTGGGGCTGCCGGAGATCCAGAAGGCGGCGGGGCCGGGCTCGATCTTCGACACGATCCTGATGATCGTCAACTACCCGCTGGACGCCGACGGTCTCGACGACGGTGGCGTGGCGATCAGCTCGATCCGCACGCGGACCGGCACCACCTATCCGCTGTCCGTGAGCGTCATCCCGGGCGCGCGCCTGCAGATCCAGCTGGACTACCGGCCCGACTGGATCGGCGGGGACCTGGCCGCCGAGATCACCGGGCAGGTCGTGCGGGTCCTGGCCCGGATGGTGGCGGAGCCCTCGCTTCCCGTCGGCCGCCTGGCCGTGACCAGCCGATCCACCCGCGGCTCCGTGACGGAGCGCTGGAACTCGACCGGTGCGGCGGCCGGCGGTTCATCGGTGCCGGAGCTGTTCCGGCGCCAGGCCGACGCGGCGCCGGACGCGACGGCGGTCATCGGCGACGGACGCACCCTGTCCTACGCCGGCCTCGACCGGGAATCGGACCGGCTGGCGGGGCACCTGGCCAGGAGGGGCGTGCGGCGCGGCGACCGCGTCGGCGTGCTGATGGAACGCGGCGCGGACCTGATCGTCGCCCTGCTCGCGGTCTGGAAGGCGGGGGCCGCGCAAGTCCCGGTGAACGTGGACTACCCGGCGGAGCGCATCGAGCGGATGCTGGCCGACGCCGGCGCGTCGGTGGCGGTGTGCGCGGGAGCGACCCGGCACGCGGTCCCGGACGGGATCGAGCCGGTGGTCATGGACGCACCCGCGACCGAGGCGGAGCGGCACGAGGCGCCACCGCTCGCGGTCGGAGCGCATGACGTGGCCTACGTGATGTACACGTCCGGATCGACCGGGGTGCCGAAGGGCGTCGCGGTGCCGCATGGGAGCGCCGCGGCTCTGGCCGGCGACCCGGGCTGGTCGCAGGGCGCCGGCGACCGCGTGTTGATGCACGCGTCGCACGCGTTCGACGCGTCGCTGCTCGAGATCTGGGTGCCGCTGGTCAGCGGAGCCTGCGTGATGGTCGCGGAACCGGGCGCGATCGACGCGCAGCGGCTGCGGGACGTGATCGCACGGGGCGCGACCACCGTCCATCTGACGGCGGGGACCTTCCGGGTGCTGGCGGAGGAGTCGCCGGACTCCTTCAGCGGGCTGCGCGAGGTCCTCACCGGCGGGGACGTGGTGCCGCTCGAGTCCGTCGCACGGGTGCGCCGGGCATGCCCGGAGGTCCGGGTCCGGGAGTTGTACGGCCCCACCGAGGTCACGCTCTGCGCCACCTGGCACCTCATCGAGCCGCACACGGAAACGGGCGACACCTTGCCCATCGGCCGTCCGCTGGCCGGCCGGCAGGTGTACGTCCTGGATGCCTTCCTCCAGCCGGTGGCGCCGAACGTCACCGGTGAGCTCTACCTCGCCGGCGCGGGCCTGGCACACGGTTACCTGGGCGCCCCCGCGGCGACCTCGGAGCGGTTCATCGCGGTGCCCGCTTCGGTGAACCCCGCGGCCTCCGGTGAGCGGATGTACCGCACCGGCGACCTGGCGCGCTGGACGGACCGAGGCGAGCTGCTGTTCGCCGGGCGGGCCGACTCCCAGGTGAAGATCCGGGGCTACCGCGTCGAGCCAGGGGAGATCGAGGCGGCGCTGGCCGAGGTTCCGCACGTCGCGCAGGCGGTCGTCGTGGCGCGGGAGGACCGTCCCGGCGAGAAGAGACTCATCGCCTACGTGACCGCGGAGGAGGGCTCGGGCCTGGATCCCGACGCGGTACGCGAGCACCTCGCGGGACGGCTGCCGGAGTTCATGGTGCCGGCGGCGGTGGTGCTGCTGGACGGCGTCCCGCTGACGCCCAACGGGAAGATCGACCGTGCCGCGCTGCCCGTCCCCGAGTTCACCGGGAAGGCGGCCGGCCGGGAGCCGCGTACCGAGGCCGAGCGGGTGTTGTGCGAACTGTTCGCCGAGGTCCTGGGCGTGGCGCGAGCCGGAGCCGAGGACAGCTTCTTCGAGCTGGGCGGCGACTCGATCCTCTCCATGCGGTTGGCCGCCCGCGCGCGACGTGAGGAGCTCGTCTTCGGCGCGAAGGACGTCTTCGAGCGCAAGACGCCCGCCGGGATCGCGATGGTCGCCGAACGCGGCGGTGCGACGCGGGCGAGCCTCGACGACGGCGTCGGTGAGGTGATGTCGACGCCGGTGATCCGGGCACTGCTCGAACGCGATCCCGACGCGATGACCCGGGGCGCCCTGTCCCAGTGGGTGACCGCCGGTGCGCCCGACGACCTGTCGGTGGACGTGCTGGCGGCCGGATTGGGCGCGGTCATCGACGCGCATGACATGCTGCGCAGCCGGATCGTCCGCACCGGGGCTGCGCAGCCCCGGCTGGTCGTGGCCGGCCGCGGAGCGGTGGACGCGGCGACGCTGGTCGAACGGGTCGAGGCCGGCACCGGTGACGTGGATGAGATCGCGGATCGCTGCGCCCGCGACGCGGCCGCACGGCTGGATCCCCACGCCGGCGTGATGATCCGGGCGGTCTGGGTGGACGCGGGGCCAGGGCGGGTGGGACGGCTCGTCGTGGCGGCGCACCATCTCGTGGTGGACGTCGTGTCGTGGCGAATCCTGCTGCCGGACCTGCAGGTGGCCTGCGAAGCCGTGGCCGCCGGCCGGCGGCCGGTGCTCGACCCCGTCGACGTCTCGTTCCGGCGCTGGGCGCGAACGCTGGCCGATCAGGCGGTGACACGGGCCACGGAGCTGGAGACGTGGACGGAGATCCTCGACGGGGCGCGATCGCGGCTGGGCGAGCTCGACCCGGCGCGCGACACCGTCTCGACCGCGGGACGCACATCGTGGACGCTGCCGCATGACCGGGCGGGCGTGCTCGTGGAGCAGGCCACCTCCGCCTTCCACTGCGGTGTCCACGAGGTGTTGCTGGCGACGCTGGCAGGCGCGGTGGCCCACTGGCGCGGCGGCACCGCGGTCGTGGTGGACGTCGAAGGTCACGGCCGCCGGCCCATCGACGAGCTGGACCTGTCGCGGACGGTCGGCTGGTTCACCGACGTGCATCCGCTCCGGCTGGATGTGACAGGGATCGATCCGGCCGAAGTGATCGCGGGTGGCGGTGCGGCCGGTCACCTGCTGAAGCAGGTCAAGGAGAACGTGCGGGCCGTGCCCGACGGCGGGCTCGGCTACGGGATCCTGCGCTATCTCAACGCCGGGACGGGGCAGGCTCTCGCGGCGGCGCCGAAGCCGGAGATCGGGTTCAACTACCTCGGCCGCTTCCCGTCCCGGTCCGCGGGCGCCCCGGAGCCCTGGCAGCTGCTGGGCACCATCGGCGGCACGGCGGAGCAGGACACGGCGTTGCGGCACGCCGTGGAGATCGACGCGGCCGTGCTGGACGGTGCGGCAGGACCTGAGCTGAGCCTGACCGTGACCTGGGCGGGGCGGCTGCTCGGCGAGGCCGAGGCGGAGTCGCTCGCGCAGGCCTGGCTGGCCATGCTGACCGGCCTTGCGGCACACGTCGGTGGCGGCGGCGCCGGCGGGCACACGCCGTCGGACTTCCCGCTCATCTCGCTGACGCAGCAGGACGTGGCGGAGGTCGAGGCCGCCGTACCGACCCTGCTCGACATCTGGCCGCTGTCTCCGCTCCAGGAGGGCCTGCTGTTCCACGCCGCCGACGAGCGCGGCCCGGACGTCTACGCGGGGATGCGCAAGCTCGCCCTCGACGGTCCGTTGGACGTCGCCCGGTTCCGCGCCTCCTGGCAGGCTCTGCTCGACCGGCACCCCGCCCTGCGGGCGAGCTTCCACCAGCTCGGGTCCGGCGCGGCCGTGCAGGCGATCGCTCGCGAGGTGCCGCTGGACTGGCAGGAGACCGATCTGTCCCGGCTGCCCGAGGACGAGGCGCTGGCGGAGTTCGACCGCCTCGCGGAGCAGCTGCACACCGAGCGGTTCGACCTGACCCGGGCGCCGCAGCTGCGGCTGCACCTGGTGCGCCTCGGCGAACGCCGGCACCGGCTGGTCCTGACCTCGCATCACATCGTGGCCGACGGCTGGTCCCTGCCGCTGATCACCGAGGACGTGCTGACCGTGTACGAGTCCGGCGGTGACGGCCGGGCCCTTCCGGCCGCGACGTCGTACCGCGACTATCTCGCCTGGATCGCCCGCCAGGACAAGGCGGCCGCCCGAGAGGCGTGGCGGGCCGAGCTGGCGGGGCTCGACGAGGCGACCCACGTCGTGCCGCCGGAGACGATCACCACTCCCCTGGAGCCCGAACGTGTCGGGTTCGAACTCGACGAGGCGCTGAGCCGGCGCGTGGTGGAGTTCACCGGTCGTCACGGCGTGACGGCGAACACGCTCTTCCAGGGGATCTGGGCACTGCACCTGGCCCGGCTGACCGGACGCGACGACGTGGTCTTCGGCGCCGCGGTGGCCGGGCGCCCGCCCGAGATCCCCGGTGTGGAGTCCGCCGTCGGCCTGTTCATGAACATGTTGCCGGTCCGGGCTCGCCTGGCCGGTGCGGAGCCGTTCCTCGACATGCTGACAGACCTTCAGGAACGGCAGGTCGCGTGCATGCCGCACCAGCACGTGGGGCTGAGCGAGATCAACCAGCTCGCCGGTCCGGGCGCGGCGTTCGACACGATCGTGGTGTTCGAGAACTACCCGCCCCCGCCGCCTCGGCCCGAAGGCCCCGACGCGCTCGTCATGCGGCCCGCGGGCATCCCGAACGACACAGGGCACTATCCGCTGTCCATGCGCGCGTCCGTGGCGGGCCGCGTCCACGGTGAGTTCATCTACCGGCCGGACGTGGTCGATCGGGCCGAGGCCGAGGAGATGCTCGCGTCGATCCTCCGGGCACTGGAGCAGGTGGTGGCCGAGCCGCGCGTGCCGGTCGGGCGCGTGGGCCTGATCGGTCCTGAGCAGCGCCGCCTGGTGGTGGAGGAGTGGAACAGGACCGGCGTGCCGCCCGCCGCGGAGCCGGTGCCGATGCTGTTCCGCCGGCAGGTGGAGCGCTCGCCGGATGCGGTGGCGGTGGTGGACGCGGCCCGGAGCCTGTCGTACAGCGGACTGCTGGACGAGGCGGAGGAGCTGGCGCGGCTGCTGGTGGGGCTGGGCGTGCGCCGTGAGACGCGGGTGGGCGTGCTCGTGGGACGCTCGGCCGAGCTGGTGGTGGCACTGCTCGGGGTGTCCTCGGCGGGCGGGGTGTTCGTCCCGATGGATCCCGATTATCCGCGCGAGCGCATCAGCTTCATCCTGGCGGATTCCGCGCCGGAGGTGCTGCTGTGCACGAGCGAGACCAGGCAGGCCGTCCCGGAGGAGTTCGCGGGCGCGGTGGTGGCGCTGGACGCGCCGCTCGCCGCCGATCCGCGCACTGCGCTGCCCCGGGTGGAGGCGGGTGACGGGGCGTATGTGATCTACACCTCGGGGTCGACGGGCGTGCCCAAGGGAGTCCTCGTCCCCCATGCCGGGCTCGGCAATCTGGCGAGCGCGCAGATCGAGCGCTTCGGCGTCACGTCCGCCTCGCGGATCCTGCAGTTCGCCGCTCTCGGCTTCGACGCCGCCGTCTCCGAGCTGTGCATGGCCCTGTTGTCGGGCGGGACCGTGGTGCTGGCCGACGCGGAGAGCATGCCGCCCCGGGTGTCGCTGGGCGACGCGGTACGCCGGTGGGGCATCACCCACGTGACCGTGCCGCCGAGCGTGCCGGCCGTCGAGGACGACCTGCCGGACAGCCTGGAGACCCTGGTCGTGGCCGGCGAGGCCTGCCCGCCCGCGCTGGTGGACCGCTGGTCGCCGGGCCGCCGGATGATCAACGCCTACGGGCCCACCGAGACGACCGTCTGCGCGACGATGAGCTCCCCGCTGTCTCCGGGACGCGACGTGGTGCCCATCGGCCGGCCGATCACCGGCCTGCGAGCCTATGTGCTCGACGCCTTCCTGCAGCCCGTGCCGCCAGGTGTGACCGGCGAGCTCTATGTGGCGGGGGCCGGGCTCGCCCGCGGCTACCTCGGCCGTCCGGGCCTGACAGCGGAGCGGTTCGTCGCGGTGCCGGCCTCGGTGAGCCCTGCCCGTCCTGGTGAGCGCATGTACCGCACCGGCAACCGGGCCCGCTGGACCCGGGACGGTGAGCTGGTCTTCACCGGCCGGGCCGACGCGCAGGTCAAGGTGCGCGGCTATCGGATCGAGCCGGGTGAGATCGAGGCCGTGCTGGCGGACCATCCGGGGGTCGCCCAGGTGGCGGTCGTCGCCCGCGAGGACGGTCCGGGCCAGAAGTACCTGGTGGCGTATGTCGTCCCCGCGGCCGAGCAGGTGGCCGGCGCTCCCTCCGAGGCCGGGCAGGACGGCGCGTTGATCTCCGCCCTCCGCGAGAGCGCGGCCGGACGCCTGCCGGAGCACATGAGGCCGGCGGCGTTCGTCCCGCTGGACACGATGCCCCTGACCCCGAACGGCAAGGTCGATCATCGGGCGCTGCGGGCCCCCGATTTCGCGAGGTCGTCGTCAGGACGCGACCCGCGCTCGGCCATGGAGGCGAAGTTGTGCGAGCTGTTCGCGGAGGTGCTCGGCCTGGAGGAGGTGGGCGCCGGCGACAGCTTCTTCGAGCTCGGCGGCGACTCGATCACCTCGATGCAGCTGTCGGCCCTGGCCCGCCGGAAGGGGCTGGACCTCACCCCGTGGCAGGTGTTCGACGAGAAGACGGCGGAACGGCTGGCGGCGGTCGTCAAGGAGCTCCCGGCCGACGGCGAGGGCACCGGGGAACCGGAGCCCCCGGCCGGCACACTCGTGGATCTTTCGCCTGATCAGCTGGACCAACTCGAGGCCGGACCGGCCGGCGGATGA	MAQSRIEDFWPLSPLQQGLLFHTTYDDDWPGLYVGHWILNLNGPVEADRLRAAWEALLARHAALRACFRQRKSGETVQLIARQVELPWRVVDLSHLSEPEEAVRAVAEEDRTRRFDLAKAPLLRLTLIRLAGDDHRLVMTCHHAIMDGWSMPIMLDELSMLYAADGSPLDLPAVPSYRDYLVWLDRQDKERTLSAWAAELRGVEEPTLVAPADANRAPAMPENITVELPEDLTRALSELARTHGLTLNTVVQGAWALLLAQLAGRTDVVFGAAVSARPPDLPGVEGMVGLFLNTVPVRVRLSGSTPVIEFLADLQKRQSALIPHQYMGLADIQRTAGAGAVFDTLLVFQNFPRELRPSDAAAAFDIRIDQGREAAHYPLTLVAVPGESMLLNLDHVTDLFDREAALAILERFTGILRQLAGAGDLTVAEVDVTSAAERALVVNAWSAAPRVAPGELAPDLFDRQVERGRDRVAVVEGKRAVSFGELAEHAERLAGYLSGRGVRRGDRVAVVMGRSPGLIATLLAVWKAGAAFVPVDPAYPAERVQFMLADAEPAAVVTERACQAAVPAGGLDPIVLDDPDTLRAVAEHARLSAGAHADDLAYVMYTSGSTGRPKGVAVSHGNVAALAGEPGWGLGPEDAVLMHASHAFDISLFELWVPLLSGARVVLAEPGAVDGEALAGYVAGGVTCAHLTAGTFRVLAEESPESVAGLREVLTGGDAVPLAAVERVRRACPDVRVRHLYGPTEATLCATWWLLQPGEPTGPVLPIGRPLAGRRVYVLDAFLRPVPPGVTGELYVAGAGVAQGYLGRPALTAERFVAEPFVPGGRMYRTGDLARWTDQGELAFAGRADDQVKIRGYRVEPGEIEAVLAGLPGVGQAVVSAREERLIGYVVAETGGDLDPVRIREQLAATLPEFMVPAAVLVLDALPLTGNGKVDRRALPEPDFAAGAVDREPATDAERILCGVFAEVLGAGRVGVADSFFELGGDSISSMQVAARARRQGIPLTPRQVFEHRTPERLAALAQQAPGRRASSVEPGVGEIPRTPVMRALGDDAVRPGFAQARVVVTPAGFAPDALVTALQAVLDVHDLLRTRVEPDGRLMVAEPGAVDAAGLVTRVAAGNGNLAERAEREARTAAGTLDPSEGIMVRAVWVDAGDAEPGRLALVVHHLVVDAVSWAILLSDLRAAYDEAVSGGTPVLEPAVTSYRQWARRLAGQALSESTVAEAGHWAGVLEGGDLPLERHPGQSASWSRTLSDAQARNLVARVPAAFHCGVQDVLLAGLAGAVARWRGADAGILVDVEGHGRHAADGEDLLRTVGWFTSVHPVRLDVSGVGPGAAAAGELLKAVKEQARAVPGDGLGYGLLRYLNPETGARLAELPSAQIGFNYLGRSGVASEDTAWQVCEGALGGQAAGPDLVQSHALEVGADVQDTPAGPRLRLAIDGRDLDPAAVERLGEAWLDTLAGLAALADTPGAGGHTPSDFELVEVRQRDVDELEAVAPGLTDVWPLSPLQEGILFERAFDEDGVDVYQTQRILDLDGPLDAQRLHAAWQSVIDRHETLRTGFHQLGSGETVQVVVGEAEVLWREADLSRLDEPDAEVERLLAADQAERFDVSRAPLLRLLLIRLGAARHRLVVTSHHVLVDGWSTPILLGEMLTAYADGRVSPAPPSYRDYVAWLSRQDEDAARSAWRAELAGLDEPTVVGLDAGKAPVMPDGHAEWLSEEATRALTGFARGHGLTLSTVVQGAWALVLARLARRTDVVFGTVVSGRPADALPDVERMVGMFINTVPVRVRLDGAVPVLDLLQDLQRRQSSLTEHQHLGLPEIQKAAGPGSIFDTILMIVNYPLDADGLDDGGVAISSIRTRTGTTYPLSVSVIPGARLQIQLDYRPDWIGGDLAAEITGQVVRVLARMVAEPSLPVGRLAVTSRSTRGSVTERWNSTGAAAGGSSVPELFRRQADAAPDATAVIGDGRTLSYAGLDRESDRLAGHLARRGVRRGDRVGVLMERGADLIVALLAVWKAGAAQVPVNVDYPAERIERMLADAGASVAVCAGATRHAVPDGIEPVVMDAPATEAERHEAPPLAVGAHDVAYVMYTSGSTGVPKGVAVPHGSAAALAGDPGWSQGAGDRVLMHASHAFDASLLEIWVPLVSGACVMVAEPGAIDAQRLRDVIARGATTVHLTAGTFRVLAEESPDSFSGLREVLTGGDVVPLESVARVRRACPEVRVRELYGPTEVTLCATWHLIEPHTETGDTLPIGRPLAGRQVYVLDAFLQPVAPNVTGELYLAGAGLAHGYLGAPAATSERFIAVPASVNPAASGERMYRTGDLARWTDRGELLFAGRADSQVKIRGYRVEPGEIEAALAEVPHVAQAVVVAREDRPGEKRLIAYVTAEEGSGLDPDAVREHLAGRLPEFMVPAAVVLLDGVPLTPNGKIDRAALPVPEFTGKAAGREPRTEAERVLCELFAEVLGVARAGAEDSFFELGGDSILSMRLAARARREELVFGAKDVFERKTPAGIAMVAERGGATRASLDDGVGEVMSTPVIRALLERDPDAMTRGALSQWVTAGAPDDLSVDVLAAGLGAVIDAHDMLRSRIVRTGAAQPRLVVAGRGAVDAATLVERVEAGTGDVDEIADRCARDAAARLDPHAGVMIRAVWVDAGPGRVGRLVVAAHHLVVDVVSWRILLPDLQVACEAVAAGRRPVLDPVDVSFRRWARTLADQAVTRATELETWTEILDGARSRLGELDPARDTVSTAGRTSWTLPHDRAGVLVEQATSAFHCGVHEVLLATLAGAVAHWRGGTAVVVDVEGHGRRPIDELDLSRTVGWFTDVHPLRLDVTGIDPAEVIAGGGAAGHLLKQVKENVRAVPDGGLGYGILRYLNAGTGQALAAAPKPEIGFNYLGRFPSRSAGAPEPWQLLGTIGGTAEQDTALRHAVEIDAAVLDGAAGPELSLTVTWAGRLLGEAEAESLAQAWLAMLTGLAAHVGGGGAGGHTPSDFPLISLTQQDVAEVEAAVPTLLDIWPLSPLQEGLLFHAADERGPDVYAGMRKLALDGPLDVARFRASWQALLDRHPALRASFHQLGSGAAVQAIAREVPLDWQETDLSRLPEDEALAEFDRLAEQLHTERFDLTRAPQLRLHLVRLGERRHRLVLTSHHIVADGWSLPLITEDVLTVYESGGDGRALPAATSYRDYLAWIARQDKAAAREAWRAELAGLDEATHVVPPETITTPLEPERVGFELDEALSRRVVEFTGRHGVTANTLFQGIWALHLARLTGRDDVVFGAAVAGRPPEIPGVESAVGLFMNMLPVRARLAGAEPFLDMLTDLQERQVACMPHQHVGLSEINQLAGPGAAFDTIVVFENYPPPPPRPEGPDALVMRPAGIPNDTGHYPLSMRASVAGRVHGEFIYRPDVVDRAEAEEMLASILRALEQVVAEPRVPVGRVGLIGPEQRRLVVEEWNRTGVPPAAEPVPMLFRRQVERSPDAVAVVDAARSLSYSGLLDEAEELARLLVGLGVRRETRVGVLVGRSAELVVALLGVSSAGGVFVPMDPDYPRERISFILADSAPEVLLCTSETRQAVPEEFAGAVVALDAPLAADPRTALPRVEAGDGAYVIYTSGSTGVPKGVLVPHAGLGNLASAQIERFGVTSASRILQFAALGFDAAVSELCMALLSGGTVVLADAESMPPRVSLGDAVRRWGITHVTVPPSVPAVEDDLPDSLETLVVAGEACPPALVDRWSPGRRMINAYGPTETTVCATMSSPLSPGRDVVPIGRPITGLRAYVLDAFLQPVPPGVTGELYVAGAGLARGYLGRPGLTAERFVAVPASVSPARPGERMYRTGNRARWTRDGELVFTGRADAQVKVRGYRIEPGEIEAVLADHPGVAQVAVVAREDGPGQKYLVAYVVPAAEQVAGAPSEAGQDGALISALRESAAGRLPEHMRPAAFVPLDTMPLTPNGKVDHRALRAPDFARSSSGRDPRSAMEAKLCELFAEVLGLEEVGAGDSFFELGGDSITSMQLSALARRKGLDLTPWQVFDEKTAERLAAVVKELPADGEGTGEPEPPAGTLVDLSPDQLDQLEAGPAGG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	734.35	gnl|BL_ORD_ID|4935|hsp_num:0	5928			159	1629	colistin A; colistin B
BGC0000289.1|A40926_19 # 38093 # 40486 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.719	BGC0000289.1|A40926_19 	38093	40486	-	Loose	1280	39.2762	macB	22.82	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCGCACCGTCTTTCTCGCGTCGCTGCGCACCCATGTCCGCAGGTACGTCGCGGCGGCGATCGCGGTCACCGTCGCCGTGGCCTTCGTCGTCGGGGTCGGCGTGCTCACCTCCGGGGCGCAGAGCGGCATCATGGCCGGCTTCGGGGCGCCGTTCCGCAACTCCGACCACGTGGTGTCCAAGCTGACGAACGAGGATGCGTTCGAGCTCGTCGAGCGTCATGGCGCGAACGCGTCACCGCTCGGCAGGGCCATGCTGACGGTGCGCGCGGGTGACCGGTCCTACCCCGAGATGGGCGTGGGGCCGGTCGCCGAGTCCAAGGACCTGCGCTGGCAGCAGCTCACCTCGGGCCGTTTCCCCGAGCGCAAGGGCGAGGCCGTGGTGGACCTGTGGGACGCCCAGAACTGGGACGTCGCCGTCGGCGACCGCATCCGGATAGGTGAGCGTGCCACGGCAGCCGACTTCACCGTGGTCGGCATCGTGCGGGCGCCTTCTCCTGTGGCGCAGGCGTCGGTGTACGTCACCTGGCCGCAGCTCATGCGCTGGGCCGACGATCCCTCCCTCGGCATCTACACGGTGACGGTGCGCGGCGCGGTCGGTCCGGTGCCCGAGACCGCGAAGGTGCAGACCCCGGAGCAGGAGATCGCGGCCCGGACGGCGCAGCTCCAGAACGGCGTGGACACCTGGTCACTGCTGCTGCTGCTCTTCGCCGGCATCGCCGTGTTCGTCTCGATCCTGGTCATCGCGAACACCTTCTCCATCCTGCTGGCCCAGCGCATGCGCGACTTCGCCCTGTTGCGCTGCGTCGGTGCGACCCGCCGCCAGGTGGTGAGTTCGGTACGCCGGGAGGCGGCCGTCGTCGGCCTCCTGTCGTCGCTGGCCGGCGTGCTGGTCGGCGCCGGACTCGGCTACGGGCTCATCGCCCTGATCAAGACCCTCTCACCGATCACCCCGATCGCCGCCCCGGCACCGCCCGCGCCGTGGCTGCTGGGCGGGCTCGCCATCGGGCTGACGGCCACCCTGGTCGCGGCCTGGCTGCCGATCCGGCGCGTGGTGCGGGTGAGCCCGCTGGCGGCACTGCGTCCCGACACCGCGACCGACCCGCGTACAGCCACGGGGCGGGCACGGCTGGTGCTCGGCGTCTTCATGTTGATCGCCGGGCTCGTCCTGCTCGCGTCGGCGATGGCTTGGCACAGCACGGTGCTCATGCTGGCCGGCGGCGGTTCGTTGTTCACCGGCGTGCTCCTGTTCGGGCCGGTGCTCATCCCCCGTCTGCTGGAGATCACCGGTACGCGGCTCGGCACCATCGGGCGGCTCGCGACGAAGAACGCCGTGCGCAACCCGCGCCGGACCGCCACCACCGCCGCCTCACTGCTGGTCGGTATCACCCTGATCACCGCCGTCCTGACCGGCGTCGCCATCACCTCCGAGGCGCTGAACGAGAGACTCGACGGCCAGCACCCCATCGACGCCGCGCTGGTCTCGACCGGCAAGCCGTTCTCCGCCGACTTCCTCGACAAGGTCCGTGGCACTTCCGGGGTGGATCAGGCCATCGCGGTGGACGGCGCCGTCGCCACGGTCTCCGGCCTCGACAAGCCGATCCCGGTGGTCACCGCGCCGGATGCCCAGCGGGTGGCCCACGACGGCGGGTCGTTCGCCCGGGTGGAGCCAGGCGTGCTCAGGCTCGATGAGTCCGCATTCCGCCAGCTGCGCCTGCGGGCCGGTGACAAGGTCAGGGTCACGGTCGGCGACCGGCGGGCCGTGCTGCAGGTCTCGCTCGCCACCGGCTGGGGGCTGCAGGCCGTCGTCGCGCCGGAGACGCTGGCCCGGCTCACCGACTCCGCCGCGCCGCGTGCCGTCTGGATCCGCGCATCCGCCGACGCCGACTCGACGCGGCTCGTCGGTGAGCTGGGCGACCTGGCGGCCGCGGCCGGGGCGAACGTGAACGACCAGCTGGAGGCCCGTGAGACGGAGAACGCGCCGCTGATGATCCTCACCTGGGCCATCGTCGCGCTGCTCGGCTTCTCCGTGGCGATCGCCCTCGTCGGGATCGCCAACACCCTGGGCCTGTCCGTTCTCGAGCGTGTTCGCGAACACGCGCTGCTGCGCGCGCTCGGGCTCACTCGCAGGCAGTTGCGGCGGATGCTGGCCGCCGAGGCCGTGCTGCTCTCCCTGGTGGCCGCCGTGCTCGGCACCGTGATCGGCATCGGGTTCGCCTGGGTCGGTTACGAGACCTTCGTGAAGCAGGCTCTCGACAACGCCACCATGCAGGTCCCCTGGCCACTGCTCGCCGTCGTCGTCCTCGTCGCCGCCCTGGCGGGGCTCCTGGCCAGTGTTCTCCCGGCACGCCGGGCCGTCCGGGTGACGCCGGCCGCGGGGCTTTCCTTCGAGTGA	MRTVFLASLRTHVRRYVAAAIAVTVAVAFVVGVGVLTSGAQSGIMAGFGAPFRNSDHVVSKLTNEDAFELVERHGANASPLGRAMLTVRAGDRSYPEMGVGPVAESKDLRWQQLTSGRFPERKGEAVVDLWDAQNWDVAVGDRIRIGERATAADFTVVGIVRAPSPVAQASVYVTWPQLMRWADDPSLGIYTVTVRGAVGPVPETAKVQTPEQEIAARTAQLQNGVDTWSLLLLLFAGIAVFVSILVIANTFSILLAQRMRDFALLRCVGATRRQVVSSVRREAAVVGLLSSLAGVLVGAGLGYGLIALIKTLSPITPIAAPAPPAPWLLGGLAIGLTATLVAAWLPIRRVVRVSPLAALRPDTATDPRTATGRARLVLGVFMLIAGLVLLASAMAWHSTVLMLAGGGSLFTGVLLFGPVLIPRLLEITGTRLGTIGRLATKNAVRNPRRTATTAASLLVGITLITAVLTGVAITSEALNERLDGQHPIDAALVSTGKPFSADFLDKVRGTSGVDQAIAVDGAVATVSGLDKPIPVVTAPDAQRVAHDGGSFARVEPGVLRLDESAFRQLRLRAGDKVRVTVGDRRAVLQVSLATGWGLQAVVAPETLARLTDSAAPRAVWIRASADADSTRLVGELGDLAAAAGANVNDQLEARETENAPLMILTWAIVALLGFSVAIALVGIANTLGLSVLERVREHALLRALGLTRRQLRRMLAAEAVLLSLVAAVLGTVIGIGFAWVGYETFVKQALDNATMQVPWPLLAVVVLVAALAGLLASVLPARRAVRVTPAAGLSFE	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	123.76	gnl|BL_ORD_ID|446|hsp_num:0	487			1521	1926	erythromycin
BGC0000289.1|A40926_20 # 40486 # 41184 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.684	BGC0000289.1|A40926_20 	40486	41184	-	Loose	1280	189.119	macB	43.64	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACCGGCCAGCGAGCCGCTCTGGAAACCGTGGCGGCCAGCGCGCGAAACCTGACCAAGGTGTACGGCCAGGGTGAAACCCGCGTGCATGCCCTGCGCGGCGTCGACCTCGACCTCCCGCGCGGCAAGTTCACCGCGATCATGGGGTCGAGCGGATCGGGCAAGTCCACGTTGATGCACTGCCTGGCCGGGCTCGATCAGGCGAGCGATGGCACTGTCACCGTGGCCGGCACCGATCTCGGATCACTCGACGACAACGAGCTCACGGTCTTCCGCCGTGAGCACATCGGCTTCGTGTTCCAGTCTTTCAACCTGCTGCCGATGCTCACGGCGTTCCAGAACATCACGCTCCCGCTCGAGCTCGGCGGCCGGCGCATCGACGACGCGGCGACCGAGCGCGTGCACGTGCTCGCCGAAACCCTCGGCATGGCCGACCGGCTCGGCCACCGGCCCTCCGAGATGTCCGGCGGCCAGCAGCAGCGGGTGGCCATCGCCCGGGCTCTGATCACCGGGCCGGATCTGCTGTTCGCCGACGAGCCCACCGGAAACCTCGACAGCACCACCTCGGCGGAGGTCCTGGGGTACCTGCACAAATCCACCCGCGAGCTGGGCCAGACCGTCGTGATGGTCACCCACGAGCGTGAGGCCGCGGCCTACGCCGACGGCGTGGTCACCCTGGAAGACGGACGGATCGCCTGA	MTGQRAALETVAASARNLTKVYGQGETRVHALRGVDLDLPRGKFTAIMGSSGSGKSTLMHCLAGLDQASDGTVTVAGTDLGSLDDNELTVFRREHIGFVFQSFNLLPMLTAFQNITLPLELGGRRIDDAATERVHVLAETLGMADRLGHRPSEMSGGQQQRVAIARALITGPDLLFADEPTGNLDSTTSAEVLGYLHKSTRELGQTVVMVTHEREAAAYADGVVTLEDGRIA	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	36.02	gnl|BL_ORD_ID|446|hsp_num:0	487			15	660	erythromycin
BGC0000289.1|A40926_22 # 43105 # 43569 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.641	BGC0000289.1|A40926_22 	43105	43569	-	Loose	1320	23.8682	lmrD	28.57	3002882	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGTCCGCCAGCAGTCGCCGGCGAACAACCACGACCTGGTCGCCGCGATCAGGGAGGACATCGAGTCCATGATCGCGGAGTGCGATCCGACGCTCGTTCTCACCTGTGTGGCCATCGGGAAACACCCCGACCACAAGGCCACGCGGGATGCCACGCTGCTCGCCGCACGCGAGCGAGGTATTCCGCTGCGACTCTGGCAGGATCTCCCGTACGCGGCGTATTCCCAGGACCTGGCTGAATTGCCTGACGGCCTCCGGCTCGGCTCTCCGGAGCTGAGTTTCGTCGATGAGGAGGCGCGGACGCGGAAATTCCAGGCGATGAAGCACTACGCGACGCAGTTGTCGGTGCTCGACGGGCCGAACAAGAACCTGTTCGCCAAACTCGATGAGCATGCCAGGAACGCCGCACCGGACGGCGGATATAACGAGACCACCTGGCCGGTCATTCGCTACGCAGCCGAGTAA	MVRQQSPANNHDLVAAIREDIESMIAECDPTLVLTCVAIGKHPDHKATRDATLLAARERGIPLRLWQDLPYAAYSQDLAELPDGLRLGSPELSFVDEEARTRKFQAMKHYATQLSVLDGPNKNLFAKLDEHARNAAPDGGYNETTWPVIRYAAE	MENTKSTRKMSDTTRAIRFFYLYLKRYKLQFAVIMIFIILATWLQVVSPSLLGDAITNLTKYVTDFFTHQHAGQSQDALQQIAQQLSQQMHQTVDWHNVPEVVKSLPQAAQDQITANLPKGTTLETLKTVATSHAASTSTFMKGMWQLLAVYVATGVSMLIYTLLFSRIVAHSTNRMRKGLFGKLERLTISYFDRHQDGDILARFTSDLDNIQNTLNQALVSVISNAAVFVGVIIQIFNKDVTFAWLTVAASPVAILSAVIIIRQSKKATDKQQEEVSQLNAYMDEKISGQKAIIVEGLQEDSINGFLEHNENVKKRTFAAQAWSGMIFPLMNGFQLLSIAIVIFGGTAYVLNDDSMSIATGLGLLVAFVQYVQSYYNPIMQISSNFGQLQLAITGATRLNVMFDEPEEVRPENGKKFDTIKDGIQIENLDFEYLPGKPVLKKVNIDVKKGQMVALVGPTGSGKTTVMNLMNRFYDVNGGAIKFDGTDIREFDLDSLRSNVGIVLQESVLFDGTIADNIKFGKPNATQEEIETVAKTTHIHDFIDSLPDKYETHVSDDESVFSVGQKQQISIARTILTNPELLILDEATSNVDTVTEQQIQWAMEAAIAGRTSFVIAHRLKTILNADKIVVLKDGEVIEEGNHHELVAQGGFYSELYHNQFVFE	23.19	gnl|BL_ORD_ID|1488|hsp_num:0	1624			309	576	
BGC0000289.1|A40926_23 # 44201 # 45463 # -1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=3bp;gc_cont=0.704	BGC0000289.1|A40926_23 	44201	45463	-	Loose	650	147.517	vanS gene in vanO cluster	33.76	3002941	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GTGGCCCATCGTCTCCGACGCCTGACAACAGCCTTCCGCAGCGTACGGCTGCGCCTCACGCTCGTCTACGGCGCGTTGTTCGCCGCCTCAGGGGTGGTCCTGCTCGCCATCACCTACCTGCTCTTCCGCGGCTCCAGACCCTTCGTGCTGGTGGACGGTGACCCTGGCGGCAGGTTCCGCGCCTTCGCGCGGCAGCAGCAGGCGGCCATTCTGGAGAACCTGCTGTTCCAATCGCTGATCGCGCTGGCCCTGATGACGGTCATCTCGTTCTTGCTCGGCTGGCTGGTGGCAGGCAGGATGCTGCGCCCGCTACGGACGATGAACACCACGCTCAAGCGGATCTCCGCCCGCAACGTCCACGAGCGGCTCGCCCTGCCCGGCCCGCGCGACGAGCTGCGCAACCTCGCCGACACGGTGGACGAGCTGCTGGAACGTCTCCACAGCGCCCTCGACGCGCAGAAGCGCTTCGTCGCCAACGCGGCCCACGAGCTGCGCACCCCGCTCACCCTGGAGCACGCGTTGCTGGAGGAGAGCCTCCTGCATCGGGACGCCGACACCCCGTCCATGCGATCGATCATGGAGCGGCTGCTCGACCTCAGCCGGCAGCAGGGGCGCCTGCTGGAATCGCTGCTGACGCTGGCCAAGAGCGAGGGCGGCCTCGATCACCGCGAGCCCCTGGATCTGGCGGAGATCGCCGAGCACACGATCCGCACGATGGAGGGGACCGGCCCCGGGGCTGACGGGAACAACCCCAGGGCCGGCGTGAGTGCCGATCGGAGGGCTGACGGGAACAGCCCCACGGCCGGCGCGGCAACCGATTCCTGGGCCGACGGGAAGTCCCTCCGGGCCGGTTGCCCACACCCCCGATTGGTGACCGGGATCGCTCATGCCCCCACCACGGGCGACCCGGCACTGGTCGAACGACTCATCACCAACCTTCTGGACAACGCCATGCGCTACAACGTGCCTGGCGGCCAGGTGGAGCTCTCCACCCGGGCCGAGGCCGGGAAGGCCGTCGTCTCCATCGCCAACACCGGCCCGGTGGTGCCCCCCGAGCAGGTCCACCGCCTCTTCGAGCCCTTCCAGCGGCTCGACCGCACCCGCGCCGACGACCACCACGGCCTCGGGCTGTCCATCGTCCGCGCCATCGCCGTCGCCCACGACGCCACGTTGACCGCGCACGCGCGCCCGCAGGGTGGCCTCTCGGTAGAGATCCACTTCCCCCTCATGCGGCGCGCGCTGCGCCGGCTGGCGCCATCCTAG	MAHRLRRLTTAFRSVRLRLTLVYGALFAASGVVLLAITYLLFRGSRPFVLVDGDPGGRFRAFARQQQAAILENLLFQSLIALALMTVISFLLGWLVAGRMLRPLRTMNTTLKRISARNVHERLALPGPRDELRNLADTVDELLERLHSALDAQKRFVANAAHELRTPLTLEHALLEESLLHRDADTPSMRSIMERLLDLSRQQGRLLESLLTLAKSEGGLDHREPLDLAEIAEHTIRTMEGTGPGADGNNPRAGVSADRRADGNSPTAGAATDSWADGKSLRAGCPHPRLVTGIAHAPTTGDPALVERLITNLLDNAMRYNVPGGQVELSTRAEAGKAVVSIANTGPVVPPEQVHRLFEPFQRLDRTRADDHHGLGLSIVRAIAVAHDATLTAHARPQGGLSVEIHFPLMRRALRRLAPS	MLAGVLLLAAVWVFLLRGRSTNFQFPALADFARVFDPSNFGPVVFVPAAILALGFLLVFGLVGGWILAGRMLAPLARITRAAREAGSGSLSYRIELEGRNDEFRELADAFDAMLARLEARDAAQQRFAANASHELRTPLAITQTLLDVARNDPNRDGGELDERLRAVNARAIELTEALLLLSRTDQRSFSREDVDLSLIAEEAAETLLPFAEKHGVSIETSGDIAPVIGSHALLLQLTTNLLHNAIVHNVPEHGSVQISTAIGSESVMLTVENTGDKLSPQLVSTLTEPFQRGTARTRGDDARVGLGLAIVKSITQAHDGSLTLSPRAAGGLSVAVRLPAAQRRP	121.74	gnl|BL_ORD_ID|4732|hsp_num:0	465			6	1029	vancomycin
BGC0000289.1|A40926_24 # 45559 # 47715 # -1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.727	BGC0000289.1|A40926_24 	45559	47715	-	Loose	200	33.113	vanT gene in vanC cluster	30.3	3002970	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGGAGCGCCCGGCACCCACCGAACAGATGTCCCTTCCGACCTGCGCATGCGGGCTGACGCCGCACGCCCCGTCGTGTGCGCCGCGAAGCGAGCACGCCGGCGGCCGGAGCTCCGAGTCCCGCACGGACATTCAGGGCCTCCGGGCGATCGCGGTGGCGGCGGTGGTCGCGTTCCACCTGTGGCCCGGCGGGCCGACCGGCGGGTACGTGGGGGTAGACGTCTTCTTCGTCATCTCCGGGTACCTCATCACGAGCCACCTGCTGCGTCAGCCGGGACACGGCGGCGGGAGACTGCTGGACTTCTGGGCACGCCGCGTCCGCCGCCTCATCCCGGCCGCGAGCCTCGCGCTCCTGGTCACGCTCGCCGCGTCGGTGGTCTGGCTGCCGCTCACGGTGCTGGGGACGGCGGCGCGTGAGGTGATCGCCGCCACGGTGTACGTGGAGAACCTGAGACTCGCGCTCACGCAGGCGAACTACCTCGACGTCGACCAGCCGGACTGGCCCGCGCAGCACTACTGGTCGCTGTCCATCGAGGAACAGTTCTACCTCGGCTGGCCGCTGCTGCTGGGGTCGGCGGCCTGGCTGGCCGCCCGGGTGGCACGGGGGCGTCGCCCTCCGGAGAACTTCACGAGGTGGAGCGCGGTGGTGGTCACGGGTGCGGTCGTGGCCGCGTCCCTCGCCTGGTCGGTGCAGAAGACGGCGACCGATCCGGCCGCCGCGTACTTCGTGTCGACGACCCGCTTCTGGGAGCTCGCGCTCGGCGGTCTGCTCGCCGCGGTTCTCACCGTACGCGCGATGCCGCGCGCGCGGGCGGTCCGGGCCGGGCTCGCGTGGGCCGGCCTGGGCATGATCGGGTGGGCCGTGGTCCGGTTCGACGCCGAGACGGCCTTCCCCGGAGCCGCCGCCCTGGTGCCGACAGTGGGGGCCTGCCTGGTGATCGCAGCGGCCGCGGACGGTCTGCGCGGCGGACCCGGGCGGGCGCTGGCGTGGCGGCCGGTCCAGTGGCTCGGCAACGCCTCCTACGCGGTGTACCTGTGGCATTGGCCGCCGATCATGATCCTCCCGTACGCGCTGGGCCGCTCGCTGACCGTGATCGAGTCCGTGGGCGTGATCGCGCTGACCCTGGTCCTCGCCGCGCTCTCGCAGTACCTCGTCGAGGACCGGCTGCGCTGGCACCCGGTCCTGGTCCGCAGCCGCAGGCTCACGTTCGCGATGCTCGCGTCGTGCGTGGTGGTCGTCGCAGGAGCGGGAGCGGGCGTCGTCGCCTACGCCGACGCCGCCGAGCGTACGGAGAGTGCCGCGTTCGAGGCCGCGGCCTCGCGGGCAGGGTCATGCCTGGGTGCCGGCGTCGTGCGCGACCCGGCGTGCCAGGATCTGGGCCTGCTGATGCCTCCTCAGGTCGCGTTGAAGGACAAGCCCGCCGTGTACGCGGACGGGTGCGTGAACAAGGAACCGTTCATCGCCCGGAACACGTGCACGTACGGACCTGACGCCGCCGGCAGGCGCATCGCCCTGGTCGGGAACTCCCACGCGGGACACTGGGTCCCGGCCCTGGAGAAGGCGCTGTGGAGCGAGCGCTGGCAGCTCACCACCTACGTACAGCTGGCGTGCTACACCGTCGATCAGCCGCTCGTCCTCGAAGGCGCGGGGGTCTCGGAGAACTGCCAGAAGATCAACAAGTGGGCGGTCGGGTCCATCGTGAACGGCGGCTACGACCTGGTGATCATGTCCAACCGTACGCATGTGCCGCTCGCCGGCGTCTCGCCAGCCGGCCAGCAGGCCGCGGCCGAGCGGGCCTACCGCGACACGCTCCGGGCCTTCACCGGCGCCGGCCTTCCGGTGCTCGTCCTGCGTGACACCCCGGCCATGCCGGACAGCGTGCCCCACTGCATCGCCAAGCACCCGGACGATCTGGACTCCTGCGGCGGCCCGGCCGGCGTCGTGCTCCGGCCGGATCCGCTCGCCGCCGCCGCCCGCGCCGACGACACCGGCCTCGTCTCCGTGGCGAGTGTCGATCACCTGGTGTGCGGCGAGCGGTGCGGCCCCGTCATCGGCGGCCTGATCGCCTACTCCGACCGCAGCCACCTCACCACCACCTTCGCCCGCACCCTGGCGCCCGAGGTCACGGCAGCGGTGCGCGGTGCGCTGACTCGGTAG	MERPAPTEQMSLPTCACGLTPHAPSCAPRSEHAGGRSSESRTDIQGLRAIAVAAVVAFHLWPGGPTGGYVGVDVFFVISGYLITSHLLRQPGHGGGRLLDFWARRVRRLIPAASLALLVTLAASVVWLPLTVLGTAAREVIAATVYVENLRLALTQANYLDVDQPDWPAQHYWSLSIEEQFYLGWPLLLGSAAWLAARVARGRRPPENFTRWSAVVVTGAVVAASLAWSVQKTATDPAAAYFVSTTRFWELALGGLLAAVLTVRAMPRARAVRAGLAWAGLGMIGWAVVRFDAETAFPGAAALVPTVGACLVIAAAADGLRGGPGRALAWRPVQWLGNASYAVYLWHWPPIMILPYALGRSLTVIESVGVIALTLVLAALSQYLVEDRLRWHPVLVRSRRLTFAMLASCVVVVAGAGAGVVAYADAAERTESAAFEAAASRAGSCLGAGVVRDPACQDLGLLMPPQVALKDKPAVYADGCVNKEPFIARNTCTYGPDAAGRRIALVGNSHAGHWVPALEKALWSERWQLTTYVQLACYTVDQPLVLEGAGVSENCQKINKWAVGSIVNGGYDLVIMSNRTHVPLAGVSPAGQQAAAERAYRDTLRAFTGAGLPVLVLRDTPAMPDSVPHCIAKHPDDLDSCGGPAGVVLRPDPLAAAARADDTGLVSVASVDHLVCGERCGPVIGGLIAYSDRSHLTTTFARTLAPEVTAAVRGALTR	MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAELAVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQVLLVNGILYHLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAVFHLLDGTRNGIFFTPLFLCLGVLVRKQSEKRSLSKTALFFLISLIGLLIESAYLHGFSIPKHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISILQNNLINYLVVLILTIGFICLFLRQKHSWFRHKQTTPVKRAVKEFSKTALLHNLQEIQRIISPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIRLRKNAVKSPILVLGYTSPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFDLPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGILNYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQTAVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIPIESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK	102.87	gnl|BL_ORD_ID|4675|hsp_num:0	734			15	279	vancomycin
BGC0000289.1|A40926_25 # 47965 # 49911 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.685	BGC0000289.1|A40926_25 	47965	49911	+	Loose	1190	396.741	novA	40.51	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGCCATAGTGTCGCCGTTCGGAGGTTTGCTGAAGGGCGACGGAGAGGATGATCCCGCGCCGTCCAGGATCCGCCCGGGGACGTTGCGACGAGTGCTCGGATACTTCCGCCCGCACGTCGGCAAGGTGGCGCTCTTCGTTCTCGTCACCGCATTGGATTCGATCTTCGTCGTCGCGTCTCCGTTGATGTTGAAGGACCTGGTGGACAAGGGGGTTCTGGGGAACGATCTGGAGCTCGTCATCCTGCTGGCGTGCCTGGCCGCCGGCTTCGCCGTGATGAGCACGCTGTTGCAGCTCGTGTCGGCCTACATCTCCGGCCGGATCGGGCAGGGGGTCAGTTACGACCTGCGGGTTCAGGCCCTTGACCACGTCCAGCGGCTGCCGATCGCGTTCTTCACCCGGACCCAGACGGGCGTGCTGGTCGGCCGGCTGCACACGGAGCTGGTCATGACGCAGATGGCGTTCACCCAGATGCTGACGGCCGCCGCCAGCGCGGTCACGGTCCTGCTGGTGCTGGCCGAGCTGTTCTACCTGTCGTGGATCGTCGCCCTCCTCACGCTGGTGCTGATCCCGGTGTTCCTGGTGCCCTGGTCTTACGTGGGACGGCGGATGCAGCGCTACACCAGAGGGCTGATGGAGGAGAACGCCGGCCTGGCCGGGCTGCTGCAGGAGCGGTTCAACGTCCAGGGGGCGATGCTCTCCAAGCTCTTCGGCCGTCCGGCCGAGGAGATGGCCGAGTACGAGAGCAGGGCCGGCCGGATCCGCGGGCTCGCCGTGAGCGTCACCCTCTACGGCCGGATGGCCCCCGCCATCTTCGCGCTGATGGCCGCGCTCGCCACGGCGCTCGTCTACGGGGTCGGCGGCGGGCTCGTGCTCTCGCAGGCGTTCCAGCTCGGCACGCTGGTCGCCCTGGCCACCCTGCTCGGGCGGCTGTTCGGGCCGATCACCCAGCTGGCCAGCATTCAGGAGAACGCGCTCACGGTCCTGGTGAGCTTCGAGCGGATCTTCGAGCTGCTCGATCTGAAGCCGCTGATCGAGGAACGCCCCGACGCGGTCGCGCTCAAGGCCGGCAAGGCCTCGGACGTCCAGTTCGAGAACGTGTCGTTCCGCTACCCCAGCGCGGACGAGGTCTCGCTGCCGTCGCTGGAACAGAACGTGCGCACCGGGCAGGAGCGTGGTGAAGCGACGCCGGAGGTGCTGCGCGACGTGAGCCTGCACGTGCCGGCCGGCACCCTCACCGCGCTCGTGGGCCCGTCCGGCGCCGGGAAGAGCACCCTCACGCACCTGGTGTCCCGGCTGTACGACCCGACCTCCGGAACCGTTCGCGTCGGCGGACACGACCTGCGGGACCTCACCTTCGACTCGCTGCGCGAAACGGTGGGGGTGGTCAGCCAGGACACCTACCTCTTCCATGACACGATTCGGGCGAACCTTCTCTACGCCCGCCCCGACGCCACCGAGGACGAGCTGGTCGAGGCGTGCCGAGGGGCGCAGATCTGGGACCTGATCGCATCCCTGCCACGCGGGCTCGACACCGTCGTGGGTGATCGCGGTTATCGCCTGTCAGGCGGGGAGAAGCAACGGCTGGCGATCGCCCGGCTGCTGCTGAAGGCACCCTCGGTCGTCGTTCTCGACGAGGCCACCGCCCACCTGGACTCGGAGTCGGAGGCCGCCGTCCAGCGGGCACTGACGACAGCCCTGCGCAGCCGTACCTCCCTGGTGATCGCCCACCGGTTGTCCACGATCCGCGAGGCCGACCACATTCTCGTGATCGACGACGGGAGGGTCAGGGAGCGCGGGACGCACGAGGAGTTGCTGGCGGAAGGCGGTCTCTACGCCGACCTGTACCACACGCAGTTCGCCAAGTCAGGCGTCAACGGGACCCGGCCGGGACAGGGCGACGGGGCGGAGCCCGTGCAAGAGGTGGTCGGTGGAGGGGAACGATGA	MAIVSPFGGLLKGDGEDDPAPSRIRPGTLRRVLGYFRPHVGKVALFVLVTALDSIFVVASPLMLKDLVDKGVLGNDLELVILLACLAAGFAVMSTLLQLVSAYISGRIGQGVSYDLRVQALDHVQRLPIAFFTRTQTGVLVGRLHTELVMTQMAFTQMLTAAASAVTVLLVLAELFYLSWIVALLTLVLIPVFLVPWSYVGRRMQRYTRGLMEENAGLAGLLQERFNVQGAMLSKLFGRPAEEMAEYESRAGRIRGLAVSVTLYGRMAPAIFALMAALATALVYGVGGGLVLSQAFQLGTLVALATLLGRLFGPITQLASIQENALTVLVSFERIFELLDLKPLIEERPDAVALKAGKASDVQFENVSFRYPSADEVSLPSLEQNVRTGQERGEATPEVLRDVSLHVPAGTLTALVGPSGAGKSTLTHLVSRLYDPTSGTVRVGGHDLRDLTFDSLRETVGVVSQDTYLFHDTIRANLLYARPDATEDELVEACRGAQIWDLIASLPRGLDTVVGDRGYRLSGGEKQRLAIARLLLKAPSVVVLDEATAHLDSESEAAVQRALTTALRSRTSLVIAHRLSTIREADHILVIDDGRVRERGTHEELLAEGGLYADLYHTQFAKSGVNGTRPGQGDGAEPVQEVVGGGER	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	105.37	gnl|BL_ORD_ID|1112|hsp_num:0	1210			75	1779	novobiocin
BGC0000289.1|A40926_26 # 49908 # 56201 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.724	BGC0000289.1|A40926_26 	49908	56201	+	Loose	1000	120.168	almE	31.46	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAGCGCCGGAACGCGGGCCACACCGACGACGGTGCTGGACCTCTTCGCCCGCCAGGTGGGCCGGGCACCCGATGCGGTGGCTCTGGTCGACGGGGACCGGGTCCTGACCTACCGGCGGCTGGACGAGCTCGCCGGAGCGCTGTCCGGGCGCCTGATCGGCCGGGGTGTCGGCCGGGGTGATCGCGTCGCGGTGATGATGGACCGCTCGGCGGACCTGGTGGTGACGCTGCTCGCCGTGTGGCAGGCGGGGGCGGCCTACGTGCCGGTGGACGCCGCCCTTCCCGCCCGGCGGGTGGCGTTCATGGTGGCGGACTCCGGAGCCTGCCTGATGGTGTGCTCGGAGGCGACGCGCGATGCGGTACCGCAAGGGGTCGAGTCGATCGCGTTGACCGGCGAGGGCGGATGCGGCACGTCGGCGGTCACGGTGGACCCGGGGGATCTGGCGTACGTGATGTACACGTCCGGCTCGACGGGCACCCCGAAGGGGGTGGCCGTCCCGCATCGGAGCGTCGCGGAGCTGACGGGAAACCCCGGCTGGGGGGTGGAGCCCGGCGAGGCGGTGCTCATGCACGCGCCCTACACCTTCGACGCCTCCCTGTTCGAGATCTGGGTGCCGCTCGTGTCGGGCGCCCGGGTGGTGATCGCCGCACCGGGTGCGGTGGACGCCCGGCGCCTGCGCGAGGCGGTCGCCGCCGGGGTGACGAGGGTGCACCTGACCGCGGGCAGCTTCCGCGCGGTGGCGGAGGAGTCGCCGGAGTCGTTCGCGCACTTCCGTGAGGTGCTGACCGGTGGTGACGTGGTGCCCGCGTACGCAGTGCAGAAGGTGCGGGCGGCCTGCCCTCACGTGCGGATCCGGCATCTGTACGGCCCGACGGAGACGACCCTGTGCGCGACGTGGCAGCTGCTGGAGCCGGGTGACGTCGTGGGGCCCGTCCTGCCGATCGGCCGCCCGCTGCCGGGCCGCCGGGCCTGGGTGCTCGACGCGTCATTGCGGCCGGTGGAGCCCGGGGTGGTCGGTGACCTGTACCTTTCCGGCGCCGGTCTGGCGGACGGCTACCTGGACCGGGCGGGGCTGACGGCGGAACGGTTCGTGGCGGATCCGTCCGCGGCGGGGAGGCGGATGTATCGGACGGGGGATCTGGCTCAGTGGACCGCGGACGGTGAGCTGCTGTTCGCGGGCCGGGCCGACGACCAGGTGAAGGTCCGCGGATTCCGGATCGAGCCGGGCGAGGTCGAGGCCGCGCTGACCGCTCAGCCGCACGTCCGCGAGGCCGTGGTGGTGGCGATCGACGGGCGCCTGATCGGTTACGTGGTGGCGGACGGGGACGTGGATCCCGTACTGATGCGCCGGCGGCTGGCGGCGTCGCTGCCGGAGTACATGATCCCGGCCGCTCTGGTCACGCTGGACGCGTTGCCGCTGACCGGCAGCGGCAAGGTGGACAGGAGGGCGCTGCCCGAGCCCGATTTCGCGTCGGCCGCGCCGCGCCGCGAACCCGGCACCGAGCCGGAGCGCGTCCTGTGCGACCTGTTCGCGGAGCTTCTGCAACCGGAGGGAAGGGGGGTAGGGGTCGATGACGGTTTCGTCGAGCTGGGCGGGGACTCGATCGTCGCGATCCGGCTGGCAGCACGTGCGTCCAGGGTGGGGCTGCTGGTGACGCCCGCCCAGATCTTCAAGGAGAAGACTCCGGCACGGCTGGCAGCCGTCGCGGGTGCCGTACCGGCCGGCAGACCCGCCGACGGCCCGCTGATCACCCTCACGGCGGAGGAGGAGGCGGAGCTGGCGACCGCCGTCCCGGGGGCCGAGGAGGTCTGGCCACTCGCACCGCTCCAGGAAGGGCTCTACTTCCAGGCCACCCTCGACGACGAGGGTCACGACATCTACCAGGCGCAATGGATCCTGGAGCTGGCGGGGCCGCTGGACGCCGCCCGGCTGCGGGCCTCGTGGGAAGCGGTCTTCGCCCGGCACCCCGAGCTTCGCGTGAGCTTCCACCGGCGCGCGTCAGGCACGATGCTGCAGGTCGTCGCCGGGCACGTCGTCCTGCCGTGGCGAGAGGTGGATCTGGCGGATGCGGGCGATATCGACGCGGCCGTGGCGGCCCTGATCAGTGAGGAACAGGAGCAGCGGTTCGACCTCGCCAAGGCACCGCTGTTCCGGCTGGTGCTGGTCCGTCACGGCGAGGACCGGCACCGCCTGCTGGTCGTCCATCACCACATCCTGACCGATGGCTGGTCGGTGGCGGTCATCCTCAACGAGGTGGCTGAGGCGTACACGAACGGCGGCCGTCTCCCGGACCGCACGGGCGCGGCCTCCTACCGGGACTACCTGGCCTGGCTGGACCGGCAGGACAAGGACGCCGCACGTGCCGCCTGGCAGGCGGAGCTGTCCGGCCTCGAAGGGCCCGCGCCGATCGCGAAGGCCGCCACCACGACCGGCGCCGGGACGGGCTACGAATATCGCATCGCCTTCCTGACCCCTGACCTCCACACGCGGCTGACGGAGCTGGCCCGCGACCACGGGCTGACGCTGAACACCCTGGCACAGGGCGCATGGGCGATGGTGCTGGCGCGGCTCGCGCGGCGCACTGACGTGGTCTTCGGCACCACGGTCGCCTGCCGTCCCGCCGAGCTCCCCGAGGTGGAGTCGGTGCCGGGTCTCATGATGAACACGGTTCCGGTCCGGGTGCCGCTGCAGGGCGCGCAATCGGTCGTGGACCTGCTCACCGGCCTGCAGGAACGGCAGGCGGCCTTGCTGCCGCACCAGCATCTGGGGCTGACGGAGATCCAGCGGGCGGCAGGACCTGGCGCGACGTTCGACACGCTGCTGGTCTTCGAGAACTACCCGCGGGACTTCGCCGGCCAGTTCACCTACCTGGGCACGATCGAGGGGACCCACTACCCGCTGACCCTCGGCATCATCCCGGGGGATCACTTCAGGATCCAGCTCGTCTACCGGCGCGGGCAGGTCGGGGAGAGCGTCGCCGAGTCGATCCTGGGATGGTTCACCGGCGCTCTCATGACGATGGCCGCTGATCCGCACGGGCCGGTGGGCCGGATCGGTGTGGGTGAGGCCCGGGCCGGCGGCTCGGACCGGGCGATGGCGGCGGGGGAGCCGCTGCCGGTGCTGCTACGGCGGGTGGTGAAGGACCGGCCGGACGAGGTGGCGGTGGTGGACGGCGACGGTGAGCTGTCGTTCGGGGAATTGTGGGAACGGGCGACGGCGCTGGCGGCCGAGCTGAGGGCTCACGGGATCGGGCCGGAGAGCCGGGTGGCCGTGATGGTGGGCAGGTCGGCGTGGTGGGCGGTCGGGGTGCTGGGCGTCTGCTTGGCGGGCGGCGCGTTCATGCCGGTGGATCCGGCGTATCCGGCTGAGCGCGTCAGGTGGATCCTGGCCGACTCCGACCCACGGCTGGTGCTGTGCGCGGGGACGACGCGGGAGGCGGTGCCGGAGGAGTTCGCAGACCGGCTGGTGGTGGTCGACGAGCTGGACCTCGCGGGGAGCGACGATGCGGGCTTGCCACGGGTGAGCCCGGATGACGCGGCTTATGTGATCTATACGTCGGGATCGACGGGGACTCCCAAGGGGGTCGTCGTCTCGCACGCGGGCCTCGGGAATCTGGCGATGGCGCAGATCGACCGGTTCGCCGTGTCGCCGTCGTCGCGAGTCCTGCAGTTCGCGGCGCTGGGCTTCGACGCGATGGTGTCGGAGATGTTGATGGCGCTGTTGTCGGGGGCGAGGCTGGTGATGGCGCCGGAGCCGGCCCTGCCACCGCGGGTGTCGCTGGCCGAGGCGTTGCGGCGGTGGGAGGTCACGCACGTCACGGTTCCGCCGTCGGTGCTGGCCACCGCCGATGCGCTGCCGGCCGGGCTGGAGACGGTGGTGGTGGCGGGGGAGGCCTGCCCGCCGGGCCTGGCCGAACGCTGGTCGGCGGGACGGCGGCTGGTCAACGCGTACGGGCCGACCGAGGCCACGGTCTGCGCGGCGATGAGCAGGCCGTTGACGGGCAGCCGGGAGGTGGTCCCGATCGGGACACCCATCGCCGGCGGCCGTTGCTACGTGCTGGACGCGTTCCTGCGGCCGTTGCCGCCGGGGATCACCGGTGAGCTGTACGTGGCCGGGATCGGGTTGGCGCGCGGCTATCTGGGTCGTGCGTCGTTGACGGCTGAGCGGTTCGTGGCGGATCCGTTCGTGGCTGGTGAGCGGATGTATCGGACGGGGGATCTGGCGTATTGGACGGGTGAGGGCGAGCTGGTGTTCGCCGGGCGGGATGACGACCAGGTGAAGATCCGTGGGTATCGGGTGGAGCCGGGTGAGGTGGAGGCGGTGCTGGCGGGGCAGCCGGGGGTGGATCAGGCGGTGGTGGTGGCGCGTGAGGGGCGGTTGCTGGGTTATGTCGTCTCCGGTGGTGGGGTGGATCCGGTGCGGTTGCGTGAGGGGGTCGCGCGGGTGTTGCCGGAGTACATGGTGCCGGCGGCGGTGGTGGTGCTGGGTGCGGTGCCGGTGACGGCGAACGGGAAGGTGGATCGGGAGGCGTTGCCGGATCCGGGCTTCGGCGGGCGGGTTTCGGGCCGGGAGCCGCGTACGGAGGTCGAGCGGGCGTTGTGCGGGCTCTTCGCCGAGGTGCTCGGGCTGCCGGGGGTGACGGCGGTGGGGCCGGACGACAGCTTCTTCGAGCTGGGCGGGGACTCGATCACTTCGATGCAGCTGGCGTCGCGGGCTCGCCGCGAGGGGATGCTCTTCGGCGCGCGGGAGGTGTTCGAGCGCAAGACGCCTGCGGGGCTCGCGGCGATCGTCGATGTGGGCGGCGAGCTTGCGGCAGGTCCGGCCGACGGCGTGGGGGAGATCGCGTGGACGCCGATCATGCGGGCGCTCGGGGACGGGATCGTGGGGTCGCGGTTCGCCCAGTGGGTGGTGCTGGGTGCGCCGCCGGACCTACGGGCGGACGTGGTGGCCGCGGGATTGGCGGCGGTGGTGGACACGCACGACGTGTTGCGGCTGCGGGTCGTCGATGACCGGGCGGGCCGCCGGCTGGCAGTGGGCGAGCGCGGGTCGGTGGACACGGCCGGGCTGGTCACGCGGCTCGAGTGCGGCGGCCGTCCGCCGGACGAGGTCGTGGAGCGCGCGGTGCGGGAGGCCGTGGGGCGGTTGGACCCGGTGGCGGGTGTGATGGCGCAGGCGGTCTGGGTGGATGCGGGGCCGGCGCGGACGGGGCGGTTGGTCGTCGTGGTGCATCATCTGGCGGTCGACGGGATGTCGTGGCGGATCCTGGTGCCCGACCTGCGGCTGGCGTGTGAGGCGGTGGCCGAGGGGCGGGATCCGGTGCTGGAGCCGGTGTGGGGGTCGTTCCGGCGCTGGGCGGCTCTGCTGGAGGAGTCGGCGCTCTCGCGGGAGCGGGTCGGGGAGCTGCACACGTGGCGGACGATCGTCGATCAGGAGGATCGGCCGGTCGGCCGGCGGCGGCTGAGCGCAGGGGATGCGGCCGGGGGCGTGCGTTCACGGTCGTGGGTGATGTCGGGGGATGAGGCGTCGCTCCTGGTGGGGAAGGTTCCGGTGGCGTTCCACTGCGGGGTCCACGAGGTCCTGCTGGCGGGCCTGGCGGGAGCGGTGGCGCGCTGGCACGGTGACGACGGGGTCCTGGTGGATGTGGAAGGCCACGGGCGTCATCCGGCCGAGGGGATGGATCTGTCCAGGACGGTGGGCTGGTTCACCAGCATGCATCCGGTGCGCCTGGATGTGGCGGGGATCGAGCTGGCGGCGGTGCCGGCCGGTGGCCGTGCGGCCGGGCAGTTGCTGAAGGCGGTCAAGGAGCAGTCGCGGGCGGCGCCCGGCGACGGGCTCGGTTACGGGTTGCTGCGCCATCTCAATCCCGAGACGGGCCCCGTTCTGGCGGCCCTGCCGTCACCGCAGATCGGGTTCAACTACATGGGCCGGTTCGTCACCGTCGACCAGGGCGGTGCGCGGCCGTGGCAGCCGGTCGGGGGGATCGGCGGTTCGCTGGACCCCGGCATGGGCCTGCCGCATGCGCTGGAGGTCAATGCGATCGTCCACGACAGGCTGGCGGGCCCGGAGCTGGTGCTCACGGTGGACTGGCGGGACGACCTGCTGGAGGAGACCGACATCGAACGACTGTGCCAGGTGTGGCTGGACATGTTGTCCGGATTGTCCCGCCAAGCGGAGGATCCTTCCGCAGGCGGACACACCGCGTCCGACTTCGCCCTACTCGACCTCGACCAGGACGAGATCGAGGGCTTCGAAGCCATAGCAGCGGAACTCTCTGGAGGCCAGACATCGTGA	MSAGTRATPTTVLDLFARQVGRAPDAVALVDGDRVLTYRRLDELAGALSGRLIGRGVGRGDRVAVMMDRSADLVVTLLAVWQAGAAYVPVDAALPARRVAFMVADSGACLMVCSEATRDAVPQGVESIALTGEGGCGTSAVTVDPGDLAYVMYTSGSTGTPKGVAVPHRSVAELTGNPGWGVEPGEAVLMHAPYTFDASLFEIWVPLVSGARVVIAAPGAVDARRLREAVAAGVTRVHLTAGSFRAVAEESPESFAHFREVLTGGDVVPAYAVQKVRAACPHVRIRHLYGPTETTLCATWQLLEPGDVVGPVLPIGRPLPGRRAWVLDASLRPVEPGVVGDLYLSGAGLADGYLDRAGLTAERFVADPSAAGRRMYRTGDLAQWTADGELLFAGRADDQVKVRGFRIEPGEVEAALTAQPHVREAVVVAIDGRLIGYVVADGDVDPVLMRRRLAASLPEYMIPAALVTLDALPLTGSGKVDRRALPEPDFASAAPRREPGTEPERVLCDLFAELLQPEGRGVGVDDGFVELGGDSIVAIRLAARASRVGLLVTPAQIFKEKTPARLAAVAGAVPAGRPADGPLITLTAEEEAELATAVPGAEEVWPLAPLQEGLYFQATLDDEGHDIYQAQWILELAGPLDAARLRASWEAVFARHPELRVSFHRRASGTMLQVVAGHVVLPWREVDLADAGDIDAAVAALISEEQEQRFDLAKAPLFRLVLVRHGEDRHRLLVVHHHILTDGWSVAVILNEVAEAYTNGGRLPDRTGAASYRDYLAWLDRQDKDAARAAWQAELSGLEGPAPIAKAATTTGAGTGYEYRIAFLTPDLHTRLTELARDHGLTLNTLAQGAWAMVLARLARRTDVVFGTTVACRPAELPEVESVPGLMMNTVPVRVPLQGAQSVVDLLTGLQERQAALLPHQHLGLTEIQRAAGPGATFDTLLVFENYPRDFAGQFTYLGTIEGTHYPLTLGIIPGDHFRIQLVYRRGQVGESVAESILGWFTGALMTMAADPHGPVGRIGVGEARAGGSDRAMAAGEPLPVLLRRVVKDRPDEVAVVDGDGELSFGELWERATALAAELRAHGIGPESRVAVMVGRSAWWAVGVLGVCLAGGAFMPVDPAYPAERVRWILADSDPRLVLCAGTTREAVPEEFADRLVVVDELDLAGSDDAGLPRVSPDDAAYVIYTSGSTGTPKGVVVSHAGLGNLAMAQIDRFAVSPSSRVLQFAALGFDAMVSEMLMALLSGARLVMAPEPALPPRVSLAEALRRWEVTHVTVPPSVLATADALPAGLETVVVAGEACPPGLAERWSAGRRLVNAYGPTEATVCAAMSRPLTGSREVVPIGTPIAGGRCYVLDAFLRPLPPGITGELYVAGIGLARGYLGRASLTAERFVADPFVAGERMYRTGDLAYWTGEGELVFAGRDDDQVKIRGYRVEPGEVEAVLAGQPGVDQAVVVAREGRLLGYVVSGGGVDPVRLREGVARVLPEYMVPAAVVVLGAVPVTANGKVDREALPDPGFGGRVSGREPRTEVERALCGLFAEVLGLPGVTAVGPDDSFFELGGDSITSMQLASRARREGMLFGAREVFERKTPAGLAAIVDVGGELAAGPADGVGEIAWTPIMRALGDGIVGSRFAQWVVLGAPPDLRADVVAAGLAAVVDTHDVLRLRVVDDRAGRRLAVGERGSVDTAGLVTRLECGGRPPDEVVERAVREAVGRLDPVAGVMAQAVWVDAGPARTGRLVVVVHHLAVDGMSWRILVPDLRLACEAVAEGRDPVLEPVWGSFRRWAALLEESALSRERVGELHTWRTIVDQEDRPVGRRRLSAGDAAGGVRSRSWVMSGDEASLLVGKVPVAFHCGVHEVLLAGLAGAVARWHGDDGVLVDVEGHGRHPAEGMDLSRTVGWFTSMHPVRLDVAGIELAAVPAGGRAAGQLLKAVKEQSRAAPGDGLGYGLLRHLNPETGPVLAALPSPQIGFNYMGRFVTVDQGGARPWQPVGGIGGSLDPGMGLPHALEVNAIVHDRLAGPELVLTVDWRDDLLEETDIERLCQVWLDMLSGLSRQAEDPSAGGHTASDFALLDLDQDEIEGFEAIAAELSGGQTS	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	377.16	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1629	colistin A; colistin B
BGC0000289.1|A40926_27 # 56258 # 59389 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.716	BGC0000289.1|A40926_27 	56258	59389	+	Loose	1000	103.605	almE	27.89	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCAGGAGGGGATCCTCTATCACGCCGCACTCGATGAGGCCCCTGACCTCTACCTCATCCAGCAGTCGCAGATCATCGAAGGACCCTTGGACACCGAGCGGTTCCGCCTGGCTTGGGAGAGCCTCCTCAACCGGCATGCGGCGCTTCGCGCGTGCTTCCACCGGCGGAAGTCCGGTGAGTCGGTCCAGCTCATCCCCCGTAAGGTGCCGCTCCCGTGGTCCGAGCGCGACCTGTCCGGCCTGTCCGAGGAGGACGCGCTGGCCGAGGCGAGCGTGATCGCGGAGAAGGAGCGCGCCACGAGATTCGACCCGGCCAAGCCTCCGCTGCTGCGGCAGGTGCTGATCCGGTTCGGTCCGGACAAGCACTGTCTGGTGACGACGAGCCATCACCTGGTCATGGACGGGTGGTCGCGGGCGATCCTCGAGTCGGAGCTCCTCGAGCTCTACGCCGCGGGTGGCGCCGAGCCGGGGCTGCGGCCCGCCGGCTCCTACCGGGACTATCTGGCCTGGCTGGAGCGGCAGGACAAGGAGGCCGCCCGCGCGGCATGGCGTGCGGAGCTGGCGGGCGCCGACCGTTCGACACTCGGCATCCCCGAAGCGTCCAGGAAGACCCAGGGGCAGCGGGTGCGGGAGGTGCTCGGCTACGCGCCGGACTTCACCTCCGCTCTGGTGGACTTCGCCCGCCGCCATGGGCTGACGCTGAACACGCTGGTGCAGGGGGCGTGGGCGTTGGTGCTGGCCCGGCTCACGCGCCGTCGTGACGTGGTGTTCGGCGCGGTGGTCTCGGGACGTCCGGCGGAGGTGCCCGGCGTGGAGCAGGCCGTCGGGCTGTTCATCAACACCGTGCCGGTGCGCGTCCGGTTGGACGGCGGGCAGCCGGTCATCCAGCTGCTGACGGAGCTGCAGGAGCGGCAGTCCACGCTCATCTCGCATCAGCATCTCGGGCTGCAGGAGATCCAGAAGCTCTCCGGGGTGAGCTTCGACACCGTCGTGTCGTTCGAGAACTACGTCGATCCGGGGGCGGGTCCGGGCTCCGATCGCGAGCTGCGCCTGAGACTGAAGGAGTTTCACCAGTCGGCGCCGTACGCGCTCCTCCTCGGCATCATGCCAGGTGAGAGCCTCCAGACCGACGTGGAGTACCGGCCCGAGCTGCTCGACGCCCGCGTCGCCAAGGAGGCCCTCCACGGGCTCGCCCGCGTCCTCGAGCGGATGATCGCCGAGCCGGAGACCGCAGTGGGCCGCCTGGACGTGGTCGGTGACGCGGGGCGCGAGCTGGTGGTCGAGCGGTGGAACGAGACGGGCGACGCGATCGGTGCGCCGTCCGCGGTGGACCTGTTCCGGCGCCAGGTTGCACGGGCACCCGCCGCGACGGCGGTGACGGCCGGGGACCTGGCCTGGTCGTACGCGGAGCTCGACGAGCGGTCCGGCCGGCTGGCGCGGGCACTGACGGAACGCGGCGTGCGACGCGGCGACCGGGTGGGCGTGGTGCTGGGGCGGTCGGCAGAGGTGCTGGCAGCCTGGCTCGGAGTGTGGAAGGCAGGCGCGGCGTTCGTGCCGGTCGACCCGGACTACCCGGCGGACCGGGTGGCGTTCATGCTGGCCGACTCCGCCGTCGCGATGGTGGTGTGCCAGGAGGCGACCTCGGGTGTGGTGCCCCCGGGCTACCAGCAGCTCCTGGTGAACGACGCCGACGACGGCGAGGCCGCCCTGGTCCCGATCGGGGCGGACGATCTCGCCTACGTGATGTACACCTCCGGATCGACCGGGACCCCGAAGGGCGTGGCGATCCCGCACGGCGGCGTGGCGGCGCTGGCGGGAGATCCGGGATGGGGCGTCGGACCCGGCGACGCGGTGCTGATGCACGCCCCGCACACCTTCGACGCGTCGTTGTACGACGTGTGGGTGCCGCTCGTCTCCGGCGCGCGGGTCATGATCACCGAGCCGGGGGTCGTCGACGCGGAGCGGCTCGCCGGGCATGTGGCCGACGGCCTCACCGCGGTCAACTTCACCGCGGGGCACTTCCGCGCGCTGGCGCAGGAGTCGCCGGAGTCGTTCTCCGGGCTGCGCGAGGTGGCGGCGGGTGGCGACGTGGTGCCGCTCGATGTGGTGGAGCGGGTACGGCGGGCGTGCCCGCGGCTCCGGGTCTGGCACACCTACGGCCCGACCGAGACCACGCTGTGCGCGACGTGGAAGGCGATCGAGCCCGGTGACGAGGTGGGGCCGGTGCTGCCCATCGGCCGGGCACTGCCGGGCCGGCGGCTGTACGTGCTGGACGCGTTCCTGCGGCCGTTGCCGCCGGGCATCGCGGGTGATCTCTACCTCGCAGGCGCCGGAGTGGCCCACGGCTATCTGGGTCGTGCGTCGTTGACGGCTGAGCGGTTCGTGGCGGATCCGTTCGTGGCTGGTGAGCGGATGTATCGGACGGGGGATCTGGCGTATTGGACGGGTGAGGGCGAGCTGGTGTTCGCCGGGCGGGATGACGACCAGGTGAAGATCCGTGGGTATCGGGTGGAGCCGGGTGAGGTGGAGGCGGTGCTGGCGGGGCAGCCGGGGGTGGATCAGGCGGTGGTGGTGGCGCGTGAGGGGCGGTTGCTGGGTTATGTCGTCTCCGGTGGTGGGGTGGATCCGGTGCGGTTGCGTGAGGGGGTCGCGCGGGTGTTGCCGGAGTACATGGTGCCGGCGGCGGTGGTGGTGCTGGGTGCGGTGCCGGTGACGGCGAACGGGAAGGTGGATCGGGAGGCGTTGCCGGATCCGGGCTTCGGCGGGCGGGTTTCGGGCCGGGAGCCGCGTACGGAGGTCGAGCGGGCGTTGTGCGGGCTCTTCGCCGAGGTGCTCGGGCTGCCGGGGGTGACGGCGGTGGGGCCGGACGACAGCTTCTTCGAGCTGGGCGGGGACTCCATCCATTCGGTGAAGCTGGCAGCGCGGGCCACGCGTGCCGGCATGCCCTTCACCGTGGTCGAGGTGTTCGAGCACAAGACGCCTGCGGGGCTCGCGACGATCGTCGACGTGGGCGGCGAGCCCGCGGCAGGTCCGGCTGATCCCCCATCGGACTCCGACCTGCTCGGCCTGGCGCAGGACGAGATAGCGGAGTTCGAGGCCGAATTCGACGACGAACGTCATTCTCTGCGCTGA	MQEGILYHAALDEAPDLYLIQQSQIIEGPLDTERFRLAWESLLNRHAALRACFHRRKSGESVQLIPRKVPLPWSERDLSGLSEEDALAEASVIAEKERATRFDPAKPPLLRQVLIRFGPDKHCLVTTSHHLVMDGWSRAILESELLELYAAGGAEPGLRPAGSYRDYLAWLERQDKEAARAAWRAELAGADRSTLGIPEASRKTQGQRVREVLGYAPDFTSALVDFARRHGLTLNTLVQGAWALVLARLTRRRDVVFGAVVSGRPAEVPGVEQAVGLFINTVPVRVRLDGGQPVIQLLTELQERQSTLISHQHLGLQEIQKLSGVSFDTVVSFENYVDPGAGPGSDRELRLRLKEFHQSAPYALLLGIMPGESLQTDVEYRPELLDARVAKEALHGLARVLERMIAEPETAVGRLDVVGDAGRELVVERWNETGDAIGAPSAVDLFRRQVARAPAATAVTAGDLAWSYAELDERSGRLARALTERGVRRGDRVGVVLGRSAEVLAAWLGVWKAGAAFVPVDPDYPADRVAFMLADSAVAMVVCQEATSGVVPPGYQQLLVNDADDGEAALVPIGADDLAYVMYTSGSTGTPKGVAIPHGGVAALAGDPGWGVGPGDAVLMHAPHTFDASLYDVWVPLVSGARVMITEPGVVDAERLAGHVADGLTAVNFTAGHFRALAQESPESFSGLREVAAGGDVVPLDVVERVRRACPRLRVWHTYGPTETTLCATWKAIEPGDEVGPVLPIGRALPGRRLYVLDAFLRPLPPGIAGDLYLAGAGVAHGYLGRASLTAERFVADPFVAGERMYRTGDLAYWTGEGELVFAGRDDDQVKIRGYRVEPGEVEAVLAGQPGVDQAVVVAREGRLLGYVVSGGGVDPVRLREGVARVLPEYMVPAAVVVLGAVPVTANGKVDREALPDPGFGGRVSGREPRTEVERALCGLFAEVLGLPGVTAVGPDDSFFELGGDSIHSVKLAARATRAGMPFTVVEVFEHKTPAGLATIVDVGGEPAAGPADPPSDSDLLGLAQDEIAEFEAEFDDERHSLR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	187.59	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1629	colistin A; colistin B
BGC0000289.1|A40926_28 # 59485 # 60318 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.658	BGC0000289.1|A40926_28 	59485	60318	+	Loose	400	42.743	ErmB	28.57	3000375	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGATAAGCAAAGCAATGCATGGACCGATTCGGCCCGCCCGCGCGGATACCCTGCTGGCCTCGGTAGGCGAGCGAGGCATTCTGTGTGACTTTTACGACGAGAACGCCTCGGAAATCTTCCGTGATTTGGAGGCGGACGCGGGCGGCACGGAAGAAGCCCACGGGTTCGCGGCGCTCGTCCGCCCGGAGTCGGGGGCGATCCTGGAGCTCGGGGCCGGAACAGGCAGGCTGACGATTCCGCTCCTGGAGCTCGGCTGGGAGGTGACCGCCCTCGAACTGTCGACCGCGATGCTCACCACCCTGCGGACGCGGCTGGCGGACGCGCCGGCGGACCTCCGGGATCGGTGCACCCTCGTTCACGCGGACATGACCGCCTTCAAACTGGGAGAACGCTTCGGAACGGCGATTCTCAGCCCGTCCACGATCGACCTCCTGGACGATGCCGACAGACCAGGGCTGTACTCGTCGGTCCGTGAGCATCTGCGGCCCGGCGGGAGATTCCTGCTCGGCATGGCCAACCCCGACGCGTCCGGCAGGCAGGAGCCGCTGGAGCGCACCCAGGAGTTCACGGGCAGGAGCGGCCGCCGATACGTGCTGCACGCCAAGGTCTACCCGTCGGAGGAGATCCGCGACGTGACCATTCATCCTGCGGATGAATCGGCGGACCCCTTCGTCATCTGCGTCAATCGCTTCAGAGTCATCACCCCGGATCAGATAGCACGAGAGCTGGAGCAAGCCGGATTCGACGTGGTCGCGCGGACCCCACTGCCCGGGGTGCGTAATCACGAACTGGTGCTGGAAGCGCAATGGGGCAGCGTGGAAGACGCGCATTAG	MISKAMHGPIRPARADTLLASVGERGILCDFYDENASEIFRDLEADAGGTEEAHGFAALVRPESGAILELGAGTGRLTIPLLELGWEVTALELSTAMLTTLRTRLADAPADLRDRCTLVHADMTAFKLGERFGTAILSPSTIDLLDDADRPGLYSSVREHLRPGGRFLLGMANPDASGRQEPLERTQEFTGRSGRRYVLHAKVYPSEEIRDVTIHPADESADPFVICVNRFRVITPDQIARELEQAGFDVVARTPLPGVRNHELVLEAQWGSVEDAH	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYNLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRKLIL	111.69	gnl|BL_ORD_ID|1424|hsp_num:0	1549			81	276	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000289.1|A40926_29 # 60379 # 61974 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.655	BGC0000289.1|A40926_29 	60379	61974	+	Loose	500	27.7202	ANT(3'')-Ib	21.62	3005062	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGAGTGAGGAGCTCCTCTTCCTCCGGCCCGACACCATTATCGAACCGCTGGCCAACCGGTTCTACGCCTCGATGTACGCGACGGCTCCCGTCACGGCCGCCATGAATCTCGCCTTCCGTAACCTGCCGATGCTGGAGTCCTACCTCGCATCCCCGGAATGGCATTTCGCAGCCGCTCGCGATCCGAAGTTCCGCGGCGGATTCTTCGTCAACATCGAGGAGCAGCGGAAGAACGAGGTCGAGGCGCTGCTCGCTGCGATCCGGCGCGACAGCGCGGACGTGCTCCGGTTCGCCGAGGCGATCGCGGAGGCCGAGAAGATCATCCGCGAGGAAGCGACCGGATACGATCTCAGGCCGCTCTACCCGAAGCTGCCTCCCGAGCTGTCGGGTCTGGTGGAGATCGCCTATGACACCGGCAACGCGGCCTCGCTGCACTTCCTGGAGCCGCTCATCTACAAGAGCAAGGCCTACGCCGAGGACTGCCAGTCCGTTCAGCTCTCCGTGGAGACCGGGATCGAGCGGCCGTTCGTGATGAGCACCCCGCGACTGCCCTCACCCGACGTGCTCGAGCTGAACATCCCGTTCCGGCATCCGGGTCTGGAGGAGCTCTTCCTGTCCAGGATCCGGCCCACCACCCTGGCCGCCCTCCGCGAGGCGCTGGAGCTCGGCGACGCGGAAGCGGCGCGGCTCGCCGACCTGCTGGTCCCGGAGCCCTCGCTCGCCTCCGACCGCCATGTCGCGGCCGGAGCCCGGATCCGCTACTGGGGGCACGCCTGCCTGCTCATGCAGACGCCCGACGTGGCCATCATGACGGACCCGTTCATCAGCGCGGATACCGACGCGACCGGCCGCTACACCTACAACGACCTGCCTGACCGCCTCGACTACGTCCTCATCACGCACGGGCATTCCGACCATCTGGTGCCCGAGACGCTGCTTCAACTGCGCGGCCGGGTGGGCACGTTCGTCGTGCCGCGAACCTCGCGCGGCAACCTGTGCGATCCTTCGCTGGCGCTCTATCTCAGAAGCTTCGGGCTGCCCGCGATCGAGGTGGACGATTTCGATGAGATCGAGTTCCCCGGCGGGAAGATCGTCTCCACCCCGTTCTTCGGCGAGCACGCCGATCTCGACATCCGGGCCAAGTCGACGTATTGGATCAACCTCGGTGGCAAGTCGATCTGGGTGGGCGCGGACTCCTCAGGCCTCGATCCGGTTCTCTACCGCCATATCCGCCGGCATCTCGGCGCGGTCAACATCGCCTTCCTCGGGATGGAATGCGATGGCGCGCCGCTGAACTGGCAGTACCAGCCGTTCATCACCAAGGCGTTGCCGAAGAAGATGAGCGACAGCCGCAAGATGTCCGGCTCCAACGCGGAGCAGGCAGGTGCGATCGTCACCGAGCTGGGCGCCGAGGAGGCGTACATCTACGCCATGGGGGAGGAGAGCTGGCTGGGGCATGTCATGGCCACCAGCTACAACGAGGACTCCTACCAGCTCCAGCAGATCGCCGAGTTCGAGGCATGGTGTTCCCGCAAGGGTGTGAAGGCCGCTCATCTGCTCGACCAGCATGAGTGGCACTGGTCGTCATCCAGGTGA	MSEELLFLRPDTIIEPLANRFYASMYATAPVTAAMNLAFRNLPMLESYLASPEWHFAAARDPKFRGGFFVNIEEQRKNEVEALLAAIRRDSADVLRFAEAIAEAEKIIREEATGYDLRPLYPKLPPELSGLVEIAYDTGNAASLHFLEPLIYKSKAYAEDCQSVQLSVETGIERPFVMSTPRLPSPDVLELNIPFRHPGLEELFLSRIRPTTLAALREALELGDAEAARLADLLVPEPSLASDRHVAAGARIRYWGHACLLMQTPDVAIMTDPFISADTDATGRYTYNDLPDRLDYVLITHGHSDHLVPETLLQLRGRVGTFVVPRTSRGNLCDPSLALYLRSFGLPAIEVDDFDEIEFPGGKIVSTPFFGEHADLDIRAKSTYWINLGGKSIWVGADSSGLDPVLYRHIRRHLGAVNIAFLGMECDGAPLNWQYQPFITKALPKKMSDSRKMSGSNAEQAGAIVTELGAEEAYIYAMGEESWLGHVMATSYNEDSYQLQQIAEFEAWCSRKGVKAAHLLDQHEWHWSSSR	MPPPANEPVPAEVQPILDVVVRALGDDIAGAYLFGSAIAGGLRPDSDVDLLVLTHRTMSRQSREDLVAALMEVSGARAGRGPARNAEVTVVVLGDIAPWRHPARSDFVYGEWLRDDFAAGVVPAPTADPDLTLVLATALQSHRALMGPGLAEFLPAIPYADIRRAMADSLPGLVANVRGDERNVMLTLARMWVTVATGDIVPKDAAADWLLPRLPPERRALLATARDAYRGHVADEAWHECRADVSEWVSEVSQAIARTLHDSVKA	199.62	gnl|BL_ORD_ID|2787|hsp_num:0	3802			474	795	spectinomycin; streptomycin
BGC0000289.1|A40926_32 # 64820 # 65920 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.673	BGC0000289.1|A40926_32 	64820	65920	+	Loose	500	26.1794	OXA-53	27.36	3001810	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACGACCAGCATCGCGTCGGCAGAAGACCTTTCCGTCCTCACCGGACTGAGCGAGATCACCACGTTCGCCGGCGTGGGGACAGCCGTTTCCGCCACGTCCTATTCGCAAGCCGAGCTGCTCGAAATCCTCGACATACGCGATCCCAGGATCCGATCGCTGTTCCTGAACAGCGCGATCGAGCGGCGTTTTCTCGCGCTTCCGCCCCAGGGCCGGGACGGGGAGCGCGTGGCGGAACCGCAGGGTGATCTCCTGGACAAGCACAAAAAGCTCGCCGTCGATATGGGATGCCGGGCCCTCGAGTCCTGCCTGAAGTCGGCGGGCGCGACGCTCTCGGATGTCCGCCACCTGTGCTGCGTCACCTCGACCGGTTTTCTCACCCCCGGCCTGAGCGCACTCATCATCCGCGAGCTCGGGCTCGACCCGCATTGCAGCCGCGCCGACATCGTCGGCATGGGATGCAACGCGGGGCTGAACGCGCTCAACCTGGTCGCGGGCTGGTCCGCGGCGCACCCGGGCGAGCTCGCCGTCGTTCTGTGCAGCGAGGCGTGTTCCGCTGCTTACGCACTGGACGGCACCATGCGCACCGCGGTGGTCAACAGCCTGTTCGGCGACGGATCCGCCGCCCTCGCCGTCGTCTCCGGTGACGGGCGCGCTGCCGGCCCGCGCGTCCTGAAGTTCGCGAGCTACGTCATCACCGACGCGATCGAGGCGATGCGCTACGACTGGGACCGCGACCAGGACCGGTTCAGCTTCTTCCTCGATCCGCAGATCCCCTACGTGGTCGGCGCGCACGCCGAGATCGTCGTCGACAAGCTGCTGTCCGGTACGGGGCTGCGCCGCAGCGACATCGGCCATTGGCTGGTGCACTCCGGCGGCAAGAAGGTGATCGACGCCATCGTCGTCAACCTCGGCCTGAGCCGGCATGACGTCCGCCACACGACCGCTGTGCTCCGCGACTACGGGAACCTCTCCAGCGGCTCCTTCCTCTTCTCCTACGAACGGCTCGCCGGCGAGGGCGTGACCAGGCCCGGAGACTACGGGGTGCTCATGACCATGGGGCCCGGCTCCACGATCGAAACGGCGCTGATCCAATGGTGA	MTTSIASAEDLSVLTGLSEITTFAGVGTAVSATSYSQAELLEILDIRDPRIRSLFLNSAIERRFLALPPQGRDGERVAEPQGDLLDKHKKLAVDMGCRALESCLKSAGATLSDVRHLCCVTSTGFLTPGLSALIIRELGLDPHCSRADIVGMGCNAGLNALNLVAGWSAAHPGELAVVLCSEACSAAYALDGTMRTAVVNSLFGDGSAALAVVSGDGRAAGPRVLKFASYVITDAIEAMRYDWDRDQDRFSFFLDPQIPYVVGAHAEIVVDKLLSGTGLRRSDIGHWLVHSGGKKVIDAIVVNLGLSRHDVRHTTAVLRDYGNLSSGSFLFSYERLAGEGVTRPGDYGVLMTMGPGSTIETALIQW	MAIQIFAILFSTFVLATFAHAQDGTLERSDWGKFFSDFQAKGTIVVADERQADHAILVFDQARSMKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVKRSFAGHNKDQDLRSAMRNSTVWVYELFAKEIGDGKARRYLKQIGYGNADPSTSHGDYWIEGSLAISAQEQIAFLRKLYQNDLPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGSMGWWVGWVEWPTGPVFFALNIDTPNRMDDLFKREAIARAILLSIEALPPNPAVHSDAAR	133.09	gnl|BL_ORD_ID|1233|hsp_num:0	1341			45	321	cloxacillin; oxacillin; cefalotin
BGC0000289.1|A40926_34 # 66570 # 67874 # 1 # ID=1_34;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.712	BGC0000289.1|A40926_34 	66570	67874	+	Loose	575	28.1054	PAU-1	24.79	3006964	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	PAU beta-lactamase	GTGACGACGGATTGGCCGGCGCTGCCGCCCAGGGCGCCGCTCGCCCTCTGGACCCTGACGGCGGAGGCCCAGCGAGTCGACGACCTGCTCGCCGGGCTGCCGGAGCCTCCTGCCAGAACCTCCGCCCAGCGCGATGCCGCGGCCTCGGCACTCGACAAGGTGAGGCGGATGCGCGCGGACTACATGGAGGCGCACGCCGAGGAGATCTACGGCGAGCTCACCTCCGGCCGCACCCGGCACCTGCGCATCGACGAGCTCGTACGGGCCGCCGCCCGCGCCTACCCCGGCCTGGTGCCCACCGATGAGCAGATGGCGGCCGAGCGCGCGCGGCCACAGGCGGAGAAGGAAGGGCGCGAGATCGATCAGGGCATCTTCCTGCGCGGGGTCCTGCGTGCCCCGAAGGCGGGCCCGCACCTGCTCGACGCCATGCTCCGGCCCACCCCCAGGGCCCTTGAGCTGCTCCCTGAATTCATCGAGTCCGGCGAGGTGCGGATGGAGGCGGTCCTGCTGCGGCGCCGTGACGGTGTCGCGTACCTGACCCTGTGCCGGGACGACTGCCTCAACGCCGAGGACGCGCAGCAGGTGGACGACATGGAGACCGCAGTCGACCTGGCGCTGCTCGACCCCCAGGTCCGGGTGGGGCTCCTGCGGGGCGGCGAGATGAGCCATCCCCGGTACCGGGGGCGCCGGGTGTTCTGCGCGGGCGTCAACCTCAAGAAGCTGAGCTCGGGCGACATCTCCCTCGTCGACTTCCTCCTACGGCGCGAGCTGGGCTACATCCACAAGATCGTTCGCGGCGTGTACACGGACGGTTCGTGGCACTCGAAGCTGACCGACAAGCCCTGGATGGCGGTCGTCGACTCCTTCGCCATCGGCGGTGGGGCTCAGCTCCTCCTGGTCTTCGACCAGGTGCTGGCGGCGTCCGACTCCTACATCAGCCTGCCTGCGGCGACGGAGGGGATCATTCCGGGGGTCGCGAACTACCGGCTCACCCGGTTCACCGGGCCACGCGCGGCCCGGCAGATGATCCTCGGCGGGCGGCGGATCCGGGCGGACGAGCCGGACGCACGGTTGATGATCGACGAGGTCGTCCCGCCGGAGGAGATGGACGCGGCGATCGATCGCGCACTGGCCCGCCTCGACGGAGATGCGGTGCCGGCCAACCGGCGCATGCTGAACCTGGCCGAGGAGCCGCCCGAGGCGTTCGGCCGGTACCTGGCCGAGTTCGCCCTGCAGCAGGCACTGCGCATCTACGGCAGGGACGTCATCGGCAAGGTCGGCAGGTTCGCAGCGGGATCGGCATGA	MTTDWPALPPRAPLALWTLTAEAQRVDDLLAGLPEPPARTSAQRDAAASALDKVRRMRADYMEAHAEEIYGELTSGRTRHLRIDELVRAAARAYPGLVPTDEQMAAERARPQAEKEGREIDQGIFLRGVLRAPKAGPHLLDAMLRPTPRALELLPEFIESGEVRMEAVLLRRRDGVAYLTLCRDDCLNAEDAQQVDDMETAVDLALLDPQVRVGLLRGGEMSHPRYRGRRVFCAGVNLKKLSSGDISLVDFLLRRELGYIHKIVRGVYTDGSWHSKLTDKPWMAVVDSFAIGGGAQLLLVFDQVLAASDSYISLPAATEGIIPGVANYRLTRFTGPRAARQMILGGRRIRADEPDARLMIDEVVPPEEMDAAIDRALARLDGDAVPANRRMLNLAEEPPEAFGRYLAEFALQQALRIYGRDVIGKVGRFAAGSA	MKRRNFSVGMAFSAFGFSAIFPKKSFALGEQGQMTAVFQQLEAKAQGRLGVHVIDTATGHEFGYRSDELFMMLSSFKLLASALVLARADRGEESLTRRIRYRKQDLVPWSPVTEAYADGEGLTLAQLCHATITTSDNTAGNLILASYGGPQALTQYARQLGDKITRLDRNEPDLNTRVEGGSLDTTSPRAMAMTMNKLLLGDALSPLSRNLLRQWLLENTTGGKRLKAGTPADWTVGDKTGTNKTDANDIGILLPPQGAPVLVTAYLADSTASSQIKDATLAEVGRLTSIGIR	148.12	gnl|BL_ORD_ID|4169|hsp_num:0	5239			321	636	
BGC0000289.1|A40926_35 # 67871 # 68668 # 1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.690	BGC0000289.1|A40926_35 	67871	68668	+	Loose	1650	28.4906	Brucella suis mprF	54.17	3003772	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGAGCGAGCCTCGCGTGCGCTACGAGAAGAAGGAACACGTCGCCCATGTGACGATGAACCGGCCCCACGTGCTGAACGCGATGGATCGCCGGATGCACGAGGAGCTCGCCGAGATCTGGGACGACGTCGAGGCCGACGACGACGTCAGGACGGTCGTCCTGACCGGTGCGGGAACGCGGGCCTTCTCCGTCGGCCAGGACCTCAAGGAACGCGCGCTGCTGGACGAGGCGGGCACGCAGGCCTCGACGTTCGGCAGCCGGGGGCAGGCAGGTCATCCCCGGCTGACCGACCGCTTCACCTTGTCCAAGCCGGTGGTCGCCCGGGTGCACGGCTACGCGCTGGGTGGCGGCTTCGAGCTGGTGCTCGCCTGCGACCTCGTCATCGCCTCCGAGGAGGCGGTGTTCGGCCTGCCGGAGGTCCGGCTCGGCCTGATCCCCGGGGCGGGAGGCGTGTTCCGGCTGCCGCGGCAGCTGCCGCAGAAGGTGGCGATGGGCCATCTGCTGACCGGGCGCCGGATGGATGCGGCCACGGCGTTCCGGTACGGATTGGTGAACGAGGTCGTACCGCTTGATGAGCTGGATCGGTGCGTGGCCGGATGGACCGACGACCTCGTACGCGCCGCTCCGCTGTCTGTTCGCGCGATCAAGGAGGCCGCCATGCGGTCGCTCGACATTCCCCTGGAGGAGGCGTTCACCACGTCCTACCCATGGGAAGAGCGTCGTCGGCGTAGCGGCGATGCGATCGAGGGCGTCCGGGCGTTCGTCGAGAAGAGGGACCCGGTCTGGACGTCGAGATGA	MSEPRVRYEKKEHVAHVTMNRPHVLNAMDRRMHEELAEIWDDVEADDDVRTVVLTGAGTRAFSVGQDLKERALLDEAGTQASTFGSRGQAGHPRLTDRFTLSKPVVARVHGYALGGGFELVLACDLVIASEEAVFGLPEVRLGLIPGAGGVFRLPRQLPQKVAMGHLLTGRRMDAATAFRYGLVNEVVPLDELDRCVAGWTDDLVRAAPLSVRAIKEAAMRSLDIPLEEAFTTSYPWEERRRRSGDAIEGVRAFVEKRDPVWTSR	MLWWDDISMSLIDDEIPSSQPQVSGRHFGWLKQYQHFLFPIAGIAIALLAIYVLENLLRHTSRTETLAALHNISWTTLALAVFFTALSYAAVALYDVVAVDTIAPNQIPRRIAAVAGAAGYAISNALGFSLLTGGALRYRIYAAEGISLADIGKIVGTSWFAIWFALIIMVGAALLIDPQDVPFLSAIDIRIDIVAGILILGGIGWLIYWLSHGERNVSIGSFSLRLPNSKGALTQIFAGVVDVGAAAATLYVLLPEGAVPSFAVFALVYVIAIVLGIASHAPGGLGAFEATIIAGLGLGGKPDAIAGLLAYRLIYTVLPLVVATAGILIWEVMRRRHMLDKQARFAKRLVEPLVPGLSASIIFLGGIILLISGATPDMRYRVKLLSDIVPEFLVEMSHLAASLVGVALLIVARGLSKRLERAWVAAMVLLLCGAVFSIAKGLDWEEASILCLFALSLWGFRDSFYRRPIAGPFELSWNWIATVGTTVLVSTWLGFFVYRHIEYSSDLWWDFAWNGNAPRFLRATVLVFAVVAAVGLHSIINRHGQRRRKVDHSIPDAVPALVARCPHTDAALAMLGDKQFLLAPDDSAFIMYAQSGGSLIALGEPIGDAEAGKELAWSFHSLADRLALRTVFYGVGPQSLPLFLDMGLIALKLGEVARVDLTDFSLEGPRRQPFRYADRKVDKDGLTFEIIPAADVPPLIPRLRAISDAWLDHKSGSEKGFSLGYFNDEYLKRFDIAVLKKDGEIVAFANIWRGADKYEITVDLMRYMPNVHKLLMDALFAKLLTFSKQEGYKWFNLGAAPLSGLSGSRLASRWNRFGSFIYRRGADLYHFDGLKAFKEKFDPVWTPHYMVCPGGLETPRALLDATTLINGSPLEFIRK	30.11	gnl|BL_ORD_ID|2057|hsp_num:0	2281			2469	2541	defensin
BGC0000289.1|A40926_36 # 68665 # 69951 # 1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.706	BGC0000289.1|A40926_36 	68665	69951	+	Loose	1080	59.6918	rosB	26.2	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGATCCCCCCGCACACGTTGCTGGTCTTCTTCGTTCAGGCTGCGGCCCTCCTGCTGCTCGCGTTGCTCCTGGGCCGCCTGGCCGTACGGCTGGGCCTGGCGGCGGTCGTCGGCGAACTGTGTGCCGGCGTCATCCTCGGCCCCTCCGTGCTGGGGCAGGTCGCGCCCGGGGCGGAGCAGTGGCTGTTTCCCTCGCCGTCGTCACACATGCTGGACGCCGTCGGGCAGCTCGGCGTGTTGTTGCTGATCGGCTTGACGGGCGCGCATCTGGATCTGCGGCTGATCCGGCGGCAGGGCGCCACGGCGGTGCGGGTGAGCGCCTTCGGGTTGGTCGTGCCGATGGCCCTCGGCATCGGCGCCGGCCTGTTGCTGCCGGCCGAGTTCCGCGGGACCGGCGGCTCGGCCGTCTTCGCCCTGTTCCTGGGGGTGACGATGTGTGTCAGCTCGATCCCCGTGATCGCCAAGACGCTGATGGACATGAACCTGCTCCATCGCAACGTCGGCCAGCTCACGCTGACCGCCGGCATGATCGACGACGCCTTCGGGTGGGTGCTGCTTTCGGTGGTGACGGCGATGGCCACCGCCGGAGCCGGTGCGGGGACCGTGGTGCTGTCGATCGCGTCGCTGCTCGGGGTGATCGTCTTCAGCGTCGTCATCGGCAGGCCGGCGGTCCGGGTGGCGTTGCGGACGACGGAGGATCAGGGGGTGATCGCCGGCCAGGTCGTGGTGCTGGTGCTCGCGGCCGCGGCCGGGACGCATGCGCTGGGCCTCGAACCGATCTTCGGGGCCTTCGTCGCCGGGCTGCTGGTGAGCACGGCCATGCCGAATCCGGTCAGACTGGCACCGCTGCGCACGGTGACGCTCGGGGTGCTGGCTCCCCTCTATTTCGCCACCATGGGCCTGCGCGTCGATCTCACGGCCCTGGCGCGGCCGGAGGTGCTCGCCGTGGGGCTGCTGGTCCTGGCCCTGGCGATCATCGGCAAGTTCCTGGGCGCCTTCCTGGGCGCCTGGACCAGCCGGCTCAGCCGATGGGAGGCCTTGGCGCTGGGGGCGGGGATGAACGCCCGTGGCGTCATCCAGATGATCGTGGCGACGGTCGGCCTGCGGCTGGGGGTGATCACTGACGAGATCTTCACGATCATCATCGTGGTGGCGGTGATCACCTCTCTGCTCGCCCCGCCACTCCTGCGCCTGGCCATGACCAGGATCGAGGCCACCGCCGAGGAGGAGGCCCGCCTCCTCGCCTACGGGCTGCGCCCCGGCGAGGCCCGGGAAGACGTACGGTGA	MIPPHTLLVFFVQAAALLLLALLLGRLAVRLGLAAVVGELCAGVILGPSVLGQVAPGAEQWLFPSPSSHMLDAVGQLGVLLLIGLTGAHLDLRLIRRQGATAVRVSAFGLVVPMALGIGAGLLLPAEFRGTGGSAVFALFLGVTMCVSSIPVIAKTLMDMNLLHRNVGQLTLTAGMIDDAFGWVLLSVVTAMATAGAGAGTVVLSIASLLGVIVFSVVIGRPAVRVALRTTEDQGVIAGQVVVLVLAAAAGTHALGLEPIFGAFVAGLLVSTAMPNPVRLAPLRTVTLGVLAPLYFATMGLRVDLTALARPEVLAVGLLVLALAIIGKFLGAFLGAWTSRLSRWEALALGAGMNARGVIQMIVATVGLRLGVITDEIFTIIIVVAVITSLLAPPLLRLAMTRIEATAEEEARLLAYGLRPGEAREDVR	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	76.02	gnl|BL_ORD_ID|466|hsp_num:0	507			42	1185	polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4
BGC0000289.1|A40926_37 # 70018 # 70794 # -1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.696	BGC0000289.1|A40926_37 	70018	70794	-	Loose	575	26.9498	SPU-1	25.68	3006998	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPU beta-lactamase	ATGAGGCCGAAGCGAGGCTACATGTCCACCTGGTTTCGGTGTTTCGACAGGCGGCCGCTCGCCACGATGCGGCTGATCTGTTTTCCGCACGCGGGCGGTTCGGCGGTCTTCTACCGGAATTGGCACCGGCTGGCCGCGCCGGAGATAGAAGTGCACGCGGTTCAGTATCCGGGCCGCGCCGACCGGTTGCACGAACCCCTCGTCGGTGATGCCCACCGGCTCGCGGAGTCGGTGGGGCGTGAGCTGAGGCCGCTCCTCGACCGGCCGGTGGCGCTGTTCGGGCACAGTATGGGCAGTTTGATCGCTTACGAGACGGCGCGGCTTCTCACCGGGTCCGGTATCCCGCCGGCTCATCTCTTCGTCTCCGGAGGTGTGGCCGCGCACGACCGTGGCCGTCTCGCGCATCGGGTGGCGCCGGCCTCCGAGGAGGCGCTCATCGACAGGCTGCGCCTGTTGGGCGGCACCGATGCCGAGGCGCTCGCGAGCGCGGAGTTCCGGGCGTTCGCCCTCCCCTACGTGCGCAACGACTTCCAGCTCGTCCAGTCCTACCGCCACACGCCTGGGCCGCCCCTGACGGTGCCGATCACGGCGTTCACCGGTGCGGACGATCCCGTCGTACGGCTCGACGCGGTCGCGCGATGGGCCGAGTTGACGGCTCGGGAGTTCTCCTGCCACGTCCTGCCCGGAGGCCACTTCTTCCTGGGGCACGAGCAGGCTGCTCTGTGGGCGCACCTGCACGCGCGGCTGGGCATCGCGACCCCGGCCCACTGTGGCTGA	MRPKRGYMSTWFRCFDRRPLATMRLICFPHAGGSAVFYRNWHRLAAPEIEVHAVQYPGRADRLHEPLVGDAHRLAESVGRELRPLLDRPVALFGHSMGSLIAYETARLLTGSGIPPAHLFVSGGVAAHDRGRLAHRVAPASEEALIDRLRLLGGTDAEALASAEFRAFALPYVRNDFQLVQSYRHTPGPPLTVPITAFTGADDPVVRLDAVARWAELTAREFSCHVLPGGHFFLGHEQAALWAHLHARLGIATPAHCG	MKKYFSFCLLGIFIFCFSQQNLKRDITKIIQGKNALVAVSVMNSKGKTEVNINGNKKVPMLSVFKFHIALAVLDLVDRGILDLEQNIFVKKSELLENTWSPIRDKYPNGNVNIPLREIIEHTVSQSDNNGCDILLRLIGGVDTVQKFIESKGIKDFAIKYNEEEMNKNGKSIYSNYTTANASSRLLQKFYNGEIISESSRDFLFRIMYETSTGADRLISLLPPDVIVAHKTGTSGIVSGIQAATNDVGIIILPDDEYYTISVFVINSKENTSTNEKIIADISKTVWDYYFQNK	88.05	gnl|BL_ORD_ID|4593|hsp_num:0	5663			258	480	
BGC0000289.1|A40926_38 # 70998 # 72227 # 1 # ID=1_38;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.672	BGC0000289.1|A40926_38 	70998	72227	+	Loose	2000	26.5646	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	30.95	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGGACCCGGCCATCGAGTCGATGAATCTACTGAACGAGATTGCCGGCAACTACCCCGACGCCATTTCCATGGCCGCGGGCCGGCCGTACGAGGAGTTCTTCGACGTCGGCCTCATCCACGACTATCTGGAGGCCTACCGCGACCATCTCCGCAACGACCGGCGGATGGATGACGCCGGGATCAGCCGCATGCTTTTCCAATACGGGACCACGAAGGGGATCATCTCCGACCTTGTCGCCCGGCACCTCGCCGAGGACGAGAACATCGAGGCCGACCCGGCCTCCGTGGTCATCACTGTGGGCTTCCAGGAGGCCATGTTCCTGGTGCTTCGCGCGCTGCGAGCGAACGAGCGGGACGTCCTGCTCGCCCCCACGCCCACCTACGTCGGCCTGACCGGAGCGGCGCTGCTCACCGACACCCCTGTCTGGCCGGTCCAGTCCACCGACAACGGCATCGACCTCGACCACCTTGAGCACCAACTGAAACGCGCCCAGGACCAGGGCGCCCGGGTCCGGGCCTGCTACGTGACCCCGAACTTCGCCAACCCCACCGGCACCAGCATGGACCTGCCCGCCCGCCATCGCCTCCTGGAGGTCGCCGCGGCCCACGGCATCCTGATCCTGGAGGACAACGCGTACGGACTCCTCGGCCAGGACCGCCTCCCCACGCTGAAGTCCCTCGACCATGCGGCGACCGTCGTCTACCTCGGCTCCTTCGCCAAGACCGGCATGCCCGGCGCCCGGGTCGGCTACGTCGTGGCGGACCAGCACGTAGCGGGGGGCGGCTCGCTCGCCGACGAGCTCGCGAAGCTCAAGGGCATGCTCACCGTGAACACCTCGCCCATCGCCCAGGCGGTGATCGCCGGCAAGCTGCTGCGCCACGACTTCAGCCTGGCCCGGGCCAACGCCCGCGAGACCGCCATCTACCAGCGCAACCTCCACCTCACGCTGGACGAACTCACCCGCCGGCTCGGCGCCGTCCCGGGAGTCACCTGGAACGCGCCGACGGGCGGGTTCTTCATCACCGTCACCGTGCCCTTCGTCGTGGATGACGAGCTGTTGGAACACGCTGCCCGCGATCATGGCGTTTTGTTCACGCCGATGCATCACTTCTATGGTGGGAAGGATGGGTTCAACCAGCTTCGGCTGTCGATCAGCCTGCTCAACCCGCAACTGATCGAGGAGGGTGTCTCCCGGCTTGCCGGGCTCGTCACCGCATGTCTCCCCTGA	MDPAIESMNLLNEIAGNYPDAISMAAGRPYEEFFDVGLIHDYLEAYRDHLRNDRRMDDAGISRMLFQYGTTKGIISDLVARHLAEDENIEADPASVVITVGFQEAMFLVLRALRANERDVLLAPTPTYVGLTGAALLTDTPVWPVQSTDNGIDLDHLEHQLKRAQDQGARVRACYVTPNFANPTGTSMDLPARHRLLEVAAAHGILILEDNAYGLLGQDRLPTLKSLDHAATVVYLGSFAKTGMPGARVGYVVADQHVAGGGSLADELAKLKGMLTVNTSPIAQAVIAGKLLRHDFSLARANARETAIYQRNLHLTLDELTRRLGAVPGVTWNAPTGGFFITVTVPFVVDDELLEHAARDHGVLFTPMHHFYGGKDGFNQLRLSISLLNPQLIEEGVSRLAGLVTACLP	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	34.49	gnl|BL_ORD_ID|4719|hsp_num:0	2914			2064	2316	rifampin
BGC0000289.1|A40926_39 # 72261 # 72461 # 1 # ID=1_39;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.687	BGC0000289.1|A40926_39 	72261	72461	+	Loose	710	21.557	tet(35)	30.77	3000481	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	TTGCGTGCGGCCGGGATGAAGGTCAACCACAAGCGGGTGGTGCGCGAGCACGGCCTCGCCGGGCGGTGGCCAGCGACCAAGGCCTCGACAAACGCCATCGCCGACCCTCCCGAGGGAGGATCGGCGGTTGAAGATCTGTGTGCCCCCTGCAGGATTCGAACCTGCGCACCCGGCTCCGGAGGCCGGTGCTCTATCCCCTGA	MRAAGMKVNHKRVVREHGLAGRWPATKASTNAIADPPEGGSAVEDLCAPCRIRTCAPGSGGRCSIP	MCVIMPASSWGAYIITIIGGILVSHGITEYSALGAYVRLIPMNFYAVFALLMVFAVAWFGLDIGKMREHEIAASQGRGFDKDKENDSQEAHDLNEELDIRESEKGKVSDLILPIVTLIVATIASMLYTGGQALAADGKEFVLLGAFENTDVGTSLIYGSLLGLAVALFTVIKQGLPMVEIARTLWIGAKSMFGAILILVFAWTIGSVIGDMKTGSYLSTMAQGNINPHWLPVILFLLSGLMAFSTGTSWGTFGIMLPIAGDMAGATDVALMLPMLSAVLAGAVFGDHCSPISDTTILSSTGARCNHIDHVSTQLPYALSVAFVSCIGFITLGMTASIAFSFIAASITFVIVCAILSWLSKSKMASCQNA	17.89	gnl|BL_ORD_ID|1927|hsp_num:0	1969			837	915	tetracycline
BGC0000289.1|A40926_40 # 72653 # 72973 # 1 # ID=1_40;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.657	BGC0000289.1|A40926_40 	72653	72973	+	Loose	400	78.9518	vanR gene in vanF cluster	36.17	3002925	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGAACCTGAACCTGGAGGGGTTCGAGGTCGTGACCGCCACGGATGGGCAGGACTGTCTGGATCGGGTGCGGGACGTCATGCCCGATGTCATCACGCTTGATGTGATGATGCCGTTCCTGGACGGGTGGACGACGGCGCAGCGGTTGCGGGCGGAGGAGGACACCAGTCACATCAAGGTGGTGCTGATCACGGCCAGGGCGCAGGACGACGACAAGATCCGGGGGTGGGGGATCGGGGTGGACGCGTATCTGACCAAGCCCTTCGATCCGGCTGAGTTGATCGAGGTGGTGCGGGAGCTGGCGGCTGGGGCGCGGGGGTGA	MNLNLEGFEVVTATDGQDCLDRVRDVMPDVITLDVMMPFLDGWTTAQRLRAEEDTSHIKVVLITARAQDDDKIRGWGIGVDAYLTKPFDPAELIEVVRELAAGARG	MKNITILIADDDAEIADLVAIHLEKEGYRVIKVSDGQETIDVIQNQPIDLLILDIMMPKMDGFEVTRRIREKHNMPIIFLSAKTSDFDKVQGLVIGADDYMTKPFIPIELVARVNAQLRRFMKLNQPKTKQNSNLEFGGLTISPEQRTVTLYGKNIELTPKEFEILFLLASNPNKVYRAEDIFQKVWGDAYYEGGNTVMVHIRTLRKKLEEDKRKNKLIQTVWGVGYKFNG	45.89	gnl|BL_ORD_ID|298|hsp_num:0	240			60	333	vancomycin
BGC0000289.1|A40926_41 # 73121 # 73789 # 1 # ID=1_41;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.680	BGC0000289.1|A40926_41 	73121	73789	+	Loose	1000	25.409	MCR-8.3	29.55	3007227	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	GTGCGTAGTTCGGTCTTTCGGAATCTCGATCCGCAGCAGTTGCCTCCGGGGTTCGCGCTTGAGAACGGCAAGATGCTGCGGGTCCAGCTCCCGCACGAGGTGCTGGCCAAGCAGGGGTCCATGGTCGCCTTCCAGGGGCGGATGGACTTCGACTACGAGGGCTCCGGCGGCATCGGGAAGATGTTCAAGAAGGCCATGACGGGTGAGGGCGCCTCGCTGATGCGGGTGCGTGGTGAAGGGCTGCTCTACCTGGCCGACAACGCCGACGACATCCACCTGTTCTACCTGGAGAACGAGGGGATCACGGTCAACGGGCGCAACCTGCTGGCCTTCCAGCCGCAGCTCACCTGGGACATCCAGCGGGTTCAGGGGGCCGGGATGGCGGCCGGTGGGCTGTTCAACACCACGGTGACGGGGACCGGGTGGGTGGCGGTGACCACGCATGGCACGCCGGTGCTGCTGGATGCGGCGCGCATGCCGACCTTCGCGGACGGGCAGTCGGCTGTGTGCTGGAGCGCGGGGTTGCAGGTCGGGGTCAATCGGACGTTGAAGGCGGGGGCGCTGATCGGGCGGGGGAGCGGGGAGGCCATGCAGCTGGCGTTCACGGGGCAGGGGTTCGTGCTGGTGCAGGCCAGTGAGGGGGCTCCTGTGGTGCAGGCGGCCCGTTGA	MRSSVFRNLDPQQLPPGFALENGKMLRVQLPHEVLAKQGSMVAFQGRMDFDYEGSGGIGKMFKKAMTGEGASLMRVRGEGLLYLADNADDIHLFYLENEGITVNGRNLLAFQPQLTWDIQRVQGAGMAAGGLFNTTVTGTGWVAVTTHGTPVLLDAARMPTFADGQSAVCWSAGLQVGVNRTLKAGALIGRGSGEAMQLAFTGQGFVLVQASEGAPVVQAAR	MFKYLLSFKLNPVQRTWAAAFFFTTIGNIALWQTLWINVDVHNIHNLLFFASLPIFLFCFLSILLTPVMVIPYLCRPLLVVLILISACCSYFMMKYNILIDRSMVQNFFETNQAELTSYLSVPFLSTLFLLGIVPAIILALPSTDNKRGAFRIELWWLAHICIAVVLLAMVTMVFYKDYASLIRNNMQIKDQALPFNFVRNTNGYLKRKYQASSTILQSVGEDAVRPIYSNAPPKLVVVVVGETARAQNFQLNGYSRVTNPYLSRRHDVISFKNVSSCGTATAISLPCMFSRMSRNEYNEVRAASEENLLDILKRTGVEVLWRNNNNGGCKGICKRVPTDDMPAMKVIGECVNKDGTCFDEVLLNQLSSRINAMQGDALIVLHQMGSHGPKYFERYPSTSKVFSPTCDSNLIEKCSNKELVNTYDNTLVYTDRMLSKTIELLQRYSGMRDVAMIYLSDHGESLGESGIYLHGTPYIIAPNEQTHIPMFMWFSSSFAQHSKLNLECLTGNADKQYSHDNFYHSILGLFNVKTSVYKPELDMFTLCRQSDHTPLSSAVVREKTDGNG	39.29	gnl|BL_ORD_ID|4835|hsp_num:0	5832			36	168	colistin A; colistin B
BGC0000289.1|A40926_42 # 73786 # 74286 # 1 # ID=1_42;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707	BGC0000289.1|A40926_42 	73786	74286	+	Loose	700	25.7942	ugd	41.94	3003577	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	TTGAGCGCGAAGGCGTCGCCGTACGCCGCCTACGAGCGTCTGATCGCCGACCTGGACGCCGCAGGAGCGCGGTACAGGCTGATCGACCACGCGCCCGAGGGCCGTACCGAGCAGGTCAGCGCGTTGCGCGGGCACGACGTGGCGCAGGCGGCCAAGTGCCTGATCGTGATGGTCAAGATCGGCAAGAAGCGGACCAGGCACGTGCTGGCCGTCGTCCCCGGCGACGCGCGCCTCGATCTGCAGGCGGTCAAGGCGCTGCTCGACGGCACGTACGTGGCCTTCGCCGGCACGGAGAAGGCCGAGGAGCTGGCGGGCAGCGTGAGCGGGACCGTGCTCCCGTTCAGCTACGACCCCCGGCTCGAGCTGGTCGCGGATCCGTCCCTGCTGGACCAGCCCGAGCTGTACTTCAACGCTGCCAGGCTCGACCGCTCCGTGGCGCTCGCCACCGCCGACTACGTACGGCTGGCGGCACCCCGCGTGGCACCCATCACGAGCAACTAG	MSAKASPYAAYERLIADLDAAGARYRLIDHAPEGRTEQVSALRGHDVAQAAKCLIVMVKIGKKRTRHVLAVVPGDARLDLQAVKALLDGTYVAFAGTEKAEELAGSVSGTVLPFSYDPRLELVADPSLLDQPELYFNAARLDRSVALATADYVRLAAPRVAPITSN	MKITISGTGYVGLSNGLLIAQNHEVVALDILPSRVAMLNDRISPIVDKEIQQFLQSDKIHFNATLDKNEAYRDADYVIIATPTDYDPKTNYFNTSSVESVIKDVVEINPYAVMVIKSTVPVGFTAAMHKKYRTENIIFSPEFLREGKALYDNLHPSRIVIGERSERAERFAALLQEGAIKQNIPMLFTDSTEAEAIKLFANTYLAMRVAYFNELDSYAESLGLNSRQIIEGVCLDPRIGNHYNNPSFGYGGYCLPKDTKQLLANYQSVPNNLISAIVDANRTRKDFIADAILSRKPQVVGIYRLIMKSGSDNFRASSIQGIMKRIKAKGVEVIIYEPVMKEDSFFNSRLERDLATFKQQADVIISNRMAEELKDVADKVYTRDLFGSD	42.78	gnl|BL_ORD_ID|894|hsp_num:0	842			156	246	polymyxin B
BGC0000289.1|A40926_44 # 75464 # 76294 # -1 # ID=1_44;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.753	BGC0000289.1|A40926_44 	75464	76294	-	Loose	565	27.335	AAC(3)-IIe	40.48	3004621	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGATCATCGTCGGTGTGGACGGCTCCCGTACCGGGCTGGAGGCCGCCGGCTGGGCCGCCGCCGAGGCCCAGCTGCGTCAGGAGCCGCTGACCGTGGCGCACGCCGTGCCGAAGTGGGTGTGCGAGGGCGCCGTCCGCTACGCCGAGGTGGCCCAGTGGATGCGCGACGGCGCCGAGACCGTGCTCAACGCCGCCTGCGACCGCGCGCGACGGGTGTGGCCGCAGGTGTCCATGGAAGGCGTGTTGCTGCCGGGCGACCCCCGCTCGGCGCTGGTCAAGGCCTCGGAGGGGGCCACGCTGCTGGTCGTGGGCAGCCGCGGGATCGGCGGGGTGCGGGGCCTGCTCGTCGGGTCGGTCGCGTACGGGGTGGCGGCGCACGCGCCTACGAACGTCATCCTGATCCACGACCCGCCCGCTGCCCCGCGCGCGGAGGTCGTCGCGGGCACCGACGGGTCGCCCTGCGCCGCGCGGGCGATGGAGTTCGCCTTCGCCGAGGCCGAGCTGCGCGGCGCGCGGCTGCGTGCCGTGCAGGCGTGGGCCTGGCCCCATCCCGGCGGCTTCGAGCCGGCCTCCCGTGAGAGCGAGCAGGACACGCTGCGTTCCCTGAAGGAGTCGCTGAGCGTGCACCGGGAGCGGCACCCCGGCGTGCACGTGGTGGCCGAGGTGGTGCACGGGCATCCGGTGGAGGTGCTCAAGGAAGCCGCCAGGCGCGCCGACCTGCTGGTGGTGGGCTCGCGCGGGCACGGGCAGCTCGCGGGCATGCTCATCGGCTCCATCAGCCAGGGCCTGCTGCACCATGCCCCGTGCCCGATGGCGGTGGTGCGCGGCTGA	MIIVGVDGSRTGLEAAGWAAAEAQLRQEPLTVAHAVPKWVCEGAVRYAEVAQWMRDGAETVLNAACDRARRVWPQVSMEGVLLPGDPRSALVKASEGATLLVVGSRGIGGVRGLLVGSVAYGVAAHAPTNVILIHDPPAAPRAEVVAGTDGSPCAARAMEFAFAEAELRGARLRAVQAWAWPHPGGFEPASRESEQDTLRSLKESLSVHRERHPGVHVVAEVVHGHPVEVLKEAARRADLLVVGSRGHGQLAGMLIGSISQGLLHHAPCPMAVVRG	MHTRKAITEAIRKFGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYASWDRSPYEETLNGARLDDKARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASMVAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPNKRWVTYEMPMLGRNGEVAWKTASEYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGVVGFAQCYLFDAQDIVTFGVTYLEKHFGATPIVPAQKAAQRSCEPSG	96.50	gnl|BL_ORD_ID|2080|hsp_num:0	3321			174	273	dibekacin; sisomicin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; 2'-N-ethylnetilmicin; gentamicin
BGC0000289.1|A40926_45 # 76291 # 76641 # -1 # ID=1_45;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=3bp;gc_cont=0.692	BGC0000289.1|A40926_45 	76291	76641	-	Loose	500	25.0238	CTX-M-8	36.11	3001871	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGAAGAGATTCGCCGCTGTCGCAGGACTACTCGTCGTGATGGCCGCGTCCGGCGCCACCGCCGCCGCCGGGGACGGCATGGATCAGCACGAAGTCAGCCAGGAACAGTACGACACTCTGATCGCCCAGTGCCGCTACGCCGACACGGGGAAGGCGAAGTGCCGTGCGGCGGTCAAGCGCATGTACCGCGTCGGCCGGACCGACCCGACGCTCGACTGCCGGACGTACTCCGGCGTGACCGTCTGCGGCACGCTCCGGCTCAGCAAGGCCGAGCGCCGATGCGCCCGCGACTCCGAGGCGCAGGGGCTGCCGTTCCGCCGCGCCGAGGTGGAATGTTACGCACTGTCATGA	MKRFAAVAGLLVVMAASGATAAAGDGMDQHEVSQEQYDTLIAQCRYADTGKAKCRAAVKRMYRVGRTDPTLDCRTYSGVTVCGTLRLSKAERRCARDSEAQGLPFRRAEVECYALS	MMRHRVKRMMLMTTACISLLLGSAPLYAQANDVQQKLAALEKSSGGRLGVALIDTADNAQTLYRADERFAMCSTSKVMAAAAVLKQSETQKKVLSQKVEIKSSDLINYNPITEKHVNGTMTLAELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARAIGDNTFRLDRTEPTLNTAIPGDPRDTTTPLAMAQTLRNLTLGSALGETQRAQLVTWLKGNTTGAASIQAGLPTSWVVGDKTGSGDYGTTNDIAVIWPEGRAPLILVTYFTQPEQKAESRRDVLAAAAKIVTDGY	39.86	gnl|BL_ORD_ID|673|hsp_num:0	729			414	522	
BGC0000289.1|A40926_47 # 78519 # 78878 # 1 # ID=1_47;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.686	BGC0000289.1|A40926_47 	78519	78878	+	Loose	700	23.8682	ADC-135	35.9	3006310	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	ATGTCGATCAGAACTCGTGCGGCGGCCGTCGCCGCGGCGTCCGTCGTCGCCGCAGGGCTCGCCGCCACCCCGGCCGCCGCGGACGTGCACCGGGGCGTGGCCGGGTGCTTCGCCTGGTCCTGGGGTGACGGCAACACCTCGGTGACCGTGTACTGGCACAACCGCTGCAGGACCAAGCACAAGATCACCATCAAGTACAGCCTGAGCTGGACCTACAAGACCTACACGGCCACCGTCGGCGGCAATGGCAAGGGGCACAAGAAGTTCCAGACCGCCTCGATCGTGTCCATCAAGGACAGCGGCCGGGCCTACCCGGCAGCGTCTCTGCCGCCGATGGGGGCCAGCACCTCGCCCGTGTAG	MSIRTRAAAVAAASVVAAGLAATPAAADVHRGVAGCFAWSWGDGNTSVTVYWHNRCRTKHKITIKYSLSWTYKTYTATVGGNGKGHKKFQTASIVSIKDSGRAYPAASLPPMGASTSPV	MRFNKISCLLLSPLFIFNTSIYAENTPKEQEIKKLVDQNFKPLLEKYDVPGMAVGIIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGIISFKDTPGKYWKELKNTPIDQVNLLQLATYTSGNLGLQFPDEVQTNQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFVNANLNPQKYPADIQRAINETHQGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKSNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKQNIGLVMLTNKRIPNEERIKAAYAVLNAIKK	31.07	gnl|BL_ORD_ID|3168|hsp_num:0	4206			249	348	
BGC0000289.1|A40926_48 # 78827 # 79678 # -1 # ID=1_48;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.697	BGC0000289.1|A40926_48 	78827	79678	-	Loose	450	54.299	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	25.0	3004045	protein variant model	G93A	I47T:1574	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGTCGCAAACACCACCACCGCAGAACCAGCCCTACCCCGGCCACACCGGCGAGATGGCGCCAGAGCCGCGCGACGAGATGCGCGACTACGTGGGCCGCGCCCTGCTCGACGGCAAGAAGGCACTGATCACCGGCGGTGACTCGGGCATCGGGCGGGCGGTCGCGGTGGCGTTCGCCAAGGAGGGCGCGGACGTCGCGATCGCGTACCTGACCGAGCACGAGGACGCTGCGCACACGCGCAAGCTGGTCGAGCAGGCGGGGCGGCGCTGTGTGCTGCTGCCCGGCGACCTGGCCGACCGCGCCCACTGCTCCTCGGTCGTCGAGCAGGCGGTCTCCGAGCTGGGCGGCCTGGACGTGCTGGTGAACAACGTGGCCTACCAGGCGCCGGTGAGCGGCCTGGAGGAGCTGGACGACGAGCAGTGGGAGCACACGTTCGCGGTCAACATCCACAGCTACTACCGCGTCACGAAGGCCGCGCTCGCGCATCTGCGCGAGGGCGCGGCCATCGTGAACACCTCGTCGATCAACGGCCTGCGCGGCAACAAGTCGCTCATCGACTACGCCGCCACCAAGGGCGCCATCAACGCCTTCACCTACTCCATGGCGCAGAACCTGGTCGAGCGCGGCATCCGCGTGAACGCCGTCGCGCCGGGCCCGGTGTGGACGCCGCTGATCCCGGCGACGATGCCGGAGGAGAAGGTGGAGAAGTTCGGCAAGCAGGTGCCGATGGGGCGGGCGGCCGATCCGGACGAGATCGCCCCGTCGTATGTGTTCTTCGCCTCGAACCGGCTGTCGTCGTACTACACGGGCGAGGTGCTGGCCCCCATCGGCGGCAGAGACGCTGCCGGGTAG	MSQTPPPQNQPYPGHTGEMAPEPRDEMRDYVGRALLDGKKALITGGDSGIGRAVAVAFAKEGADVAIAYLTEHEDAAHTRKLVEQAGRRCVLLPGDLADRAHCSSVVEQAVSELGGLDVLVNNVAYQAPVSGLEELDDEQWEHTFAVNIHSYYRVTKAALAHLREGAAIVNTSSINGLRGNKSLIDYAATKGAINAFTYSMAQNLVERGIRVNAVAPGPVWTPLIPATMPEEKVEKFGKQVPMGRAADPDEIAPSYVFFASNRLSSYYTGEVLAPIGGRDAAG	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	108.02	gnl|BL_ORD_ID|4712|hsp_num:0	2666			6	750	triclosan
BGC0000289.1|A40926_50 # 80666 # 81442 # -1 # ID=1_50;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	BGC0000289.1|A40926_50 	80666	81442	-	Loose	500	25.409	SPG-1	28.21	3003720	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPG beta-lactamase	GTGACGGTCGAGAGCGCGGCGGCCAAGGAGGCGACCACCCCGGAGCCCCGGATCGGGCGGTCGTGGCACGTCGTCCTGCCCCCGCTGTGCTACCTGGCCGTCGCGGTGGCGATGGTCGCCTACACGCAGATCGTGCCGCTCGACAGCATCGAACGCGGCTCGCTGAACCTGCCGTTCCTGCTCAGGCGCACGTGGGAGCACATCCAGCTGGTGTTCTTCTCCACCGTGCTGGTGCTGGTGGTGGCGCTGCCGCTGGGCGTGCTGCTGACCAGGCGGGCGCTGCGCCGGGCCACCCCGGTCGTGCTGGCCCTGGTGAACCTGGGCCAGGCCACCCCGGCGGTGGGCCTGGTGGTGCTGCTGGCGGTGCTGTTCAGCATCGGGTTCTGGACGGCGGTGGCCGCACTGTTCGCCTACAGCCTGCTGCCCACGCTGCGCAACACCATGGTGGGCATCGAGCAGGTGGACCCACGGCTGGTGGACGCGGGCCGGGGCATCGGCATGTCGGCGGCGGGGGTGCTGTTCAAGGTGGAGCTGCCGATGGCGGTGCCGGTCATCCTGTCGGGCGTGCGGACCACGCTGGTGCTGAACGTGGGCACGGCCGGCATCGCGGCGTTCATCGGCTCCGGCGGGCTCGGCGATCTGATCACCGCGGGAGTGAGCACGCAGCGCAACCTGGTCCTGATCACCGGATGCGTGCTGATCGCGGTGCTCGCGCTGATCATCGACTGGCTGGGCGGGCTCGCGCAGCGCTACCTGTCGCCGAAGGGGCTGGCGTGA	MTVESAAAKEATTPEPRIGRSWHVVLPPLCYLAVAVAMVAYTQIVPLDSIERGSLNLPFLLRRTWEHIQLVFFSTVLVLVVALPLGVLLTRRALRRATPVVLALVNLGQATPAVGLVVLLAVLFSIGFWTAVAALFAYSLLPTLRNTMVGIEQVDPRLVDAGRGIGMSAAGVLFKVELPMAVPVILSGVRTTLVLNVGTAGIAAFIGSGGLGDLITAGVSTQRNLVLITGCVLIAVLALIIDWLGGLAQRYLSPKGLA	MRPLILLASALAMTAPSGALAQSAEQRAKWNGPREPFRITGNLYYVGTSGLSAYLIAGPRGHVLIDGALPESAPLIAANIRKLGFKLSDVKYLLSNHSHVDHAGGLAELKRLTGAQMVANVADKPDLEAGTTIGRTDIADFPAVKVDRVIGDGDRLTLGPIALVAILTPGHTKGATSWTTRIGSKNVIFTSSISVAGQNLINNINYPNAAADFRASFAKLRALKADIFLSFHAEAFALDEKRARAQAGATDAFVDPNELSRQVDLAEKAFDATLAKQQAANADRR	90.53	gnl|BL_ORD_ID|2032|hsp_num:0	2235			6	240	
BGC0000289.1|A40926_51 # 81439 # 82614 # -1 # ID=1_51;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.719	BGC0000289.1|A40926_51 	81439	82614	-	Loose	570	117.472	bcrA	34.6	3002987	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGGCTGAGCAGGCCACCGGCGGCGTGCCGATCGAGCTGCGCAAGGTGACCAAGGCGTTCCCCGGCGGCGGCGAGCCGGCCGTCCAGGAGCTGGACCTGAACATCCCGGCAGGCGAGATCGTGGTCCTGCTCGGCCCCTCGGGCTGCGGCAAGACGACCACCATGCGCATGATCAACCGCCTGATCGAGCCGTCCTCCGGCGACATCCTCATCGGCGGCCAGAACTCCCGCGACATCGACCCCGACCGCCTGCGCAGGCACATCGGCTACGTGATCCAGCAGGCCGGCCTGTTCCCGCACATGACGGTCGCGGCCAACATCGCCCAGGTCCCGAAGATGCTCGGCTGGGAGCGCGGGCGCGTCGCCGAGCGCGTGGACGAGCTGCTCACGCTCGTGGGCCTGGACCCTGGAACGTTCCGGGAGAGCTACCCGCGCCGGCTGTCCGGCGGCCAGCAGCAGCGGGTCGGCGTGGCCAGGGCGCTGGCCGCCGACCCGCCCGTGCTGCTCATGGACGAGCCGTTCGGCGCCCTCGACCCCATCAGCCGCGAGCGCATCCAGGACGAGTTGCTGCGGCTGCAGGAAGAGCTGGCCAAGACGATCGTCTTCGTCACCCACGACGTGGACGAGGCGCTCAAGCTCGGCGACCACATCGCCATCATGCAGCGGCCCGGGCACGTCGTGCAGTACGCCAGACCCGCCGAGATCCTCACGAACCCGGCCAGCGACTACGTCGAGCAGTTCCTCGGCGGCGGCTCCTCGATGCGGCTGCTGCGCCTGACTCAGGTGGGCGACATCGAGCTGGACGCGGTGCCGTACGCGTCGGAGGACATGGACGCCCGCGACCTGCTGCGCGAGGTGGAGCTGGACGGCCGCGGCTACGCGCTGATCCTCGACGGCATGCGCCGCCCGCTCAGGTGGGTCACCCAGGCGGCGCTCGAAGGCGTGCACGGCCCGGTCGGCCCGGCCGGCGACCCGATCACGGGCTCCATCGGCCACCGCATGACCCTTCAGGACGCCCTGGAGACGCTGCTCAACGCCGACACCGACTTCCTGCCGGTGCTGAGCAGGCGCCGGGCGTACGCGGGGGCGCTGTCGCTGGCCACGGTGCAGAACGCGATCCAGGCCATCAAGGCCCGCGAGCGGGAGCGCCGCCTGCGCAGGGGCGAGGCGCGGTGA	MAEQATGGVPIELRKVTKAFPGGGEPAVQELDLNIPAGEIVVLLGPSGCGKTTTMRMINRLIEPSSGDILIGGQNSRDIDPDRLRRHIGYVIQQAGLFPHMTVAANIAQVPKMLGWERGRVAERVDELLTLVGLDPGTFRESYPRRLSGGQQQRVGVARALAADPPVLLMDEPFGALDPISRERIQDELLRLQEELAKTIVFVTHDVDEALKLGDHIAIMQRPGHVVQYARPAEILTNPASDYVEQFLGGGSSMRLLRLTQVGDIELDAVPYASEDMDARDLLREVELDGRGYALILDGMRRPLRWVTQAALEGVHGPVGPAGDPITGSIGHRMTLQDALETLLNADTDFLPVLSRRRAYAGALSLATVQNAIQAIKARERERRLRRGEAR	MSTIIKTTDLTKMYGSQKSVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQIEIFGENFFKNKKEILRRIGSIVEVPGFYANLTARENLLINAKIIGIHKKNAIDEVLEIVGLQHETKKLVGKFSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGIKEMRRLIHSLAKERNITIFISSHILSEIEQLVDHVGIIHEGKLLEEIPFDHLKKRNRKYLEFQLSDQNKAVVLMEQHFDIHDYEVHQDGIIRVYSHLGQQGKLNKLFVENGIDVLKITMSEDSLEDYFVKLIGGGTIG	127.78	gnl|BL_ORD_ID|315|hsp_num:0	345			12	621	bacitracin; bacitracin A; bacitracin B; bacitracin F
BGC0000289.1|A40926_52 # 82607 # 83341 # -1 # ID=1_52;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.694	BGC0000289.1|A40926_52 	82607	83341	-	Loose	700	26.5646	Klebsiella pneumoniae OmpK37	29.31	3004122	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	reduced permeability to antibiotic	General Bacterial Porin with reduced permeability to beta-lactams	GTGTTCACCGAATCAAAACATGGGGATCAGGGTGACTGGTGTGGCGTTTTGGGGTTGACCATCACGGTTAAGTTCACGGGGATGAACCTGTGGGAGTACATCGAGGACCGATGGGACCTCATCGTCTTCGAGACCGTGCAGCACGCCAGCATGGTCGCCCAGTGCGTGCTGGTCGCGACCGTCCTCGGCGTGCTGGTCGGCGTGGCCACCTACCGCCGCCCCAGGCCGTCGGCCTTCGCCACGGCGGTGGCGGGGGTGCTGTTCACGATCCCGTCGCTGGCCATGCTCGGCCTGCTGATCCCGCCACTCGGCCTCGGGGTGGCGCCGAGCGTGACCGCGATCGTGCTGTACGCGCTGCTGCCGATCATCCGCAACACCGTGGTGGGCCTGCGCGGCGTGGACCCGGCGCTGGTCGACGCCGCGCGTGGGATCGGCATGAGCCGCCACAGGTCGCTCACCAGGGTGGAGCTCTCGCTGGCCTGGCCGGTGATCCTGACGGGCATCAGGGTCGCCACGCAGCTCGCGATGGGCATCGCCGCCGTGGCCGCCTACGTCTCGGGCCCCGGCCTGGGCGAGCAGATCTTCTCGGGCCTGGCCAGGCTGGGCGGCGCGAACGCGGTCAACTCCACCCTGACCGGCACCATCGGGGTGGCGATCCTGGCGCTGCTCTTCGACGGCTGCTTCGTCCTGCTCGGGAAGCTCACCACGCCGGGCACGGGAGCCGTCCGTGGCTGA	MFTESKHGDQGDWCGVLGLTITVKFTGMNLWEYIEDRWDLIVFETVQHASMVAQCVLVATVLGVLVGVATYRRPRPSAFATAVAGVLFTIPSLAMLGLLIPPLGLGVAPSVTAIVLYALLPIIRNTVVGLRGVDPALVDAARGIGMSRHRSLTRVELSLAWPVILTGIRVATQLAMGIAAVAAYVSGPGLGEQIFSGLARLGGANAVNSTLTGTIGVAILALLFDGCFVLLGKLTTPGTGAVRG	MKRKVLALVIPALLAAGAAHAAEIYNKDGNKLDLYGKVDGLHYFSSDSKKDGDQTYLRFGFKGETQINDILTGYGQWEYNVQANNTETSSDQAWTRLAFAGIKVGDYGSFDYGRNYGVLYDVEGWTDILPEFGGDSYTYADNFMAGRANGVATYRNSDFFGLVEGLNFALQYQGKNEGQNAQDINVGTNNRSSDSDVRFDNGDGFGLSTSYDFGMGISAAAAYTSSDRTNDQMTQTNARGDKAEAWTAGLKYDANDIYLATMYSETRNMTPYGNDGVANKTQNFEVTAQYQFDFGLRPAISYLQSKGKDLYNNGRYADKDLVKYMDVGATYYFNRNMSTYVDYKINLLDGNDKFYEDNGISTDNIVALGLVYQF	65.24	gnl|BL_ORD_ID|2625|hsp_num:0	2785			615	789	cefoxitin; cefotaxime
